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ABSTRACT
Infectious bursal disease virus (IBDV) has a tropism for the lymphoid tissue of poultry and
infects actively dividing and differentiating B-lymphocytes in the bursa of Fabricius. This
results in a high mortality rate and severe immunosuppression. These immunodepressed
chickens are highly susceptible to secondary infections and have a reduced capacity to respond
to vaccination. The principal method to control IBDV is through extensive vaccination using
either attenuated live or inactivated IBDV vaccines. However, in recent years due to the
emergence of new virulent strains, risk of reversion to pathogenicity, cost considerations and
intervention by maternal antibodies, the effectiveness of these vaccines in the veterinary field
is being reduced. An alternative approach to prevent infection is by interfering with the
binding of IBDV to its receptor protein on the surface of bursal cells. Hence this study was
undertaken on the characterisation of a possible IBDV receptor on bursal membranes.
Infectious bursal disease virus was isolated from infected bursal tissue using CsCl density
gradient centrifugation and visualised with Tris-Tricine sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS-PAGE) and transmission electron microscopy.
Following purification of double stranded RNA from infected bursal tissue and commercially
available live IBDV vaccines, a polymerase chain reaction (PCR)-based diagnostic assay
based on sequences from the highly conserved viral protein (VP2) region was performed. The
presence of the virus was demonstrated by the amplification of a 150 bp band in 2% agarose
and 15% nondenaturing PAGE gels. The correctness of this product was confirmed by
restriction digestion with a specific restriction endonuclease (BamHI) that resulted in the
predicted digestion fragments of 93 and 57 bp.
Following preparation of bursal membrane proteins from uninfected bursal tissue, usmg
sucrose density gradient centrifugation, isolation of IBDV receptor protein was carried out by
immobilising IBDV on a Sepharose 4B chromatography matrix. After affinity purification,
two prominent protein bands around 40 kDa were visualised using a silver stained Tris-Tricine
.SDS-PAGE gel. Previous work in this laboratory identified two possible IBDV receptor
proteins on bursal membranes of 32 and 40 kDa. Antibodies against peptide sequences derived
from the 32 kDa receptor protein were raised in rabbits in the present study. These anti-IBDV
11
receptor peptide antibodies recognised the affinity purified native 40 kDa IBDV receptor
proteins in an enzyme-linked immunosorbent assay (ELISA). However, due to the possible
epitope denaturation by the reducing treatment buffer prior to Tris-Tricine SDS-PAGE such as
SDS and 2-mercapthethanol or detergent (Na-deoxycholate) used during the affinity
purification of the IBDV receptor protein, the anti-IBDV receptor peptide antibody did not
recognise the receptor protein on a western blot.
An inhibition assay was performed in an ELISA format by ooating the 40 kDa IBDV receptor
protein to see if the anti-IBDV receptor peptide antibody could inhibit IBDV binding to the
receptor. The result showed that the anti-IBDV receptor peptide antibody effectively inhibited
the binding of IBDV to the receptor. This result could pave the way for reducing IBDV
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Infectious bursal disease virus (IBDV) was first discovered in chickens by Cosgrove in 1962
in the Gumboro area of the Southern Delaware, USA (Mcllroy et al., 1992; Yamaguchi et al.,
1997). Because of its origin, further outbreaks were _subsequently known as 'Gumboro
disease'. The virus infects most prominently the bursa of Fabricius, thus the current name of
the disease. This tropism for the-bursa was confirmed by electron microscopy analysis, which
detected large numbers of virions in the bursa of infected birds (Murphy et al., 1999). Based
on its structure/morphology, IBDV was temporarily classified as a picornavirus, adenovirus or
orbivirus, until the essential structural features of the cloned virus were determined that
showed significant homology with infectious pancreatic necrosis virus (IPNV) (Becht, 1994).
Like IPNV and DrosophilaX virus, IBDV belongs to the family of Birnaviridae (Lejal et al.,
2000).
Infectious bursal disease (IBD) is a highly transmittable disease of young chickens, typically
in the age between two and eight weeks, with mortality rates up to 80% (Mundt and Muller,
1995). The virus replicates in the developing bursa of Fabricius, thymus, spleen and coecal
tonsils of young birds and causes severe B-cell depletion by inducing apoptosis, resulting in
severely immunodepressed chickens. For that reason chickens are highly susceptible to
secondary infections and have a reduced capacity to respond to vaccination (Boot et al.,
2000b). The acute form is characterised by sudden onset, short course and extensive
destruction of lymphocytes particularly in the bursa of Fabricius and also in other lymphoid
tissue (Jordan, 1990).
Economically IBDV is a very important viral disease throughout the world, which results in
mortality and heavy financial losses to the poultry industry (Baxendale, 1981; Pitcovski et al.,
1996). Direct economic losses can be as a result of high mortality rates due to an acute course
of the disease. The indirect impact of the disease is due to the virus-induced
immunosuppression and/or potential interactions between IBDV and other viruses, bacteria or
parasites. These indirect losses induce growth retardation and condemnation of carcasses at
the slaughterhouse. Furthermore, the increased use of antibiotics against the secondary
infections constitutes a growing public health concern (van den Berg et al., 2000).
The first option for IBDV control is vaccination using either attenuated live or inactivated
IBDV vaccines (Amakye-Anim et al., 2000). Using a series of live attenuated and killed
commercial vaccines the disease was successfully controlled until the late 1980's (Brown and
Skinner, 1996). However, as a consequence of the appearance of new virulent variants
resulting in heavy outbreaks of the disease worldwide, the effectiveness of these vaccines has
decreased (Muller et al., 1992; Pitcovski et al., 1999). Since 1987 a growing number of acute
cases of IBDV with high mortality have been reported in many European countries (Bumstead
et al., 1993), Asia (Mandeville et al., 2000) and Africa (Brown and Skinner, 1996). The latest
emergence of the highly virulent strains of IBDV in Europe and the United Kingdom made
IBDV a major problem in the poultry industry and the need for the development of a new
vaccine has become critical (Bayliss et al., 1991).
1.2 Geographical distribution of infectious bursal disease virus
Three years after the first case of IBD was diagnosed in the Gumboro area of Delaware, USA,
the virus was detected in other regions of the USA, and very soon appeared in the United
Kingdom and Western Europe (Lasher and Davis, 1997; Sainsbury, 2000). From 1962 to
1974, the disease was identified in the Middle East, Southern and Western Africa India the, ,
Far East and Australia (van den Berg et al., 2000).
Outbreaks of "very virulent" IBDV strains with high mortality rates have been gradually
increasing (Fernandez-Arias et al., 1997). In 1987 a pathogenic variant of IBDV appeared in
the Benelux countries and spread rapidly through Europe including the United Kingdom
(Bayliss et al., 1991), Germany (yamaguchi et al., 1996a) and France (Eterradossi et al.,
1992). The term "very virulent" (VV) was used for the IBDV strain as it caused high flock
mortalities up to 70% for pullets, 25% for broilers and 100% for specific pathogen free birds
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(SPF), (Lim et al., 1999). Based on pathological data, VV IBDV appears to have reached
South Africa by 1989 and Poland by 1991 (Brown and Skinner, 1996). Since the late eighties,
outbreaks of newly evolved viral strains have caused significant economic losses to the
poultry industry in China (Lim et al., 1999) and Japan (Nunoya et al., 1992; Lin et al., 1993).
Unreliable reports indicate that the pathogenic variant may also be present in the Middle East,
Asia and in Central Africa but have not been identified in Northern, Central or South America
and Australia (Mandeville et al., 2000).
1.3 Taxonomy and classification of IBDV
Infectious bursal disease virus belongs to the family Birnaviridae, which gets its name from
their bi-segmented RNA (Porterfield, 1989). This family is made up of three genera:
Avibirnavirus, Aquabirnavirus and Entomobirnavirus. The genus Aquabirnavirus includes
IPNV of salmonid fish and viruses of oysters and crabs. Viruses that infect only insects belong
to the genus Entomobirnavirus (Murphy et al., 1999) while the virus infecting chickens,
belongs to the genus Avibirnavirus (Brown et al., 1994).
Infectious bursal disease VIruS IS nonenveloped, icosahedral VIruS made up of 132
morphological subunits with a diameter of 60 to 70 nm (Spies et al., 1987; Granzow et al.,
1997; Schroder et al., 2000). The single shell capsid has a thickness of ca 9 nm, with 780
subunits clustered as 260 outer trimers, arranged with a triangulation number of T=13. This
arrangement of IBDV was confirmed by cryoelectron microscopy and image processing
analysis (Caston et al., 2001). At the outer radii between 31 and 33 nm, the comparative
arrangements of trimers produce a honeycomb like structure on the surface of the virus. At
inner radii between 26 and 30 nm, the trimers have a triangular or V-shaped pattern and
arrange more closely to form a continuous shell. The subunits adjacent to the five-fold axes lie
at a larger radius from the core of the particle than those perform around the three- or two-fold
axes, giving the capsid a markedly nonspherical shape (Bottcher et al., 1997).
There are currently two different serotypes of IBDV, namely serotype I and n. Serotype I,
which is a wild type, isolate is pathogenic for chickens, while serotype n isolates, which are
mainly from turkeys are considered as non-pathogenic for chickens (Boot et al., 2000b). Viral
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strains may also be classified according to their virulence i.e. mortality and bursal lesion.
Serotype I strains can be divided into four groups: classical virulent strains, attenuated strains,
antigenic variant strains and very virulent strains. Classical virulent strains can cause bursal
inflammation and severe lymphoid necrosis, which results in immunodeficiency and moderate
mortality rates (20 to 30% in SPF chickens). Antigenic variant strains have the ability to
escape cross neutralisation by antisera against classical strains. Unlike classical strains, variant
strains are characterised by severe atrophy of the bursa without showing inflammation..
Attenuated strains, which are made by adapting the classical and variant strains to chicken
embryo fibroblast (CEF) cells or other cell lines through serial passage, do not cause disease in
chickens and some of them are therefore being used as livevaccines (Lim et al., 1999).
1.4 Stability of the virus
Infectious bursal disease virus is reasonably resistant to environmental factors such as extreme
pH, temperature, a wide range of chemical treatments, photodynamic and DV radiation
(Lasher and Davis, 1997). The study by Alexander and Chettle (1998) confirmed that IBDV is
extremely resistant to temperatures up to 80°C for 1 min. In an early study Cho and Edgar
(1969) showed that after the virus was exposed to 60°C for 90 min, it retained nearly 100% of
its infectivity in live birds. In a prior study infectivity of the virus was analysed following
exposure of the virus at 56°C for 5 h and no difference in infectivity was found in comparison
to the control (Benton et al., 1967). It is difficult to achieve consistent denaturation of IBDV
either by heat denaturation or heat in the presence of dimethylsulfoxide. Consequently for the
purposes of translation and reverse transcription, the genetic material has to be heated in the
presence of methyl mercuric hydroxide. It was found that the melting temperature of the
dsRNA in the presence of 150 mM NaCI is 95.5°C (Davis and Boyle, 1990).
Despite its resistance to temperature, infectivity can be reduced by treatment of the virus with
1% formalin and 1% phenol or cresol for 1 h (Becht, 1994). Although infectivity is not
affected at pH 2, the virus is totally inactivated in sodium hydroxide at pH > 12. It is also
sensitive to iodinated and chlorinated derivatives, to formaldehyde and glutaraldehyde (van
den Berg et al., 2000). However, it is resistant to organic solvents and can remain active in the
environment for at least 4 months (Jordan, 1990).
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1.5 Modes of transmission and progression of the disease
Mode of transmission is horizontal via the faecal-oral route (Sharma et al., 2000). The virus is
extremely resistant; it can continue to live in feed and in pens for over seven weeks and four
months respectively. Since usual cleaning and sterilisation measures often do not lead to
elimination of the virus from contaminated premises, indirect transmission through water,
contaminated feed, dust, litter, clothing or mechanical spread via insects may reintroduce the
virus. Vertical transmission probably occurs via the egg. However, there is no evidence that
older birds act as carriers or that the virus is egg transmitted. Meal worms and litter mites have
been found infected with the virus eight weeks after an outbreak of disease in chickens on the
premises and could be important in the transmission of infection. Due to the stability of the
virus outside the host, fomites are also of significance; wild birds and vermin perhaps act as
mechanical carriers. Some reports also stated that the virus could directly spread through air or
imported by migratory bird species (Jordan, 1990; Ogawa et al., 1998a).
A kinetic study using immunofluorescence showed that four hours after oral inoculation the
virus is found in the lymphoid tissues related with the digestive tract, where the first cycle of
viral replication occurs. The virus then enters the circulatory system via the hepatic portal
vein. A phase of primary viraema proceed, during which the virus reaches the bursa, 11 hours
after infection, and major secondary replication cycle occurs (van den Berg et al., 2000).
1.6 Host range
Infectious bursal disease virus affects chickens from different avian species (Sanchez and
Rodriguez, 1999). The virus has been shown to occur wherever poultry are kept intensively.
Although there was no strong evidence that the virus affected birds other than fowl, turkeys
have been found to be susceptible even if ten years earlier they were not (Baxendale, 1981).
The serotypes determine the host range of the virus. Only chickens (Gallus gallus) develop
IBD following infection by serotype I viruses. The pekin duck (Cairina moschata) and the
turkey (Meleagris gallopavo) may be asymptomatic carriers of serotype I and IT respectively.
Anti-IBDV antibodies have been identified in common pheasants (Phastanus colchicus),
guinea fowl (Numida meleogris), and ostriches (Struthio camelus), which also appear to carry
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serotype IT viruses. Neutralisation and precipitating antibodies have also confirmed the
presence of the virus in various species of wild duck, goose, tern, puffin, crow and penguin
(van den Berg et al., 2000). The virus has also been isolated from mealworms (Andrewes et al.
1978), mites, mosquitoes (Porterfield, 1989), and ducks (Murphy et al., 1995).
1.7 Economic impact offfinV
Since the emergence of the VV strains in the late 1980's, IBDV has become a pathogen of
considerable economic interest to the poultry industry worldwide (Yehuda et al., 1999). Due
to its severe immunosuppressive effect in young chickens, IBDV causes mortality and heavy
financial losses to the poultry industry. Until 1987 most of the IBDV infections were sub-
clinical, with insignificant financial losses due to impaired growth and acquired
immunodeficiency. However, the emergence of a highly virulent strain of serotype I IBDV
(HV-IBDV) in 1987 in the Netherlands and Belgium caused high mortality not only in young
chickens but also in older birds (Yamaguchi et al., 1997). The best way to control the virus is
by vaccination using live attenuated or inactivated vaccines. However, despite the
implementation of bio-securitj measures and the intensive use of vaccines, the virus still
causes substantial economic losses (Hassan and Saif, 1996).
1.8 Bursa of Fabricius
The bursa was discovered by Hieronymus Fabricius in 1621. Its function was not clear until
Bruce Glick (1956) revealed that it plays an important role in the production of antibody
(Pllard, 1967). This was confirmed using chickens with surgically removed bursa, which
failed to produce antibodies following immunisation with the Salmonella typhimurium 0
antigen. The bursa is a sac-like lymphatic organ situated dorsal to the cloaca in the caudal
body cavity (Fig. 1.1) (Nieminen et al., 2001).
The small subset of B-cell which survive the selection during apoptosis and emigrating to the
peripheral lymphoid organ has been shown to express high levels of B-L (a chicken major
histocompatibility complex (MHC) class IT molecule) and ChIl2, a 38-40 kDa alloantigen also
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expressed by a range of thymocytes, peripheral T-cells and haematopoietic precursors
(Lampisuo et al., 1998).
1.9 Clinical signs of IBD
Newly introduced IBDV can increase morbidity to approximately 100% and mortality may be
up to 90%. The disease is most severe in young chickens especially at age three to six weeks,
when the bursa of Fabricius reaches its maximal stage of development. However, due to the
presence of maternal antibodies chicks between the ages of 1 to 14 days are less sensitive.
Although they produce antibodies to the virus, birds older than six weeks hardly show signs of
disease (Murphy et al., 1999). Two or three days after infection birds usually show clinical
signs such as anorexia, huddling, lack of co-ordination, severe depression, prostration and
white or watery diarrhea (Andrewes et al., 1978; Sainsbury, 2000). Ruffling of feathers with a
messy flock appearance are also clinical signs of IBDV infection. Normally infection is
followed by a sharp increase in temperature within two days and a high death rate two or three
days later followed by a rapid decline so that the course of the disease is about seven or eight
days. In less acute forms no symptoms are observed. However, due to their severe
immunosuppressive effect, these sub-clinical infections are economically important
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Figure 1.1 Anatomy and structure of the avian bursa of Fabricius. (a) Cross-section of the bursa of
Fabricius. The bursa with a highly folded surface surrounding the central lumen is connected to the intestine by
the bursal duct. The lymphoid follicles are positioned within the longitudinal plicae. In total, the bursa contains
around 10000 follicles. The follicular-associated epithelium (FAE), is situated inbetween the bursal medulla and
lumen. (b) Avian B-cell development. The para-aortic mesenchyme is the origin for the progenitor cells seeding
the bursal primordium. Before bursal colonisation, the perbursal 'stem cells' are committed to the B-ce1llinage.
Inside the bursal follicles the surface immunoglobulin-expressing bursal stem cells start to divide and diversify
their immunoglobulin V genes. The proliferating bursal B cells are densely packed in the cortical (C) part of the
bursal follicles and the loosely packed lymphocytes and stromal cells are mainly contained in the medulla (M).
Although following hatching, the diversified B-cells start to emigrate from the bursa, more than 95% of bursal
cells die by apoptosis. By gene conversion and somatic hypermutation, postbursal B cells can further modify their
immunoglobulin gene specificity within the peripheral lymphoid organs. However, the peripheral lymphoid
organs cannot replace the important function of the bursa as a mutant-generating organ (after Nieminen et al.,
2001).
1.10 Pathogenesis of IBDV
Infectious bursal disease virus causes more extensive lymphoid cell necrosis in the bursa
although lymphoid organs such as thymus, spleen, coeca1 tonsil and Harderian glands may
show various degrees of lymphoid cell necrosis (A1amsyan et al., 1993). Depending on their
degree of pathogenicity IBDV strains induce lesions in the coeca1 tonsils, thymus, spleen and
bone marrow. For that reason VV IBDV strains cause more severe thymic atrophy, greater
. lymphoid cell depletion in the coeca1 tonsil and spleen, and greater hematopoietic cell
depletion in bone marrow than attenuated strains (Tanimura et al., 1995).
After two days of infection the bursa becomes congested and oedematous. This becomes
noticeable four days later. The acute form is characterised by severe inflammation of the
mucosa and yellow transudate on the serosal surface. This is followed by an increase in size of
the bursa (it becomes twice the normal size), and gradual fading of 1ymphocytes, proliferating
reticulendothe1ia cells and intrafollicu1ar oedema with central necrosis (Porterfie1d, 1989).
Pathological examinations revealed bursal and thymus necrosis, pancytopenic bone marrow,
followed by acute hepatitis, aplastic anaemia and functional abnormality of the liver
(Nakamura et al., 1992). Death is characterised by bursal atrophy and gray, enlarged kidneys,
with accumulation of urates due to dehydration and immune complexes in the glomeruli
(Murphy et al., 1999).
Infectious bursal disease virus infection is characterised by morphological and biochemical
features of apoptosis in chicken embryo fibrob1asts and chicken peripheral blood 1ymphocytes
(Tanimura and Sharma, 1998). Apoptosis is an individual and active type of cell death that is
accompanied by nuclear fragmentation and cellular breakdown into apoptotic vesicles. There
is no release of cellular components into the interstices and no inflammation surrounding the
dead cells, which are characteristics of necrosis. Although pathological stimuli, such as viral
infections, can also be the triggering factors, this type ofcellular self-destruction is usually
initiated by physiological stimuli such as maturation of lymphoid cells, metamorphosis,
organogenesis, and during hormone or growth factor removal-induced involution
(Vasconcelos and Lam, 1994; Vasconce10s and Lam, 1995; Rou1ston et al., 1999). Despite the
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above understanding the mechanism by which these events are triggered, regulated and
coordinated is poorly understood (Hara et al., 1996).
The initial stage of apoptosis is characterised by cell shrinkage and disconnection from the
adjacent cells. The reduction of the mitochondrial transmembrane potential, and activation of
the caspase proteolytic signalling cascades are also indications of an early event in the
apoptotic pathway. Subsequently the apoptotic cells undergo extensive membrane blebbing,
and chromatin condensing (Tham and Moon, 1996). Membrane blebbing is associated with an
unfolding of the lipid bilayer leaflets and exposure of phosphatidylserine residues. The
chromatin condensation induces nuclear fragmentation by activating an endogenous
endonuclease that cleaves genomic DNA at internucleosomal sites. Such DNA degradation
has become a unique characteristic of apoptosis. In the final stages of apoptosis, the cell
fragments, which form apoptotic bodies, are eliminated by macrophages to prevent the extra-
cellular leakage of cellular constituents and the development of an inflammatory response
(Tham and Moon, 1996; Compton and Wickliffe, 1999).
Developing B-cell populations in the bursa of Fabricius have been reported to be highly
susceptible to programmed cell death (Neiman et al., 1991). Since the replication of IBDV
specifically takes place in developing B-Iymphoid cells in the bursa of Fabricius, the
replicating IBDV induces apoptosis, which leads to a rapid reduction in the number ofB- cells
(Boot et a!., 2000b). Although the mechanism of IBDV-induced apoptosis remains unknown,
two viral proteins (vp2 and VP5) have been suspected to play a major role in the induction of
apoptosis (Jungmann et al., 2001).
1.11 Virus receptorsite
The viral receptor is the structure on the surface of a cell membrane to which a virus binds
prior to crossing the membrane barrier and enter the cell. The presence or absence of a viral
receptor determines whether a specific cell can be infected by a specific virus (Lentz, 1990).
There are also membrane structures on cell surfaces to which a virus binds, but they do not
serve as receptors for viral entry into the cell. However, viral binding to such sites could have
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other biologically important consequences, such as cellular metabolism induced by surface
structures or the generation of an immune response against the virus. The identity of a receptor
is usually determined by measuring the biological effect of receptor-virus binding in a
biologically relevant manner (Tradieu et al., 1982). Three major criteria, derived from models
of ligand-receptor interactions, need to be satisfied by a potential receptor protein, i.e.
saturability, specificity, and competition as elaborated on below.
Saturability. During interaction of viral particles with receptor sites only a limited number of
sites will be available for viral binding. Therefore viral binding can continue until no further
binding sites are available (saturation point). This can be confirmed experimentally by
determining viral binding as a function of increasing viral concentration (Tradieu et al., 1982).
Specificity. Specificity can only be confirmed according to "biologic parameters". That is
viruses can only bind to host cells with specific receptors for the virus or to cells where viral
binding induces some other biologically measurable response. Although most viruses bind to
cells in a biologically relevant manner or with specificity, a certain proportion of viral binding
is non-specific and unrelated to specific viral receptors. The nonspecific component contained
in any binding curve is usually not saturable and therefore it is a linear function, which can be
measured, and subsequently subtracted from total binding to reveal "specific" binding
(Tradieu et al., 1982).
Competition. It should be possible to inhibit specific viral binding competitively using a
second ligand, which has the affinity to bind to the same receptor. In neuropharmacology, for
example, specific binding of acetylcholine to muscarinicacetylcholine receptor can be blocked
by atropine. Such types of specific blockers are usually unavailable in viral systems and
blocking can only be accomplished by the binding of radio-Iabeled virus with unlabeled virus
or ifpossible, the viral attachment protein (Tradieu et al., 1982; Lentz, 1990).
Due to the fact that virus particles can adhere to many substances, including inert materials,
identification of virus receptors has proved to be very difficult, especially to differentiate
between non-specific and biologically relevant binding. Non-specific binding of viruses to cell
surfaces can be mediated through electrostatic interactions. During internalisation of solutes
and small particles via fluid-phase or constitutive endocytosis, there is a possibility that some
non-specific viruses might be internalised through this non-specific mechanism. Another
major problem, which makes receptor identification very difficult, is availability of specific
virus receptors in low numbers on the cell surface. There is also a possibility that some viruses
can use more than one type ofreceptor (Lentz, 1990).
Until the mid 1980s the only virus receptor that was clearly identified was sialic acid for the
myxoviruses and paramyxoviruses. However, many more virus receptors have since been
identified due to advances in technology, and the list is rapidly growing (Haywood, 1994). For
example, sialyloligosaccharides are receptors for influenza virus and phosphatidylserine and
phosphatidylinositol are receptors for vesiCular stomatitis virus (VSV). The CD4 molecule is a
receptor for human immunodeficiency virus type one (HIV- 1) (Borrow and Oldstone, 1992),
the C3d receptor, CR2, for Epstein-Barr virus (Roberts et al., 1996), the acetylcholine receptor
for rabies virus (Gastka et al., 1996) and foot and mouth disease virus (FMDV) uses RGD-
dependent integrins as receptors (Jackson et al., 2000).
A flow cytometric virus-binding assay showed that most of the cells, which bound IBDV,
were surface immunoglobulin M (SIgM)-positive (Ogawa et al., 1998b). Treatment of the
cells with proteases and N-glycosylation inhibitors appeared to affect the binding of IBDV to
the LSCC-BKJ cells. This finding revealed that the IBDV host range is mainly controlled by
the presence of a virus receptor composed ofN-giycosylated proteins (Ogawa et al., 1998b).
Results of Nieper and Muller (1996) showed that IBDV serotypes I and II specifically bound
to proteins of 40 kDa and 46 kDa exposed on the surface of lymphoid cells. This result was
proved by competition experiments, which indicated that these proteins might represent the
common receptor sites ofIBDV.
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1.11.1 Identification of receptor
A useful screening procedure is the virus overlay protein blot assay (VOPBA) (Haywoodet
aI., 1994). In this technique membrane proteins are separated by sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to a nitrocellulose
membrane. Membrane strips are incubated with the virus and viruses bound to the receptor are
detected with anti-virus antibody. Visualisation of bound antibodies is done with radio or
enzyme labelled secondary antibodies (Dalziel et al., 1991). Prior to SDS-PAGE analysis,
membrane proteins should be carefully purified to remove associated components such as
lipids by using detergent. For carbohydrate receptor identification, glycolipids can be
separated by thin-layer chromatography, followed by the virus overlay test for binding
(Haywood et a!., 1994).
1.11.2 Biochemical and immunological approches
Direct purification and biochemical characterisation has been the most frequently used
techniques for identification of various icosahedra1 viral receptors on host cell surfaces. Most
of the purification methods couple viral attachment proteins to an affinity matrix to isolate
specific cell surface receptors. This purification strategy is a powerful technique for the
isolation and purification of specific viral receptors. However, poor affinity for monomeric
virus-receptor complexes in comparison to the multivalent binding which functions in vivo is
the major limitation of this approach (Bass and Greenberg, 1991).
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Two immunological approaches, i.e. anti-cell surface monoc1ona1 antibodies and antiidiotype
antibodies have been used in the study of viral receptors. In both approaches, antibodies are
raised against cell surface epitopes, which are essential for viral binding. Such reagents are
generally selected based on their ability to block viral attachment and infection. However, the
use of these reagents to identify biologically essential receptors can cause production of
antibodies directed against the actual receptor. Antiidiotype antibodies (anti-Id), are based on
the concept that the hypervariable antigen binding sites of antibodies may function as antigens.
Hence an antibody (an anti-Id) against the binding site of an antibody against an antibody,
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against an antigen may be structurally the same as the original antigen (Bass and Greenberg,
1991). If the original antigen is the viral receptor protein, the anti-Id may attach to the anti-












Figure 1.2 Schematic representations of anti-Id production in rabbits. Production of antibody
against the Fab (hypervariable antigen binding) region of the anti-receptor antibody resulted in anti-Id. The
Fab portion of the anti-Id is structurally equivalent to the original antigen, i.e. the receptor protein.
1.12 Viral attachment and penetration
The attachment of the virus particle to the host cell membrane is the initial stage in the viral
infectious life cycle. Attachment is mediated by the interaction of a viral surface protein
(VAP) with a cell surface molecule; such molecules could be proteins, carbohydrates or lipids,
which serve as a virus receptor (Lentz, 1990; Freed and Martin, 1995). Attachment is followed
by a series of events including internalisation, uncoating, replication, and assembly that finally
results in viral replication (Tradieu et al., 1982).
Binding of the virus to the receptor on a host cell triggers the stage of crossing the host
membrane barrier, allowing viruses to enter the host cell by one of two pathways. These are
either direct fusion with the plasma membrane or by adsorptive or receptor mediated
endocytosis (Schneider-Schaulies, 2000). In the adsorptive endocytosis pathway the receptor-
virus complex is internalised in clathrin-coated pits and transported to endosomes. Following
triggering of the acidic interior of the endosomes, a conformational change occurs in the viral
fusion protein. Hydrophobic sequences thus exposed induce fusion of the viral membrane or
virus particles with the endosome membrane, allowing the viral genome to enter the host
cytoplasm. Before fusion can occur, some viruses require proteolytic cleavage of a fusion
protein or haemagglutination protein by a host protease to expose a new hydrophobic N-
terminal region. Similarly, direct fusion of virions with the plasma membrane releases the
genome into the cytoplasm (Fig. 1.3). Many viruses appeared to enter by both mechanisms,












Figure 1.3 Entry of enveloped viruses into cells. The virus particle bears VAPs embedded in its plasma
membrane, which interact with the virus receptor, hence attaching the virion to the cell surface. The virus can
then cross the cell membrane barrier through one of two pathways. The membrane of the virion may fuse directly
with the plasma membrane· releasing the genome into the cytoplasm. Alternatively, the virus particle is
internalised by adsorptive or receptor mediated endocytosis and transported to an endosome. The acidic pH
triggers fusion of the viral membrane with the endosome membrane, thereby releasing the genome (Lentz, 1990).
Surface glycoproteins (G and F) of the human respiratory syncytial virus (HRSV), as with
other members of the family, play an important role in the initial stages of the infectious cycle.
The G and F glycoproteins mediate binding of the virus to an as yet unidentified cell surface
receptor and triggers fusion of the viral and cellular membranes respectively, to allow
transportation of the virus ribonucleoprotein into the host cell cytoplasm. In addition, the F
protein promotes fusion of infected cell membranes with those of neighboring cells resulting
in formation of characteristic syncytia (Garcia-Beato and Melero, 2000). Similar F protein
structures were found in the influenza virus HA, simian parainfluenza virus 5 F, human
immunodeficiency virus (HIV) gp41, mouse moloney leukemia virus envelope transmembrane
protein, and Ebola virus gp2 protein. While structurally different, the tick-borne encephalitis
virus E protein is also functionally analogous (Schneider-Schaulies, 2000). Measles virus
appears to use CD 46 in the process of cell recognition and attachment. Although it lacks
haemagglutinin and neuraminidase activities, respiratory syncytial virus (RSV) has a type two
integral membrane glycoprotein that is believed to mediate attachment. In consequence of
their high carbohydrate content, G proteins are significantly important m pneumoVlrus
attachment (Gonnan et al., 2001).
VP2 and VP3, the major viral proteins of IBDV, are responsible for viral attachment and
penetration into the bursal cells. This was shown by the inhibition of virus attachment to the
susceptible cells using anti-VP3 virus neutralising monoclonal antibody. The amino acid
residue at position 805 was believed to play an important role in receptor-mediated virus cell
attachment, although the recognition site for the monoclonal antibody was not clearly defined.
Two specific amino acid changes in the VP2 region of VV IBDV at positions 279 (Asp to
Asn) and 284 (Ala to Thr) resulted in tissue culture adaptation and attenuation of the virus. It
was supposed that the two amino acid residues were important for virulence of IBDV. Since
these amino acid substitutions were responsible for attenuation of the virus it was speculated
that the amino acid residues might play a significant role in virulence of IBDV as viral
attachment protein (Yamaguchi et al., 1996b). Subsequent work by van Loon et al. (2002)
showed that amino acid residues at positions 279 and 284, in the variable region of VP2 were
responsible for infection of tissue culture. IBDV binding or membranepenetration activates
intracellular signals in chicken embryo fibroblasts. Report by Repp et al. (1998) showed that
the K+ current changes induced by IBDV were not due to virus replication, but were as the
result of IBDV attachment and penetration. This phenomenon may delay the apoptotic process
in CEFs after IBDV infection
1.13 IBDV genome and protein composition
Infectious bursal disease virus has a dsRNA genome that is divided over two segments, the A-
and B-segment. These segments encode five viral proteins namely VPl, VP2, VP3, VP4 and
VP5 (Tacken et al., 2000). The VP2 is the most abundant, making up 51% followed by VP3
(40%), VP4 (6%), and VP1 (3%) (Muller and Becht, 1982; Kibenge et al., 1988). Segment A
(3.2 kb) is made up of two open reading frames (ORFs), namely a long ORF of 3039 bp and a
short ORF of 438 bp, which overlaps with the 5' end of the long ORF (Femandez-Arias et al.,
1997). The smaller ORF, designated ORFA-2, encodes the non-structural viral protein, VP5
consisting of ca 145 amino acid residues (17 kDa) (Tacken et al., 2000). This protein is only
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detected in cytoplasms of IBDV infected cells and not in the virion. It is highly basic, cysteine
rich and conserved among all serotype I IBDV strains (Mundt et al., 1997; Yao et al., 1998).
Although it is important in virus release and dissemination (Lombardo, et al., 2000), its
function is not clearly understood (Barlic-Maganja et al., 2002).
The 110 kDa precursor polyprotein (NH2-VP2-VP4-VP3-COOH), encoded by the larger ORF
of segment A is autoproteolytically cleaved into three proteins: VPX (ca 48 kDa), VP3 (32
kDa) and VP4 (28 kDa) (Dybing and Jackwood, 1998; Schr6der et al., 2001). The VPX (also
known as PVP2) is further proteolytically processed to VP2 (41 kDa) by cleavage near its C-
terminus (Lejal, et al., 2000). VP4, the viral protease, is responsible for the inter-domain
proteolytic autoprocessing of the VP2-VP4-VP3 polyprotein (Birghan et al., 2000). The
dibasic residues Arg 452 - Arg 543 and Lys 722 - Arg 723 are suspected VP2-VP4 and VP4-
VP3 cleavage sites respectively (Yamaguchi et al., 1997).
The proteinacious capsid of the virus is made up of the two major structural proteins VP2 and
VP3 (Da Costa et al., 2002). VP2 possesses the conformational dependent epitopes in its
hypervariable region, which are capable of inducing virus-neutralising antibodies, suggesting
that it is at least partly exposed on the outer surface of the capsid. The second major structural
protein, VP3, contains a very basic carboxy terminus that may interact with the packaged
RNA and is therefore expected to be on the inner surface of the capsid (Tacken et al., 2000).
VP3 forms a complex with VP1; this complex may play an important role in the
morphogenesis ofIBDV (Brandt et aI., 2001).
The B-segment (2.9 kb) contains one large ORF and encodes the RNA dependent RNA
polymerase, the 91 kDa VP1. This protein is believed to be linked to the 5'-ends of the
genomic RNA segments. Although the exact mechanism of replication and transcription of
IBDV is not clearly understood, VPl is reported to be involved in IBDV replication and
transcription (Boot et al., 2000b).
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1.14 Immunology of IBDV
The 32 kDa structural protein (VP3) has been revealed as the major immunogen of IBDV
(Azad et al., 1986). This was confirmed after VP3 electro-eluted from SDS-PAGE gels and
injected into chickens, produced antibodies that neutralised the virus and provided passive
protection (Azad et al., 1987). This was further confirmed after chickens, immunised with
recombinant VP3, expressed as a ,B-galactosidase fusion protein in Escherichia coli, produced
low levels of neutralising antibodies, which gave passive protection. However, similar
preparations ofVP2 did not induce neutralising antibodies (Bayliss et al., 1991).
Western blotting analysis using IBDV antibodies also showed that VP3 was recognised as a
major immunogen (Fahey et al., 1989). However, these experiments were undertaken in the
presence of SDS, which is a powerful denaturating agent (Fahey et al., 1991). This detergent
may destroy important immunogenic sites on the other structural polypeptides of IBDV
(Fahey et al., 1985a; 1985b). This was proved by the finding that neutralising monoclonal
antibodies raised against virus particles recognized VP2 under non-denaturing conditions
(Jagadish et al., 1988; Bayliss et al., 1991).
VP2, the major host-protective protein of IBDV, is highly conformationally dependent with at
least two to three closely linked antigenic positions responsible for inducing the production of
virus neutralising antibodies and serotype specificity (Schnitzler et al., 1993; Liu et al., 1994).
Sequencing studies showed that changes in any region ofVP2 result in antigenic or pathogenic
variants of the virus. This was proved by a change from Pro to Thr at position 22 in variants
that caused the virus to lose an epitope and escape neutralisation by maternal antibody
(Dormitorio et al., 1997). VP2 is made up of 454 amino acid residues that form the external
surface of the virion. Expression studies have shown that amino acid positions between 206
and 305 of VP2 represents a region called "VP2 variable domain" which is a major
conformational and neutralising antigenic domain. Most of the amino acid residue changes
between IBDV strains take place in this region (Eterradossi et al., 1998). The region consists
of hydrophobic residues, flanked by two hydrophilic peaks A and B, which include residues
210 to 225 and residues 312 to 324, respectively (Crisman et al., 1993). In conclusion, a small
number of changes in the amino acid sequence within the viral proteins, particularly in the
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variable domain ofVP2 can cause extreme changes in the ability of the host immune system to
give protection against virulent viruses (Lana et al., 1992).
1.15 Diagnosis of IBDV
In the acute form of the disease diagnosis can be made based on the clinical symptoms of the
disease and post-mortem examination of the pathogenic lesions (van den Berg et al., 2000).
However, in the less severe form of the disease, which does not show any clinical symptoms,
further diagnostic tests are required. This includes haemorrhagic syndrome tests for muscular
and other types of haemorrages; avitaminosis A for caseous plugs in the bursa; and visceral
gout, fatty liver and kidney syndrome and water deprivation for swollen kidneys and excess
renal urates is required (Jordan, 1990).
The best technique to diagnose IBDV is direct visualisation using electron microscopy.
However, sensitivity, cost and time are among the limitations of electron microscopy as a
diagnostic tool. It requires skilled manpower using very expensive equipment (Gupta and
Yamatoto, 2000). A relatively cheap diagnostic method, i.e. agar gel precipitation, can be used
to demonstrate IBDV-specific antigens in bursal samples (Becht, 1994). Antibody against the
virus and a sample suspected to have viral antigen are placed in opposing wells cut in an
agarose gel. Following diffusion a visible precipitation line will be formed if antigen reactive
with the antibody is present in the sample (Murphy et al., 1999). However, it is not a very
sensitive technique and time consuming, taking 48 h for results to be obtained (van den Berg
et al., 2000).
An agglutination test, usmg latex beads coated with antiviral antibody is the simplest
immunoassay and results can be visualised within one min. However, lack of sensitivity and
specificity as well false positive results are the main limitations of this method (Murphy et al.,
1999). Qualitative detection and quantitative estimation of IBDV can also be made using
rocket immunoelectrophoresis. This method can also be used to quantify IBDV specific
antigen in commercial killed vaccines (Raj et al., 2000).
Identification of IBDV can also be done using an immunofluorescent staining technique,
which is a simple, highly specific and quick technique. This method requires a specific labeled
antibody to locate and identify the antigen of interest inside the cell or tissue. The
identification could be either by direct or indirect immunofluorescence.. The direct method
requires fluorescent isothiocyanate (FITC) labelled specific antibody against the virus to be
identified, while the indirect method uses unlabelled primary antibody and labelled secondary
antibody. The direct technique is more specific but less sensitive than the indirect method
(Burleson et al., 1992).
Identification of IBDV in the bursal follicles of infected chickens can also be carried out using
horseradish peroxidase coupled antibody specific to the antigen (van den Berg et al., 2000).
Binding is visualised using a substrate forming a coloured insoluble precipitate and light
microscopy. The superiority of this method over immunofluorescence is that preparations are
permanent and requires relatively inexpensive equipment. Another powerful diagnostic
method is radioimmunoassay, but although highly sensitive, the cost of the equipment and the
health hazard of working with radioisotopes make the technique impractical in small
laboratories (Murphy et al., 1999).
Infectious bursal disease virus diagnosis by isolation of the virus from inoculated eggs and/or
cell cultures and the demonstration of bursal lesions is a common practice in veterinary
laboratories. The disadvantage of this technique is that not all pathogenic strains of IBDV
grow readily in eggs or cell cultures on primary isolation. Although these stains can be
isolated by experimental infection of SPF chickens, this method has evident drawbacks for
routine diagnosis (Allan et al., 1984). Although it is not convenient for routine diagnostic
purposes, the virus neutralisation assay in cell culture and embryonated chicken eggs can be
used as a diagnostic tool to identify antigenic subtypes of IBDV (Jackwood and Jackwood,
1997).
The antigen-capture enzyme-linked immunosorbent assay (AC-ELISA) is very sensitive,
specific, simple to perform, and a relatively cheap diagnostic method. The presence of IBDV
in infected bursal tissue and from experimentally infected SPF chickens can be analysed using
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monoclonal AC-ELISA. Despite its simplicity and low cost, it is slightly less sensitive than
cell culture or embryonated egg titration (Hassan et al., 1996b). Detection using serological
diagnosis by specific immunoglobulin M (IgM) against the virus is also a commonly used
method. However, a false positive result due to cross-reactivity is a major limitation of this
method (Mosquera et al., 2002).
Although all these diagnostic methods are very important in IBDV diagnosis, they all
experience various limitations such as being time-consuming, expensive, labour-intensive,
nonspecific or insensitive. Therefore to control the disease, a specific and sensitive diagnostic
method is required (Wu et al., 1992). Many of the above limitation can be resolved using
polymerase chain reaction (PCR), which is an excellent tool for the direct detection of viruses
in clinical samples (Mosquera, et al., 2002). Reverse transcription polymerase chain reaction
(RT-PCR), which is a very sensitive and specific diagnostic tool for viruses, has been used
successfully to amplify the IBDV VP2 region with oligonucleotide primers selected from the
highly conserved VP2 gene. The detection sensitivity of IBDV in bursal tissue is higher when
nested primers are included in the PCR amplification (Barlic-Maganja et al., 2002).
1.16 IBDV control
Although hygienic safety measures including cleaning, disinfection and depopulation of
infected chickens are extensively used to eradicate infection on premises, the virus is
extremely persistent and it is unlikely to be completely eliminated (Mandeville et al., 2000;
Sainsbury, 2000). However, these precautions are probably helpful in reducing the degree of
infection and should be practiced wherever possible (Jordan, 1990). The principal means for
IBDV control is vaccination (Snyder, 1990; Snyder et al., 1992). This could be through a
passive route where young birds are protected by the passive immunity transmitted from the





Passive protection can be achieved against IBDV for the first few weeks after hatching (the
critical period when young chickens are most susceptible to the immunodepressive effects of
the disease), via maternal antibodies (Macreadie et al., 1990). Maternal antibody levels in the
fertilised egg can be effectively increased by injecting breeder hens (previously sensitised to
live rBDV) with inactivated vaccine to ensure high levels of maternal antibody in the fertilised
eggs and hence the newly hatched chickens to reduce problems caused by immunosuppression
(Azad et al., 1985; Nakamura et al., 1992; Darteil et al., 1995). However, the level of passive
immunity is inconsistent and unpredictable (Kibenge et al., 1988).
1.16.2 Active protection
Vaccination with a live vaccine during the first three weeks of life is the best way to control
IBDV (Kibenge et al., 1988). The use of modified live or inactivated vaccines prepared from
classical serotype r strains is very successful (Fahey et al., 1991; Heine et al., 1991; Hassan et
al., 1996a). However, the interference of maternally derived antibody is the main problem and
only vaccines of intennediate virulence were shown to be efficient in vaccination of the
offspring (van den Berg et al., 1996). Secondly, due to its cost and the difficulty to propagate
the virus in the bursa of Fabricius of SPF chickens, the currently used inactivated vaccine is
not convenient for practical purpose (Azad et al., 1986). Live IBDV vaccines can be applied
either in ovo or at hatching and in the field via booster vaccinations (Fussell, 1998).
The best way to control IBDV effectively is through extensive vaccination; hence there is a
continuous need to develop efficacious vaccines for commercial poultry production. The
currently available vaccines are tissue culture, egg embryo or bursa of Fabricius propagated
(Hassan and Saif, 1996). Adaptation of wild-type IBDV correlates with attenuation of the
virus. Adapted IBDV can infect non-B-Iymphoid chicken cells, probably resulting in a
reduced viral load in the B-Iymphoid cells in the bursa of infected chickens (Boot et al.,
2000a)
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Commercially used IBDV vaccines are selected based on their ability to induce strong, long
lasting antibody responses (Kim et al., 2000; Juu1-Madsen et al., 2002). An immune complex
vaccine has been also used. This vaccine is made by mixing a certain amount of specific
antibodies obtained from the serum of hyperimmunised chickens with live IBDV (Jeurissen et
al., 1998). Additionally it was found that infectivity of IBDV could be reduced under higher-
pressure conditions. This pressure inactivated IBDV with its original immunogenic properties
can induce long lasting high titre of virus neutralising antibody (Tian et al., 2000).
Generally, vaccination managed to limit the occurrence and diversity of IBD in chickens
(Lana et al., 1992). However, the effectiveness of conventional vaccines used in the field,
including attenuated or inactivated vaccines, is gradually reducing due to the emergence of
new virulent or variant strains of IBDV (Ho et al., 1999). Improper administration of the
vaccine, antigenic differences among viruses and insufficient potency of live-attenuated
vaccine virus may also affect the ability to control IBDV infections through vaccination
(Jackwood and Sommer, 1998). Interference from maternal antibodies, the date of vaccination
of the offspring, improper storage, non-observance of recommended doses, non-observance of
the expiry date, deficiency in vaccination techniques, may also contribute to the failure of live-
virus vaccinations (van den Berg et al., 2000).
1.16.3 Subunit vaccine
Subunit vaccines with the advantage of using only part of the infectious microorganisms to
induce a protective immune response are vaccines of choice. Since subunit vaccines cannot
replicate inside the host, there is no risk of pathogenicity (Roitt, 1997). The composition of a
subunit vaccine can be clearly defined, which is a major advantage in terms of safety and
minimisation of side effects. Production of subunit vaccines is based on peptides, proteins or
polysaccharides that appeared to contain protective epitopes (Hansson et al., 2000). Many of
the cell surface carbohydrates of pathogenic microorganisms are important antigenic
determinants for vaccine development (Mundt and Muller, 1995). In prior studies subunit
vaccines for IBDV were produced using VP2, the surface protein of IBDV. Reports by
Macreadie et al. (1990) and Fahey et al. (1991) showed that neutralising and protective
antibodies were produced in chickens using VP2 isolated from the virus.
The advantage of using a subunit vaccine is no risk of pathogenicity, large-scale production,
various delivery systems, and a possibility of further modification (Table 1.1). However,
subunit vaccines require multiple doses and the use of adjuvants (Hansson et al., 2000).






- One or few doses normally required
- Long-lasting protection
- Both humoral and cellular responses
Disadvantages
- Controlled attenuation normally
required
- Risk of reversion to pathogenicity
- Certain risk of transmission
-'Poorly defined composition
Killed vaccines -No risk of reversion to pathogenicity
- No risk of transmission
Subunit vaccine - Defined composition
(non-recombinant) - Various delivery systems available
Subunit vaccine -No risk of pathogenicity since the
(recombinant) pathogen organism is not present
- Defined composition
- Various delivery system available
- Simplified large-scale production
- Further engineering possible
- Multiple doses typically required
- Poorly defined composition
- Antigen must be produced by
cultivation of a pathogen
- Mainly humoral responses
- Adjuvants normally needed
- Multiple doses typically required
- Adjuvants needed
- Multiple doses typically required
- Adjuvants needed
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Advances in immunology and protein engineering have allowed the design and production of
recombinant subunit vaccines. The epitopes recognised by neutralising antibodies are usually
found on the surface of the pathogenic microorganisms. In the case of IBDV the major
neutralising epitopes that determine the immunogenic properties of the virus are found in a
specific region of VP2 on the surface of IBDV (Tian et al., 2000). Isolation of the genes
encoding such epitopes and their expression in heterologous hosts form the basis of
recombinant-subunit-vaccine development (Hansson et al., 2000). The method is in use in
veterinary medicine and involves the use of virus as vector to carry the genes for the protective
antigens of other viruses. Recently a complete, long-lasting recombinant vaccine against
IBDV was developed by single vaccination with an avian herpesvirus vector expressing VP2
antigens. The herpesvirus of turkey expressing larger amounts of VP2 antigen conferred
complete protection against a lethal IBDV challenge, which is expected to persist for the
lifetime of the chicken (Tsukamoto et al., 2002).
The concept of this vaccine involves insertion of the VP2 gene of IBDV into the genome of
the vector. Following injection the virus can multiply and present the VP2 gene to the immune
system of the chicken and the chicken will mount both a humoral and a cell-mediated immune
response to it (Murphy et al., 1999; Tsukamoto et al., 2002). The advantage of using single
proteins displaying immunodominant epitopes as vaccine is to induce protective immunity
without having side effects and immune reactions caused by other parts of the pathogenic
organism. It is a safe and cost effective production systems can be used. Recombinant
strategies further offer the possibility of delivering protein subunits with the help of live
delivery systems, bacterial or viral, or even as antigen-encoding genes, so-called nucleic acid
vaccines (Table 2) (Hansson et al., 2000).
However, variable immune response, inefficient delivery, risk of integration into host
chromosomes, risk of reversion when using attenuated pathogenesis as a carrier and
cumbersome large-scale production are the main disadvantages of recombinant subunit
vaccines (Hansson et al., 2000).






Protein immunogens -No risk of pathogenicity since the pathogenic
.organism is not present
-Efficient production system available
Live delivery system -May induce both humoral and cellular
response
-Adjuvants normally not needed
- Multiple doses required
- Adjuvants needed
- Risk of reversion when using
attenuated pathogens as carriers
Bacterial
Viral
-Surface display of antigens possible
-Mucosal administration possible
- Efficient induction of cellular responses
Nucleic acid vaccine - No risk ofpathogenicity
- Simple production






- Dedicated delivery systems exist
- No risk of integration in to host
chromosomes
-No need to inter the nucleus for translation
-In vivo amplification systems available
- Inefficient delivery
-Risk of integration into host
chromosomes must be considered




1.16.4 Control based on interfering with virus-receptor interactIon
Unlike CD4, the receptor for HIV-l, which is a component of the molecular complex that
facilitates the interaction of the T-cell receptor with MBC class IT molecules (Levesque et al.,
2003; Staudinger et al., 2003), the biological role of IBDV receptor protein on the surface of
bursal cells is not yet known. A safe and effective vaccine against viruses should elicit
humoral responses that are effective against entire strains of the virus (Fouts et al., 2002).
Some reports showed that generation of cross-reactive neutralising antibodies is possible using
complexes of virus surface proteins and receptors. Fouts et al. (2002) and Moulard et al.
(2002) showed that covalently crosslinked complexes of soluble human CD4 and HIV-l
envelope glycoproteins (gp 120 or gp 140) generated antibodies that neutralised a wide range
of primary HIV-1 isolates. Their result suggests that these complexes induce long lasting
neutralising humoral responses that, in part, may be directed against novel epitopes found on
the HIV-1 envelope. Production of such antibodies could be possible using covalently
crosslinked complexes of soluble IBDV receptor protein and IBDV attachment protein (VP2).
This complex commences a series of conformational changes that are the foundation of the
fusion machinery leading to viral penetration (Moulard et al., 2002).
Reduction of Hantaan virus infection was obtained by blocking the binding of Hantaan virus
to the 30 kDa receptor protein on the surface of Vero-E6 cells using the anti-30 kDa receptor
antibody (Kim et al., 2002). In previous studies the same method was used to block Hepatitis
B virus binding to human hepatocytes (Petit et al., 1992). Thus blocking of IBDV binding to
the IBDV receptor protein using anti-IBDV receptor antibody could be applied to reduce
IBDV infection.
In conclusion, these approaches are essential for the development of molecular models for
virus-host interaction. Furthermore, such models can allow the rational design of agents,
which might be effective in preventing virus interaction by blocking the attachment stage of
the infections cycle (Lentz, 1990). Virus-receptor interactions could be blocked with either
anti-receptor antibodies or with soluble receptors. Additionally, other chemicals or
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pharmacologies could be developed that specifically block virus attachment either at the level
of the cell receptor or the viral attachment protein (Fig. 1.4).
Figure 1.4 Interaction of virus with a host cell receptor and agents interfering with the attachment step.
Virus binding to the receptor is mediated by the interaction of a YAP (forming the envelope or capsid of the
virus) with receptors on the cell surface. The receptor is a structural molecule on the cell surface and may
function as a receptor for a physiological ligand such as a hormone, neurotransmitter, growth factor or
immunoglobulin. The ability of the virus to bind to the receptor is conferred by a portion of the VAP that mimics
the normal ligand structurally or conformationally. Following binding of the virus to the receptor, internalisation
of the virus may proceed either by receptor-mediated endocytosis or by direct fusion with the plasma membrane
(see Fig. 1.3). Binding of virus to the receptor can be blocked using two groups of substance at the attachment
step, i.e. ligand or receptor mimics. Ligand mimics resemble the ligand and will bind to the receptor. Such ligand
mimics include antibodies against the binding site of the receptor, anti-idiotypic antibodies against anti-ligand
antibodies, natural ligands of the receptor, and designed or engineered ligand mimics such as drugs or synthetic
peptides. Receptor mimics resemble the binding domain of the receptor and will bind to the VAP. Receptor
mimics include antibodies against the binding domain ofthe ligand, anti idiotypic antibodies against anti-receptor
antibodies, soluble forms of the receptor itself, and designed receptor mimics such as synthetic peptides
representing the binding domain of the receptor (Lentz, 1990).
1.17 Objectives of this study
The main objectives of this study were to evaluate a peR-based diagnostic assay for IBDV
based on sequences from VP2 and confirmation of the identity of an IBDV receptor on the
surface of bursal cells. To this aid anti-putative IBDV receptor peptide antibodies were raised
for possible blocking of viral binding to the receptor. This would confinn that the putative
receptor previously identified in this laboratory is a specific receptor for IBDV.
For the diagnostic purposes, IBDV was isolated from IBDV infected bursal tissue using
cesium chloride (CsCl) density gradient centrifugation and the identity of the virus was
confinned by Tris-Tricine SDS-PAGE and transmission electron microscopy. Double stranded
RNA was isolated from the virus for the PCR-based diagnostic studies. Primers were designed
from the highly conserved VP2 genome and synthesised for the amplification of VP2 protein
by RT-PCR. The RT-PCR assay was evaluated using commercially available live IBDV
vaccines and the resulting PCR product were subjected to restriction digestion with a specific
restriction endonuclease (BamHI) to confinn the correctness of the amplified PCR product
(Chapter 3).
For the identification of IBDV receptor protein, membrane proteins were isolated from
uninfected bursal tissue. IBDV was attached to Sepharose 4B chromatography matrix for
affinity purification of the viral receptor protein and purity was assessed on Tris-Tricine SDS-
PAGE (Chapter 4). Anti-IBDV receptor peptide antibodies were raised against the 32 kDa
IBDV receptor protein sequences obtained in this laboratory by Edwards (2000) in rabbits.
Inhibition assays was performed in an ELISA fonnat to see if the anti-IBDV receptor peptide
antibodies could inhibit the binding of IBDV to the receptor, thus confinning the identity of





This chapter describes general methods used during the course of this research project.
Methods pertaining only to particular sections of the study are described in the relevant
chapter. For ease of reference all the materials used in this study are listed here with their
suppliers.
2.1 Materials
General chemicals used in this study were purchased from, BDH, Fluka or Roche, and were of
the highest purity available. Coomassie brilliant blue G-250, cesium chloride, lithium chloride,
5, 5'-dithio-bis (2-nitrobenzoic acid) (Ellman's reagent), pepstatin A, rabbit serum albumin,
m-maleimidobenzoilacid-N-hydroxysuccinimide ester (MBS), agarase I, agarose, deoxycholic
acid (sodium salt), Sepharose 4B, 4-chloro-1-naphthol, L-cysteine, Sephadex G-10 and
Freund's adjuvants were from Sigma. DNA molecular weight marker Il, 1,4-dithiothreitol
(DTT), bovine serum albumin, ovalbumin, titan one tube RT-PCR kit, 2,2'-Azinobis[3-ethyl-
2,3-dihydrobenzthiazole-6-sulphonate] (ATBS), proteinase K, 4-(2-hydroxyethyl)-1-
piperazin-ethan-sulfonaure (Hepes), DNA molecular weight marker XIII and
phenylmethylsulfonylfluoride (PMSF) were from Roche. Ethylenediaminetetra-acetic acid
disodium salt (Na2-EDTA), N, N, N,' N-tetramethylethylenediamine (TEMED) and N, N-
methylenebisacrylamide were from BDH. Dialysis tubing was from PIERCE. N, N-
dimethylformamide (DMF), 2-mercaptoethanol and dimethylsulfoxide (DMSO) were from
Fluka. Low molecular weight marker, nitrocellulose (Hybond™- C extra), 0.45Micron and
Sephadex G-25 were from Amersham Pharmacia Biotech. 8-hydroxy-chinolin was from
Merck. Goat anti-rabbit antibody (HRPO linked) was from Jackson Immuno-Research
laboratory. ELISA plates (Nunc-Immuno™, MaxiSorpTM) were from Nunc™. Low melting
point agarose was from Whitehead Scientific. Deoxy nucleotide tri-phosphates (dNTPs) stock
solution was from Takapo. Thin walled PCR reaction tubes (O.2ml) were from QSP (Petaluma,
USA). Restriction enzymes were from Promega (Madison, USA). Commercial vaccines
nobils® gumboro D78 and nobils® gumboro 228E were from Intervet (South Africa). Tad
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Gumboro vac forte 1000ds and tad Gumboro vac 1000ds (cloned) were from Lohmann
Animal Health Germany.
2.2 Protein quantification
The Bradford dye-binding protein assay (Bradford, 1976) is a frequently used method to
quantify proteins in biochemical and clinical laboratories. It is a sensitive assay with a
capacity to detect less than 5 Jlg of protein and very easy to use requiring only one reagent.
Furthermore it is rapid, requiring a short time for colour development. An additional
advantage is its relative freedom from interference by common laboratory reagents with the
exception of relatively high concentrations (1 %) of detergents and basic buffers (Bradford,
1976).
The dye consists of Serva blue or Coomassie brilliant blue G-250 dissolved in ethanol and
phosphoric acid. The assay is based on the binding of the dye to basic (Arg, His, Lys) or
aromatic (Phe, Tyr, Trp) amino acid residues. This binding causes a shift in the absorbance
maximum of the dye from the cationic red form at 465 nm to the anionic blue form at 596 nm
(Compton and lones, 1985). The limitation of this dye-protein binding assay is variability of
colour developments with different protein samples, hence variability in absorbance (Congdon
et al., 1993). Read and Northcote (1981) modified the Bradford method to decrease the level
of protein-protein variability in dye binding and to increase the sensitivity of the assay, by
replacing the Coomassie brilliant blue G-250 with Serva blue G dye, and by increasing the
concentration of the dye in the assay solution or decreasing the concentration of phosphoric
acid.
2.2.1 Materials
Dye Reagent. Coomassie brilliant blue G-250 (50 mg) was dissolved in 88% phosphoric acid
(50 ml) and 99.5% ethanol (23.5 ml). The solution was made up to 500 ml with dist.H20,
stirred for 30 min on a magnetic stirrer, filtered through Whatman No.1 filter paper and stored
in a brown bottle. The solution could be stored for up to 6 months, although visual checks for
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precipitation were made before use. If precipitation was visible, the reagent was filtered and
re-calibrated before use.
Standard protein solution. Ovalbumin (1 mg), was dissolved in 1 ml of dist.H20 and the
solution was diluted to 100 Jlg/ml in dist.H20.
2.2.2 Method
Protein standard (0-50 JlI of the 100 Jlg/ml solution, i.e. 1-5 Jlg) was diluted to a final volume
of 50 JlI with dist.H20 in 1.5 ml polyethylene microfuge tubes. Dye reagent (950 JLI) was
added, mixed in by inversion and allowed to stand for 2 min for colour development. The
absorbance was read at 595 nm against an appropriate blank (950 Jll of dye reagent + 50 JLl of
dist.H20) in 1 ml plastic micro-cuvettes. Mean values of four replicates were used to construct
a standard curve. The concentration of the samples of unknown concentration was calculated
from an equation generated by linear regression analysis of the standard curve data using
Microsoft Excel.
2.3 Concentration of protein samples
Dilute affinity purified IBDV receptor protein samples (Section 4.4.2.2) were concentrated
prior to Tris-Tricine SDS-PAGE, analysis. A simple, and inexpensive concentrating technique,
employing dialysis against polyethylene glycol (PEG) (Mr 20 000), was found to be
sufficiently gentle to keep proteins in their native state and was the method of choice for the
concentration of protein samples. Dialysis against the soluble high molecular weight PEG,
which is too large to pass into the dialysis membrane, was only used when the presence of
sucrose, which diffuses into the dialysis bag (Mr 12 000 cut-off), was not desirable. The
principle of concentration by these polymers is based on the movement of water along a
concentration gradient out of the dialysis bag to dissolve the dry polymer, leaving a
concentrated sample solution inside the dialysis bag. In cases where more concentrated sample
was required prior to Tris-Tricine SDS-PAGE analysis, a rapid, small-scale method, based on
the precipitation of SDS-protein complexes by KCI, was used and resulted in an overall 50-
fold concentration of samples. However, the SDS-KCI precipitation method was found to be
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unsuitable for non-reducing SDS-PAGE analysis, possibly as a result of the very high salt
concentration in the samples.
2.3.1 Dialysis against PEG 20 000
The protein sample to be concentrated was placed in a dialysis bag (Mr 12 000 cut-off).
Following sealing, it was placed in a plastic tray, and covered with (PEG 20 000) at 4°C for a
limited time (5 to ID-fold concentration was usually achieved in 2-4 h), the bag was briefly
rinsed in dist.H20 and the sample was squeezed out.
2.3.2 SDSIKCI Precipitation
2.3.2.1 Materials
5% (w/v) SDS. SDS (0.5 g) was dissolved in 10 ml of dist.H20.
3 M KCl. KCl (2.24 g) was dissolved in 10 ml of dist.H20.
2.3.2.2 Method
5% SDS (10 ILl) was added to the sample (100 ILl) in a 1.5 ml polyethylene microfuge tube.
The solution was mixed by inverting the tube followed by the addition of 3 M KCI (10 ILl).
The mixture was again inverted and centrifuged (12 000 g, 2 min, RT). The supernatant was
discarded and the precipitate was dissolved in reducing treatment buffer (20 ILl, solution G,
Section 2.4.1).
2.4 SDS-PAGE (Laemmli and Tricine) systems
SDS-PAGE (both Laemmli and Tris-Tricine) was used to evaluate the identity of purified
IBDV bursal membrane proteins and the affinity purified IBDV receptor protein. When
proteins are treated with the anionic detergent, SDS, the secondary, tertiary and quaternary
structure of the protein is denatured resulting in a negatively charged linear polypeptide chain
of a constant charge/mass ratio and uniform shape. Denaturation is assisted by the presence of
35
2-mercaptoethanol that reduces all disulfide bonds (Smith, 1984; Boyer, 1993). The resulting
negatively charged detergent-polypeptide complexes will have similar charge-to-mass ratios
and hence size dependent anodal migration in an electric field. The anionic detergent binds
tightly to most hydrophobic regions of the denatured protein chain in a constant ratio of about
1.4 g ofSDS to 1 g ofprotein (Reynolds and Tanford, 1970).
The most commonly used technique is that developed by Laemmli (1970). This method uses
two different gel systems, a running (lower) and stacking (upper) gel with different pore sizes,
pH and ionic strength. The function of the stacking gel is to concentrate large volume samples,
resulting in improved resolution of proteins.
Protein samples prepared in low conductivity buffer (0.06 M Tris-HCI buffer, pH 6.8) are
loaded between the higher conductivity electrode (0.025 M Tris, 0.192 M glycine, pH 8.3) and
stacking gel (0.125 M Tris-HCI buffer, pH 6.8) buffers. When the power is applied, a voltage
drop develops across the sample solution, driving the samples into the stacking gel. Glycinate
ions from the electrode buffer follow the proteins into the stacking gel. A moving boundary
region is quickly formed with the highly mobile chloride ions at the front and the relatively
slow glycinate following behind. A restricted high-voltage gradient created between the
leading and trailing ion fronts causes the samples to form a thin zone (stack) and migrate
between the chloride and glycinate phases. Because of the larger pore size in the staking gel
no retardation of sample migration occurs. Once the samples reach the running gel, movement
is restricted by the pore size. The glycinate ions overtake the proteins, which then move in a
zone of uniform pH (pH 9.5) formed by the Tris and glycine. Samples thus separate according
to their size, with the smaller molecules migrating the longest distance down the gel (Garfin,
1990).
The limitation of the Laemmli method is that it does not separate small proteins « 20 kDa)
very well, hence an alternative method with a higher resolving power for small proteins was
needed. Schagger and von Jagow (1987) described an alternative SDS-PAGE method, using a
Tricine buffer, which gives exceptionally good resolution for proteins under 20 kDa. The
power of this technique (or resolving proteins, particularly in the range of 5 to 30 kDa, is
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mainly due to the addition of Tricine as the trailing ion and making the stacking limits as
narrow as possible within the low molecular mass range.
Despite its higher molecular mass, Tricine migrates much faster than glycine in a stacking gel
at pH values between 6.8 and 8.8, because much more Tricine is in the migrating, anionic
fonn. As a result, the stacking limit is shifted to the low-molecular mass range. The stacking
and destacking of proteins therefore could be achieved at lower acrylamide concentrations
than those in the glycine systems (Schagger and Jagow, 1987).
2.4.1 Materials for Laemmli SDS-PAGE
Solution A: Monomer Solution [30% (w/v) acrylamide, 2.7% (w/v) bis-acrylamidel.
Acrylamide (73 g), and bis-acrylamide (2 g) were dissolved and made up to 250 ml with
dist.H20 and stored in an amber coloured bottle at 4°C.
Solution B: 4 x Running Gel Buffer (1.5 M Tris-HCl buffer, pH 8.8). Tris (45.37 g), was
dissolved in 200 ml of dist.H20, adjusted to pH 8.8 with HCl and made up to 250 m!.
Solution C: 4 x Stacking Gel Buffer (500 mM Tris-HCl buffer, pH 6.8). Tris (3 g), was
dissolved inAO ml dist.H20, adjusted with HCl to pH 6.8 and made up to 50 m!. This buffer
was made up weekly, because, as a result of its poor buffering capacity at 2.1 pH units below
the pKa of Tris at 4°C, pH drift led to anomalous running patterns in non-reducing SDS-
PAGE.
Solutions A, B, and C were filtered through Whatman No. 1 filter paper before use.
Solution D: 10% (w/v) SDS. SDS (10 g) was dissolved in 100 ml dist.H20.
Solution E: Initiator [10% (w/v) ammonium persulfatel. Ammonium persulfate (0.1 g) was
made up to 1 ml just before use.
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Solution F: Tank buffer [250 mM Tris, 192 mM glycine, 0.1 % (w/v) SDS, pH 8.31. Tris-base
(15 g), and glycine (72 g) were dissolved and made up to 5 litres with dist.H20. Prior to use,
2.5 ml of SDS stock (solution E) was added to 250 ml.
Solution G: Reducing Treatment Buffer [125 mM Tris-HCI buffer, 4% (w/v) SDS, 20% (v/v)
glycerol, 10% (v/v) 2-mercaptoethanol, pH 6.81. Buffer C (2.5 ml), 10% SDS (4 ml) (solution
D), glycerol (2 ml) and 2-mercaptoethanol (1 ml) were made up to 10 ml with dist.H20.
Solution H: Non-reducing Treatment Buffer [125 mM Tris-HCI buffer, 4% (w/v) SDS, 20%
(v/v) glycerol, pH 6.81. Buffer C (2.5 ml), 10% SDS (4 ml) (solution D) and glycerol (2 ml)
were made up to 10 ml with dist.H20.
Molecular weight markers. The standard molecular weight markers were phosphorylase b
(94 kDa), bovine serum albumin (67 kDa), ovalbumin (43 kDa), carbonic anhydrase (30 kDa),
soybean trypsin inhibitor (20.1 kDa) and a-lactalbumin (14.4 kDa). Lyophilised markers were
reconstituted in non-reducing treatment buffer (100 J-tl) and heated for 5 min for Coomassie
staining or western blot analysis. For silver staining the reconstituted markers were diluted
1:50 in non-reducing treatment buffer (solution H), and stored at 4QC.
Table 2.1 Preparation of Laemmli running and stacking gels
Volume (ml)










The Bio-Rad mini-PROTEAN n® unit was assembled as described in the manufacturer's
manual. This involved cleaning a smaller and larger glass plate with ethanol for each of the
two sides of the apparatus, and clamping these with two 1.5 mm polyethylene spacers
separating them at the edges in the casting stand. The running gel was run into the space
between the plates, to a depth of 3 cm from the top of the larger glass plate, and overlayered
with dist.H20 to allow for even polymerisation. Once the gel had set (evidenced by the
appearance of the interface between the gel solution and water, usually 1 h), the water was
removed with a syringe. Staking gel solution was poured on top of the running gel layer, and a
comb was inserted to form the sample application wells. Once this gel had set (about 30 min)
the comb was removed and the wells were rinsed with dist.H20. The gel assemblies were
clamped to the inner cooling core.
Tank: buffer, containing SDS, was poured into the upper and lower electrode compartments.
Samples were prepared with an equal volume of reducing treatment buffer and boiled for
2 min. A marker dye, bromophenol blue (5 ILl), which migrates with the buffer front, was
added to each sample before loading onto the gels. Suitable amounts of samples (at least 1 j1..g
of protein per band for the Coomassie blue R-250 staining procedure) were applied to the
wells using a Hamilton microsyringe. The gel unit was connected to a power pack and run at
18 mA per gel until the bromophenol blue tracker dye was about 0.5 cm from the bottom of
the running gel. At this point, the apparatus was disconnected from the power supply, the
plates were removed, and levered apart using a plastic spacer. The gel was removed and
stained (Section 2.7).
2.4.3 Materials for Tris-Tricine SDS-PAGE
Solution A: [3 M Tris-HCl buffer, 0.3% Cw/v) SDS, pH 8.45]. Tris (72.7 g), was dissolved in
180 ml of dist.H20, SDS [6 ml of a 10% (w/v) solution] was added, adjusted to pH 8.45 with
HCl, and made up to 250 ml.
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Solution B: [49.5% (w/v) acrylamide, 3% (w/v) bis-acrylamide1. Acrylamide (48 g), and bis-
acrylamide (3 g) were dissolved and made up to 100 ml with dist.H20 and stored in an amber
coloured bottle at 4Qc.
Solution D: [10% (w/v) ammonium persulfate]. Ammonium persulfate (0.1 g) was made up to
1 ml just before use.
Anode buffer [200 mM Tris-HCl buffer pH 8.91. Tris (24.22 g) was dissolved III
approximately 950 ml ofdist.H20, adjusted to pH 8.9 with HCl and made up to 1litre.
Cathode buffer [lOO mM Tris-HCl buffer, 100 mM Tricine, 0.1% (w/v) SDS, pH 8.25]. Tris
(12.2 g), and Tricine (17.9 g) were dissolved in 950 ml of dist.H20, SDS [10 ml of 10% (w/v)
solution] was added, adjusted to pH 8.25 with HCl, and made up to 1 litre.
2.4.4 Method
The procedure outlined in Section 2.4.2 was followed, except that the running and stacking
gels were prepared as shown in Table 2.2. The cathode buffer was placed in the top chamber
and the anode buffer in the bottom chamber of the vertical slab gel electrophoresis unit.
Samples were combined with reducing treatment buffer and prepared as described in Section
2.4.2 before loading onto the gels. Two gels were run at 80 V until the tracking dye had
entered the running gel, before the voltage was increased to 100 V. Electrophoresis continued
until the tracker dye was about 0.5 cm from the bottom of the gel. The gel was removed as
before and stained (Section 2.7).
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2.5 Nondenaturing PAGE for DNA Separation
Due to its higher resolution power especially for small size nucleic acid fragments (Table-
2.3), nondenaturing PAGE was used to evaluate the homogeneity of the purified double
stranded viral RNA (dsRNA), amplified peR products and restriction digestion fragments.
These gels are run at very low voltage (1-8 V/cm) to avoid denaturation of DNA fragments by
the electric current. Double stranded DNA migrates in nondenaturing polyacrylamide gels at a
rate inversely proportional to the 10glO of its size. DNA's mobility can also be affected by the
base composition and sequence, therefore DNA-strands of exactly the same size can differ in
their mobility by up to 10%. This is may be caused by kinks that form at specific sequences in
double stranded DNA (Sambrook et al., 1989).
















30% Acry1amide. Acrylamide (29 g), and N, N -methylenebisacry1amide (1 g) were dissolved
in 100 ml of dist.H20.
I x TBE [89 mM Tris-borate buffer, 2 mM EDTA, pH 8.0l. Tris (10.8 g), boric acid (5.5 g)
and EDTA (0.93 g) were dissolved in 950 ml of dist.H20, adjusted to pH 8.0 with HCI and
made up to one litre.
5 x TBE. Tris (54 g), boric acid (27.5 g) and EDTA (4.65 g) were dissolved in 950 ml of
dist.H20, adjusted to pH 8.3 with HC1 and made up to one litre.
10% Ammonium persulfate. Ammonium persulfate (1 g) was dissolved in 10 ml of dist.H20
the solution was made up fresh weekly and stored at 4°C.
Staining solution [0.5 gg/ml ethidium bromide]. Ethidium bromide 10 JlI of a 5 mg/ml solution
was made up to 100 ml with 1 x TBE.
Table 2.4 Volume of reagents used to cast nondenaturing polyacrylamide gels of
different concentrations (Sambrook et al., 1989)















The Bio-Rad Mini-PROTEAN I:r® electrophoresis apparatus was assembled as described in
Section 2.4.2. After the running gel mixture (Table 2.4) was poured into the space between the
glass plates, a plastic comb was inserted immediately and carefully to avoid entrapment of air
bubbles and the gel allowed to set for 60 min at room temperature. Following polymerisation,
the comb was removed carefully and wells were rinsed immediately with distilled water
followed by 1 x TBE buffer.
After the 1 x TBE buffer was poured into the upper and lower electrode compartments,
samples (PCR product combined with gel loading buffer, Section 2.6.1) were loaded into the
wells using a Hamilton™ syringe and electrophoresis was performed at 30 V for 16 h. The
gels were removed and stained in ethidium bromide (0.5 JLg/ml ethidium bromide in 1 x TBE)
for 45 min at room temperature.
2.6 Agarose gel electrophoresis
Agarose gel electrophoresis was used to analyse the identity of purified IBDV dsRNA,
amplified PCR products and restriction digestion fragments in this study. Despite their
superiority in protein analyses, PAGE and SDS-PAGE with smaller pore sizes are not suitable
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to analyse large nucleic acid fragments or intact DNA molecules. However, agarose gels are
available to analyse RNA and DNA in the range of 200 to 50 000 base pairs (50 kilobases).
Agar is extracted from various genera of the class Rhodophyta and consists of a mixture of
polysaccharides. The polysaccharides are mostly alternating copolymers of 1,4 linked 3,6
anhydro-a-L galactopyranose and 1,3 linked {3-D- galactopyranose (Boyer, 1993).
Agaropectin, a heterogeneous mixture of smaller molecules, occur in less significant amounts.
They contain negatively charged constituents, i.e. sulfate, pyruvate and glucuronate. They
have poor gelling capacity and is removed from the readily gelling agarose molecules, using
anion exchange chromatography (Fukui et al., 1983).
Agarose gels are prepared by dissolving the required amount of agarose in warm
electrophoresis buffer to give a specific % gel. Upon solidifying, the agarose gel forms. a
matrix, the density of which is determined by the concentration of the agarose. When an
electric current is applied, nucleic acids, which are negatively charged at neutral pH, migrate
toward the anode. The mobility of nucleic acids in an agarose gel is influenced both by
concentration of agarose and size of the nucleic acids. Like proteins in SDS-PAGE, nucleic
acids migrate in an agarose gel according to their size, with the smallest molecules migrating
the greatest distance. As a result, molecular weight can be estimated based on the
electrophoretic mobility of the nucleic acids in relation to that of molecular weight markers
(nucleic acids or DNA fragments of known molecular weight) (Boyer, 1993). Nucleic acids
are detected in agarose and polyacrylamide gels with ethidium bromide, a fluorescent dye that
intercalates between stacked base pairs, extending the length of linear and nicked circular
nucleic acid molecules and making them more rigid (Sambrook et al., 1989).
2.6.1 Materials
EtBr stock solution (la mg/ml EtBr). EtBr (1 mg) was dissolved in dist.H20 (100 ml) by
stirring for several hours on a magnetic stirrer. The container was wrapped in aluminium foil
to prevent photo bleaching, and the solution was stored at RT. EtBr was used at a working
concentration of 0.27 JLg/ml.
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Gel loading buffer [0.25% (w/v) bromophenol blue, 0.25% (w/v) xylene cyanol FF, 1 mM
Naz-EDTA, pH 8.0 ,50% (v/v) glycerol]. Bromophenol blue (50 mg), and xylene cyanol FF
(50 mg) were dissolved in dist.H20 (8 ml), 100 mM Na2-EDTA (200 J1.l) and 99.5% (v/v)
glycerol (10 ml) were added and the volume made up to 20 ml. The solution was sterilised by
autoclaving and stored at RT.
50 x Tris-acetate buffer (TAB) (2 M Tris-acetate, 50 mM NarEDTA, pH 8.0). Tris base
(242 g), glacial acetic acid (57.1 ml) and Naz-EDTA (18.61 g) were dissolved in dist.H20
(500 ml), adjusted to pH 8.0 and made up to 1 litre. The stock solution was stored at RT and
diluted 50-fold with dist.H20 to yield a 1 x TAE working solution.
1 x TAE working solution. 50 x TAE buffer (20 ml) was made up to 1 litre with dist. H20.
2.6.2 Method
The casting tray was placed on a level surface and the open ends sealed with masking tape.
The comb was positioned in the tray to provide about 1mm of space between the ends of the
teeth and the surface of the plate. Agarose (0.3 g) was dissolved in 30 ml of 1 x TAE buffer in
an Erlenmeyer flask, its weight was recorded and boiled in a microwave oven for 1 min. The
boiled solution was weighed and the volume was readjusted by adding more TAE buffer.
After addition of EtBr (0.7 JLl) the gel was cooled to ±55°C by rotating the flask under running
tap water and poured rapidly and carefully into the prepared casting tray. Any air bubbles were
removed and the gel was allowed to set completely at RT (30 min). The comb was carefully
removed and the casting tray positioned on the centre platform of the unit. The unit was filled
with approximately 250 ml of I x TAB buffer until a depth of about 1 mm. EtBr (5 JLl) was
added to the tank buffer and dispersed with gentle agitation of the pod. Gel loading buffer
(3 JLl) was mixed with nucleic acid samples and molecular weight markers, and samples were
loaded into the wells. Following electrophoresis (100 V, unlimiting current, I h, RT) the gel
was examined by DV light and scanned.
2.7 Protein staining methods
The permanent and growing interest in the detection of very small amounts of proteins and
nucleic acids in polyacrylamide gels required staining techniques which are highly sensitive,
inexpensive and easy to operate (Blum et al., 1987). Different proteins exhibit different
staining properties and mechanisms. Although depending on pH proteins may be stained with
anionic (acidophilia) or cationic (basophilia) dyes, only their staining with anionic dyes is of
practical significance. Anionic dyes are negatively charged due to the presence of sulphonate
(Sot) groups on the dyes. At pH < 7.0, the net charge of proteins is positive, contributed by
the positively charged amino groups of Lys, Arg, and His residues. Once electrostatic
attraction took place between protein and dye, the staining mechanism is through hydrophobic
interactions, van der Waals, ionic forces and hydrogen bond formation (Horobin, 1988;
Prento, 2001; Puchtler et aI., 1988). The two staining methods used in this study are
Coomassie blue dye and silver staining.
2.7.1 Coomassie blue R-250 staining
Due to its simplicity and reliability, Coomassie blue staining is the most widely used staining
technique. However, it requires long stainingldestaining times and has a detection limit of 1 j1,g
protein/band (Choi et al., 1996). In addition it causes variable background staining (Goldring
and Ravaioli, 1996). In slight acid media, the dye-anion is electrostatically attached to the
NH/ groups of the protein, and within this primary fusion van der Waals forces hold the
reactants together. The dye-protein complex is fixed, although fully reversible by dilution
under appropriate conditions of pH (Fazekas De St. Groth et al., 1963).
2.7.1.1 Materials
Stain stock solution [1% (w/v) Coomassie blue R-250J. Coomassie blue R-250 (1 g) was
dissolved in 100 ml of dist.H20 by magnetic stirring for 1 h at room temperature. The solution
was filtered through Whatrnan No. 1 filter paper.
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Staining solution [0.125% (w/v) Coomassie blue R-250, 50% (v/v) methanol, 10% (v/v) acetic
acid). Stain stock (62.5 ml) was mixed with methanol (250 ml) and acetic acid (50 ml), and
made up to 500 ml with dist.H20.
Destaining solution I [50% (v/v) methanol, 10% (v/v) acetic acid). Methanol (500 ml) was
mixed with acetic acid (100 ml) and made up to 1 litre with dist.H20.
Destaining solution II [7% (v/v) acetic acid, 5% (v/v) methanol]. Acetic acid (70 ml) was
mixed with methanol (50 ml), and made up to 1 litre with dist.H20 .
2.7.1.2 Method
The gel was removed from the glass plates using gloves (Section 2.4.2) and placed into
staining solution for 4 h. The staining solution was removed at the end of this time and,
following rinsing with dist.H20, the gel was placed into destaining solution I, overnight, and
into destaining solution II to effect complete destaining . Gels were stored in polythene zip-
seal bags and kept well hydrated until photographed. They were stable in this form for long
periods.
2.7.2 Silver staining
Silver staining is a common technique used to detect low concentration samples separated by
SDS-PAGE. Silver staining is reported to be 50-100 times more sensitive than Coomassie blue
staining and is comparable to the sensitivity of autoradiography of esS] methionine-Iabeled
proteins. This sensitivity allows for the detection of less than 1 ng protein in a gel. This
method is very rapid and relatively simple and results can be obtained within 2 h. Colour
development is as a result of silver complexes formed with ionic amino acid side chains in
proteins (Nielsen and Brown, 1984). Despite its sensitivity and simplicity silver staining has
still a number of limitations: (1) purity of the water can affect the background; (2) different
proteins can be stained differently, i.e. some proteins can be stained perfectly, others may stain
only weakly or not at all (Femandez-patron et al., 1995). However, a modification of the silver
staining method by Blum et al. (1987) prevents unspecific surface or background staining
during image development. This was achieved by the addition of low amounts of thiosulfate
for the pre-treatment of fixed gels, which can chemically dissolve the formation of insoluble
silver salts in the developer by complexation.
2.7.2.1 Materials
Fixing solution [50% (v/v) methanol, 12% (v/v) acetic acid, 0.019% (v/v) formaldehyde.
Methanol (100 ml), acetic acid (24 ml) and formaldehyde (100 JLl Of 37% solution) were
diluted to 200 ml with dist.H20.
Pre-treatment solution (4 mg/ml Na2.fu0l, 5HI Q}. Na2S203.5H20 (40 mg), was dissolved in
200 ml dist.H20.
Impregnation solution [0.2% Cw/v) AgN03, 0.028% (v/v) formaldehydel. AgN03 (400 mg),
was dissolved in 200 ml of dist.H20 and formaldehyde (150 JLl ofa 37% solution) was added.
Developing solution [0.019% (v/v) formaldehyde, 0.0004% Na2,fu0l.5HIO, and 60 g/l
Na2C03}. Na2C03 (12 g) was dissolved in 190 ml of dist.H20 and Na2S203.5H20 (4 ml ofpre-
treatment solution) and 37% (v/v) formaldehyde (100 JLl) were added and the volume made up
to 200 ml.
Stopping solution [50% (v/v) methanol, 12% (v/v) acetic acidl. Methanol (50 ml) and acetic
acid (12 ml) were diluted to 100 ml with dist.H20.
Washing solution [50% (v/v) methanol]. Methanol (50 ml) diluted to 100 m1 with dist.H20.
2.7.2.2 Method
All steps were carried out on an orbital shaker (50 rpm; RT) and in scrupulously cleaned glass
containers to minimise background staining. The electrophoresis gel was soaked in fixing
solution (100 ml, 1 hr or overnight), before incubation in washing solution (3 x 20 min),
followed by soaking in pre-treatment solution (1 min). The gel was rinsed in dist.H20 (3 x
20 s) and soaked in impregnation solution (20 min). Following rinsing in dist.H20 (2 x 20 s)
the gel was incubated in developing solution until the first protein bands become visible.
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Developing solution was immediately replaced with dist.H20 and the gel washed until colour
was sufficiently developed. Development was stopped by immersing the gel in stopping
solution (10 min). The gel was washed in 50% methanol and stored in polythene zip-seal bags
2.8 Isolation of Antibodies
Antibody (IgG) was isolated from serum using the neutral water-soluble high molecular mass
polymer PEG 6 000, which proved to be very simple and efficient in the purification of both
IgG and IgY to near homogeneity (PoIson et al., 1964; PoIson et al., 1985). PEG precipitation
is performed by exclusion of water from the hydration pocket of protein molecules, which
alters the dielectric constant of the surrounding medium. This may change the steric
relationships of the hydrophilic groups of the protein molecules and proteins precipitate
because they exceed their solubility limit (Fried and Chun, 1971; Giorgione and Epand, 1997;
Goldring and Coetzer, 2003).
2.8.1 Materials
Borate buffered saline, pH 8.6. Boric acid (2.16 g), NaCI (2.19 g), NaOH (0.7 g) and 37% HCl
(0.62 ml) were dissolved in 950 ml of dist.H20, adjusted to pH 8.6 and made up to 1 litre.
100 mM Na-phosphate buffer, 0.02% (w/v) NaN3, pH 7.6. NaH2P04.H20 (13.8 g) and NaN3
(0.2 g) were dissolved in 950 ml of dist.H20, adjusted to pH 7.6 and made up to 1 litre.
2.8.2 Method
Isolation of serum from blood was carried out according to the method of Harlow and Lane
(1988). Collected blood was allowed to clot for 60 min at 37°C. The clot was separated from
the sides of the container (ringing), using a Pasteur pipette and placed at 4°C overnight to
allow the clot to contract. The serum was removed from the clot and any remaining insoluble
material was removed by centrifugation (10 000 g, 10 min, 4°C) ~nd stored at -20°C. One
volume of rabbit serum was mixed with two volumes of borate buffered saline. Solid PEG
6000 was added to the diluted serum to 14% (w/v), dissolved with constant gentle stirring,
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and the mixture was centrifuged (12 000 g, 10 min, RT). The pellet was re-dissolved in the
original serum volume, using 100 mM Na-phosphate buffer pH 7.6. PEG was again added to
14% (w/v), dissolved with stirring, and the solution was centrifuged (12 000 g, 10 min, RT).
Finally the pellet was re-dissolved in half the original serum volume using 100 mM Na-
phosphate buffer, pH 7.6, containing 30% (v/v) glycerol, and stored at -20°C.
2.9 Enzyme linked immunosorbent assay (ELISA).
The ELISA technique was used to monitor the progress of anti-peptide antibody production
during the immunisation period. ELISA is a frequently used technique to determine the
reactivity of biological molecules (antigens) with their antibodies. Antigens or lectins are
immobilised on the wells of microtiter (ELISA) plates. Since immobilisation of proteins onto
plastic surfaces depends on hydrophobic interaction, protein antigens are adsorbed by
hydrophobic interaction (Suzuki et al., 1997).
ELISA is usually carried out in microtitre wells (96 well plates, 8 or 12 well strips). Following
coating with antigen, all unoccupied sites are blocked with a non-reactive protein, such as
BSA. A primary antibody specific for the antigen of interest is used to allow the antigen-
antibody interaction to take place. After washing, the bound primary antibody is detected
using an enzyme-linked secondary antibody, which upon addition of a substrate produces a
soluble colored product that can be quantified visually or photometrically (Thorpe and Kerr,
1994; Switzer and Garrity, 1999).
2.9.1 Materials
Phosphate buffered saline (PBS), pH 7.2. NaCI (8 g), KCI (0.2 g), Na2HP04.2H20 (1.15 g)
and KH2P04 (0.2 g) were dissolved in 950 rnl of dist.H20, adjusted to pH 7.2 and made up to
1 litre.
0.5% (w/v) Bovine serum albumin-PBS (BSA-PBS). BSA (0.5 g) was dissolved in 100 rnl of
PBS.
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0.1 % (v/v) PBS-Tween. Tween 20 (1 m1) was made up to 1 litre in PBS.
0.15 M Citrate-phosphate buffer, pH 5.0. A solution of citric acid.H20 (21.0 g/l) was titrated
with a solution ofNaHP04.2H20 (35.6 g/l) to pH 5.0.
Substrate solution [0.05% (w/v) ABTS and 0.0015% (v/v) H2ili in citrate-phosphate buffer].
ABTS (7.5 mg) and H20 2 (7.5 JLI) were dissolved in citrate-phosphate buffer, pH 5.0 (15 ml)
for one ELISA plate.
Stopping buffer (citrate-phosphate buffer-O.1% (w/v) NaN~. NaN3 (0.1%) was made up to
100 ml in citrate-phosphate buffer.
2.9.2 Method
The IBDV receptor peptide (Chapter 5) was coated (5 JLg/ml) in PBS (150 JLl per well,
overnight at 4°C). Non-specific binding of antibody was prevented by blocking the wells with
0.5% BSA-PBS (200 JLI, 1 h at 37°C), and the plates were washed three times with PBS-
Tween. Serial two-fold dilutions of primary antibody, starting from 100 JLg/ml was prepared
on the plate in 0.5% BSA-PBS and incubated (100 JLI, 2 h at 37°C). The plates were washed
three times with PBS-Tween, and HRPO~linked secondary antibody, at a suitable dilution (1
in 20 000 in 0.5% BSA-PBS) was added to each well and incubated (120 JLI, 1 h at 37°C).
Following washing three times with PBS-Tween, substrate solution (150 JLl) was added to
each well and colour was allowed to develop in the dark against the background of the
controls (usually 10-15 min) and the ~05 of each well was measured in a Titertek ELISA plate
reader.
2.10 Western blotting
Western blotting has been a powerful molecular biology technique for the identification and
characterisation of proteins separated· by SDS-PAGE and electrophoretically transferred to a
nitrocellulose sheet for detection by antibodies (Hughes et al., 1988). In this technique binding
of protein-SDS complexes to the nitrocellulose membrane is enhanced by the addition of
methanol into the transfer buffer. After blocking of the unoccupied binding sites on the
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nitrocellulose membrane with non-fat milk, the proteins (antigens) are available to react with
their corresponding primary and secondary detection antibodies. The detection system
comprises a secondary antibody which has a strong affinity for the primary antibody, labelled
with an enzyme such as HRPO, which catalyses a reaction leading to the formation of
insoluble (precipitating) coloured product.
2.10.1 Materials
Blotting buffer. Tris (27.23 g) and glycine (64.8 g) were dissolved in 3.5 litres of dist.H20,
and methanol (900 ml) was added. The volume was made up to 4.5 litres. Prior to use, 10%
(w/v) SDS was added (4.5 ml solution Section 2.4.1).
Tris buffered saline (TBS; 20 mM Tris, 200 mM NaCl, pH 7.4). Tris (2.42 g), and NaCI
(11.69 g) were dissolved in 950 ml of dist.H20, adjusted to pH 7.4 with HCl, and made up to
1 litre.
Blocking solution [5% (w/v) non-fat milk powder]. Low fat milk powder (5 g) was dissolved
in TBS (100 ml).
1% (w/v) Ponceau S. Ponceau S (0.1 g), was dissolved in 100 ml of 1% (v/v) glacial acetic
acid.
4-chloro-1-naphthol substrate solution [0.06% (w/v) 4-chloro-l-naphthol, 0.0015% (v/v)
fuiliJ. 4-chloro-1-naphthol (0.03 g), was dissolved in methanol (10 ml). Two ml of this
solution was diluted to 10 ml with TBS, with the addition of 30% hydrogen peroxide (4 ILl).
2.10.2 Method
Following SDS-PAGE, usually on duplicate gels, one gel was stained to show the total protein
pattern, while the other was used for blotting. Nitrocellulose was cut to a suitable size. To
avoid entrapment of air the nitrocellulose was carefully floated onto blotting buffer, before
being totally immersed. The immersed nitrocellulose was sandwiched, with the gel lying
squarely on top of it, between three pieces of Whatman No.4 filter paper and two pieces of
Scotchbrite foam, also totally immersed in blotting buffer. The sandwich was placed into a
Western blotting apparatus filled with blotting buffer. The apparatus was connected to a power
supply so that the nitrocellulose was on the anodal side of the gel, and blotting was effected
for 16 h at 200 mA. The buffer was stirred by a magnetic stirrer throughout. the process to
ensure even distribution of cooling. After 16 h, the sandwich was removed and the filter paper
was peeled off the gel. The gel was carefully removed, and stained to assess the efficiency of
blotting.
The nitrocellulose sheet was removed from the filter paper and air dried for about 1.5 h. The
nitrocellulose strip was blocked for 1 h with 5% (w/v) low fat milk powder in TBS, washed in
TBS (3 x 5 min), and incubated for 2 h in primary antibody in 0.5% BSA-PBS. Following
washing in TBS (2 x 5 min), it was incubated in HRPO-linked secondary antibody in 0.5%
BSA-PBS for 1 h. After washing with TBS (3 x 5 min), it was immersed in substrate solution
and reacted in the dark until bands were clearly evident against a lightly stained background.
Finally the strip was removed from the substrate solution, and washed in dist.H20 and dried
between filter paper. This last step insured good preservation of the bands before scanning.
2.11 Reverse transcription polymerase chain reaction (RT-PCR)
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A very sensitive diagnostic method called reverse transcription polymerase chain reaction
(RT-PCR) has been used successfully to amplify the IBDV viral protein-2 (VP2) gene region
of the virus with specific primers designed from the highly conserved region of VP2 (Barlic-
Maganja et al., 2002). This molecular technique is very fast, sensitive and specific that allows
the detection and the analysis of very small samples (Lee et al., 1992).
2.12 Polymerase chain reaction (PCR)
Although direct amplification of RNA using a single enzyme called polymerase (Tth) from
Thermus thermophilus is possible, originally the procedure was based on the reverse
transcription (RT), of the RNA into cDNA by a reverse transcriptase prior to amplification by
Taq polymerase (Kawasaki, 1990) (Fig. 2.1). The reaction components are a DNA template
containing the region to be amplified, two primers flanking this region, and thermostable DNA
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polymerase isolated from T. aquaticus, called Taq polymerase. This technique is based on
three successive cycles of denaturation, annealing and synthesis at different suitable
temperatures. The primary step is denaturation of the double stranded DNA template at 90-
95°C. After cooling the mixture to the annealing temperature, which is approximately 55°C,
the target specific oligonucleotide primers anneal to the 5' end of the two single stranded
templates. For the third step, which is the extension step, the temperature is raised to 72°C and
the primer target hybridisations serve as initiation points for the synthesis of new DNA
strands. The time of incubation required for each step is usually between 1-2 min. One cycle
of PCR comprises this sequence of three steps. In the second cycle, the newly synthesised
DNA strand serves as a template for the next cycle (Fig 2.2) (Edel, 1998). Normally, PCR is
carried out for about 30-40 cycles, which is sufficient to amplify specific parts of DNA, which
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Figure 2.1 Synthesis of the first strand of cDNA using an oligo(dT) primer and reverse transcriptase
(after Sambrook and Russell, 2001) .
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Figure 2.2 Principle of peR amplification (after Edel, 1998).
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2.12.1 Materials
Primer 1 (anti-sense primer) stock solution (Section 3.6.1). 720.1 OD/ml (4036.92 p.M).
Primer 2 (sense primer) stock solution (Section 3.6.1).890.5 OD/ml (4538.36 p.M).
Primer 1 (anti-sense primer) working solution (30 gM). Primer stock solution (0.37 p.l) was
diluted in 49.63 ILl of DEPC treated deionised H20 to final volume of 50 p.l.
Primer 2 (sense primer) working solution (30gM). Primer stock solution (0.33 p.l) was diluted
in 49.67 p.l of DEPC treated deionised H20 to final volume of 50 p.l.
Enzyme mix: Expand High Fidelity enzyme mix, reverse transcripytase, AMV, in storage
buffer (100 gI). From Roche.
RT-PCR reaction buffer (5 x Cone.) with 7.5 mM MgCh and DMSO (1.0 mI). From Roche.
MgCh solution (25 mM) (1.0 mI). From Roche.
Dithiothreitol solution (100 mM) (1.0 mI). From Roche.
dNTP stock solution [2.5 mM of each dATP, dCTP, dGTP and dTTPl. From Takapo.
DEPC treated ddH20 [0.1% (v/v) DEPC]. Diethylpyrocarbonate (DEPC) (lOO p.l) was made
up to 100 ml with deionised dist.H20, the solution incubated at 37°C for 12 hand autoclaved
at 121°C for 15 min.
2.12.2 Method
One tube RT-PCR was performed according to Barlic-Maganja et al. (2002). RNA sample
(lOO ng), AMV (1 p.l), sense and anti-sense primer (0.6 p.l/20 pmol), 5 mM DIT (2 p.l), mixed
dNTP (4 p.l/0.2 mM) and 5 x RT-PCR buffer with Mg2+ (l0 p.l) was made up to 50 p.l with
DEPC treated ddH20. The RT-PCR reaction was carried out with uninterrupted thermal
cycling under the following conditions: 45 min at 48°C for reverse transcription and 2 min at
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94°C for AMY reverse transcriptase inactivation and RNA/cDNA/primer denaturation, 40
cycles of 30 s at 94°C, 1 min at 60°C and 2 min at 68°C for PCR, and a final extension step of
7 min at 68°C. The reaction products were analysed by electrophoresis on a 2% agarose gel





DIAGNOSTIC METHODS FOR INFECTIOUS BURSAL DISEASE VIRUS (IBDV)
3.1 Introduction
The objective of this part of the study was the development of diagnostic tests for IBDV
infection. Infectious bursal disease virus was isolated from IBDV infected bursal tissue using
CsCI density gradient centrifugation and its identity was analysed using Tris-Tricine SDS-
PAGE and electron microscopy. Double stranded IBDV RNA (dsRNA) was purified from
IBDV using proteinase K digestion followed by phenol:chloroform extraction and ethanol
precipitation. For further purification, the impure RNA was run on a low melting point agarose
gel and double stranded RNA was subsequently extracted from the gel and recovered by
agarase I enzyme. The homogeneity of the purifications was evaluated by agarose gel
electrophoresis. Specific primers were designed from the highly conserved genome coding for
the IBDV VP2 and RT-PCR was performed on the isolated dsRNA. Following isolation of the
double stranded RNA; four commercial IBDV live vaccines were also tested for the presence
of IBDV using RT-PCR. The test was proved to be positive by the amplification of a 150 bp
band. The correctness of the amplified PCR product was confirmed by restriction digestion
with a specific restriction endonuclease (Barn HI) resulting in correct digestion fragments of
size 93 and 57 bps.
3.2 IBDV purification using CsCI density gradient centrifugation
Various biological studies of viruses require the presence of highly purified and concentrated
virus particles, either from clinical or infected tissue culture cells. The most frequently used
purification method has been Freon (tri-chloro-tri-fluoroethane) extraction and concentration
of viruses by pelleting, followed by CsCl gradient centrifugation (Chen and Ramig, 1992).
Purification of viral particles has been performed using cesium chloride isopycnic density
gradient centrifugation, a method which can exploit the difference in G + C content of the host
cellular and viral nucleic acids (Mellerick and Fraser, 1987).
The usual method used to establish a CsCl gradient is through homogenisation of the virus
with the CsCI solution and centrifugation until the sedimentation-diffusion equilibrium is
reached. The time required for the separation of the viruses by their buoyant density depends
on the type of rotor used. When a fixed-angle rotor is used, the time ranges from 36 to 50 h,
because the centrifugation time is mostly spent in collecting the virus molecules into the
equilibrium bands. This time problem can be solved by the use of a steep step gradient
technique i.e. when the virus is placed in the upper or lower portions of the CsCI solution, the
centrifugation time required for the separation of the virus reduces to 12 h. Further reduction
can be achieved, with swing out rotors; this technique can reduce the time required for the
formation of virus bands in their equilibrium position to 2 h.
During the course of centrifugation using an isopicnic density gradient the force affecting viral
sedimentation is
F = MV (pm -pg)alr,
N
where M is the molecular weight of the viruses, V is the partial specific volume of the viruses,
N is Avogadro's number, pm is the equilibrium buoyant density of the viruses, pg is the
density of the gradient at the position of the viruses, ill is the angular velocity, and r is the
distance from the centre of the rotation (Babykin and Zinchenko, 1984).
CsCl gradient centrifugation is a powerful technique for purification of viruses from infected
tissue with higher yield and purity. In this project IBDV purification was performed according
to the method of Femandez-Arias et al. (1998) with slight modifications. Homogenisation
buffer containing only Tris-HCI was used in this study instead of TEN buffer (10 mM Tris-
HCI, pH 7.2; 100 mM NaCI and 1 mMEDTA). Since the objective was to purify IBDV from
bursal cells there was no need of stabilising the inclusion bodies following lysis of the cell
(Sambrook and Russell, 2001). A two-step density gradient centrifugation using 1.37 and
1.27 glml of CsCl solutions was employed as a replacement for the one-step density gradient
centrifugation using 1.3 glml CsCI solution, as clearer bands were evident following the
addition of the second step i.e. 1.27 glml of CsCl solution.
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3.2.1 Materials
Homogenisation buffer (0.02 M Tris-HCI buffer pH 7.8). Tris (2.42 g), was dissolved in
950 ml of dist.H20, adjusted to pH 7.8 and made up to 1 litre.
40% (w/v) sucrose. Sucrose (60 g) was dissolved in a minimum of homogenisation buffer and
made up to 150 ml with homogenisation buffer.
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Dialysis buffer (0.01 M Tris-HCI buffer pH 7.8). Tris (1.21 g), was dissolved in 950 ml of
dist.H20, adjusted to pH 7.8 and made up to 1 litre.
Cesium chloride solutions. Two solutions of cesium chloride were prepared by dissolving
cesium chloride in homogenisation buffer until the density reached 1.27 g/cm3 and 1.37 g/cm3
respectively. The density of the solution was estimated by withdrawing 1 ml fractions of the
solution and determining the mass on a balance. The density was adjusted by adding more
cesium chloride or homogenisation buffer.
3.2.2 Method
An equal volume of homogenisation buffer was added to the infected bursal tissue and
homogenised using a Potter S homogeniser. After removing the cell debris by low speed
centrifugation (17 000 g, 15 min, O°C), the supematant was recovered, loaded on top of 2 ml
sucrose cushions (40%) and centrifuged in a Beckman SW 40 rotor (86 000 g, 2.5 h, 2°C).
After centrifugation, the pellet was thoroughly resuspended in homogenisation buffer and
layered over half its volume of a density of 1.37 g/cm3 CsCI in homogenisation buffer. The
preparation was centrifuged (86000 g, 6 h, 2°C). After centrifugation,·a viral band was clearly
visible towards the top of the gradient. This band was collected by aspiration using a Pasteur
pipette, resuspended in homogenisation buffer and dialysed overnight against dialysis buffer
for removal of cesium chloride.· The dialysed suspension was layered again over half its
volume of a density of 1.27 g/cm3 cesium chloride and centrifuged (86 000 g, 6 h, 2°C). Virus
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particles from the interface were resuspended in homogenisation buffer, dialysed overnight
against dialysis buffer and analysed by Tris-tricine SDS-PAGE (Section 2.4.4).
3.3 Identification of IBDV using transmission electron microscopy
Electron microscopy is a useful diagnostic tool to identify infectious virus particles (Curry,
2000). IBDV can be identified using a negative staining diagnostic method, which is used to
resolve the shape, size or structure of a particular microorganism using high-resolution
electron microscopy. The viral suspension is fixed in a negative stain, e.g. a metal such as
phosphotungstic acid (PTA) and uranyl acetate. On drying, the electron-dense metal atoms
surround the specimen. The difference in intensity between the specimen and the surrounding
heavy metal atoms produces the necessary contrast. The specimen appears bright, surrounded
by the dark background of dried metallic stain. The electron beam passes though the low
electron density of the specimen (virus), but not though the metallic background. The
specimen base is revealed by the penetration of the stain into its holes and crevices. The clarity
of the specimen depends on the degree to which the stain remains nebulous as it dries, as well
as on the thickness of the dried negative stain envelope (Hayat, 1989).
3.3.1 Materials
Washing buffer (0.05 M cacodylate buffer, pH 7.1). Sodium cacodylate (8 g), was dissolved in
950 ml dist. H20, adjusted to pH 7.1 with NaOH and made up to 1litre.
2% (w/v) uranyl acetate. Uranyl acetate (2 g) was dissolved in washing buffer (lOO ml).
3.3.2 Method
Electron microscopy analysis of infectious bursal disease virus was performed according to
the method of Fernandez-Arias et al. (1998). Purified infectious bursal disease virus particles
(viral suspension obtained after centrifugation though 40% sucrose cushion, Section 3.2.2),
were attached to electron microscopy (EM) copper grids covered with collodion and carbon
that had previously been made hydrophilic by glow discharge. These grids were placed on
drops of the viral suspension, and incubated for 2 min. Adsorbed particles were negatively
stained for 30 s with a 2% solution ofuranyl acetate and viewed on the EM 120 Brotwin TEM
at 80 KU.
3.4 RNA isolation
Infectious bursal disease virus has a double stranded viral RNA (Boot et al., 2000a). There are
several methods for the detection, isolation and characterisation of double stranded RNAs
(dsRNAs) from viruses. Most of the methods developed involve enzymatic treatment for the
extraction of total nucleic acids from virally infected tissues (Diaz-Ruiz and Kaper, 1978).
Purification of double stranded IBDV RNA requires purification of IBDV from infected bursal
tissue and dsRNA extraction from the purified viral particles by proteinase K digestion over an
extended period of time. Following proteinase K digestion the resulting IBDV RNA is
obtained by ethanol precipitation (Akin et al., 1998). The IBDV dsRNA can be recognised
,.. according to its electrophoretic mobility in 1% agarose gels (Diaz-Ruiz and Kaper, 1978).
3.4.1 Materials
Homogenisation buffer (0.02 M Tris-HCI buffer pH 7.8). As per Section 3.2.1
40% (w/v) sucrose. As per Section 3.2.1
Diethylpvrocarbonate (DEPC) treated ddH20 rO.1 % (v/v) DEPC]. DEPC (100 pI) was made
up to 100 ml with ddH20, incubated at 37°C for 12 h and the solution was autoclaved (12l oC,
15 min).
0.5 M Tris-HCl buffer, pH 8.0. Tris (30.28 g) was dissolved in 450 ml of dist.H20, adjusted to
pH 8.0 and made up to 500 ml. The solution was sterilised by autoclaving prior to use.
0.1 M Tris-HCI buffer, pH 8.0. Tris (6.05 g) was dissolved in 450 ml of dist.H20, adjusted to
pH 8.0 and made up to 500 ml. The solution was sterilised by autoclaving prior to use.
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Viral lysis buffer [lOO mM Tris-HCl buffer, 150 mM NaCl, 12 mM EDTA, 1% (w/v) SDS,
pH 7.5]. Tris base (3.03 g), and NaCl (2.19 g) were dissolved in dist.H20 (150 ml), 100 mM
EDTA (30 ml) and 10% (w/v) SDS (25 ml) were added. The pH was adjusted to 7.5 with HCl,
and made up to 250 ml. The solution was sterilised by autoc1aving prior to use.
Tris-saturated phenol. Equilibration of phenol was performed according to the method of
Sambrook and Russell (2001). Crystallised phenol (stored at -20°C) was allowed to warm at
room temperature and melted in a boiling water bath (68°C) in a fume hood.
Hydroxyquinoline was added to a final concentration of 0.1 % (v/v). An equal volume of 0.5 M
Tris-HCl buffer, pH 8.0 was added and the mixture stirred for 15 min. After the mixture had
settled, as much as possible of the aqueous (upper) phase was removed by aspiration. The
same process was repeated using 0.1 M Tris-HCl buffer, pH 8.0 until the pH of the phenolic
phase was> 7.8 (as measured with pH indicator paper). After the phenol was equilibrated, 0.1
volume of 0.1 M Tris-HCl, pH 8.0 was added and stored at 4°C in an amber bottle.
Hydroxyquinoline is an antioxidant, a partial inhibitor of RNase, and a weaker chelator of
metal ions. In addition, its yellow color provides a convenient way to identify the organic
phase.
Proteinase K (5 mg/ml). Proteinase K from Tritirachium album (5 mg) was dissolved in sterile
ddH20 (1 ml), dispensed into aliquots of (50 III each) and stored at -20°C. Multiple freeze-
thaw cycles were avoided.
25 x agarase I buffer (0.75 M Bis-Tris buffer, 0.25 M EDTA, pH 7.1). Tris (60.55 g), EDTA
(4.65 g) and glacial acetic acid (14.27 ml) were dissolved in 200 ml of dist.H20, adjusted to
pH 7.1 and made up to 250ml.
3 M sodium acetate buffer pH 5.2. Sodium acetate (24.61 g), was dissolved in 80 ml of dist.
H20 adjusted to pH 5.2 and made up to 100 ml.
10 mM sodium phosphate buffer, pH 7.0. NaH2P04.2H20 (1.56 g) was dissolved in 950 ml of
dist.H20 adjusted to pH 7.0 and made up to 1 litre.
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Acridine orange stock solution (50 mg/ml acridine orange). Acridine orange (0.5 g) was
dissolved in 10 ml of 10 mM sodium phosphate buffer, pH 7.0 and stored at RT. Stock
solution was diluted with dist.H20 to give a working concentration of 30 /Lg/ml.
3.4.2 Method
Viral pellets isolated as described in Section 3.2.2 were resuspended in viral lysis buffer
(depending on size ofthe pellet) for RNA isolation according to Femandez-Arias et al. (1998).
The resuspended pellets were digested with proteinase K (500 /Lg/ml) for 1 h at 37°C. The
solution was extracted with half a volume of phenol and half a volume of chloroform and the
aqueous phases were removed into a clean microfuge tube. A second phenol:chloroform
extraction was performed on this aqueous phase. Viral RNA was precipitated by the addition
of 2 volumes of cold ethanol and stored at -20°C for 2 h. Total RNA was pelleted by
centrifugation (15 000 g, 15 min, O°C) and resuspended in an appropriate volume of DEPC
(diethyl polycarbonate) treated ddH20.
Crude RNA was subjected to 1% low-melting point agarose gel electrophoresis (Section 2.6.2)
to separate the two genomic segments of IBDV. The large RNA segment (dsRNA) of
approximately 3.2 kb was excised from the gel and recovered by agarase 1. The weight of the
excised band was determined (100 mg = 100 /LI agarose gel) and 0.04 volumes of25 x agarase
I buffer was added before incubating at 65°C for 15 min or until the agarose gel melted. The
agarose was cooled to 45°C and 0.01 /LI of agarase I per 1 mg of gel was added and incubated
for 1 h at 45°C. To isolate the dsRNA, 0.1 volume of 3 M sodium acetate buffer, pH 5.2 was
added to the melted agarose solution and incubated on ice for 15 min. Oligosaccharides were
pelleted by centrifugation (16 000 g, 15 min, RT) and the supematant was placed in a suitable
centrifuge tube. Three volumes of ice-cold ethanol was added to the supematant and kept for
1 h at -20°C. The tubes were centrifuged (14 000 g, 25 min, 4°C) and the RNA pellet was air
dried by careful aspiration before resuspended in DEPC treated ddH20.
Following nondenaturing gel electrophoresis (Section 2.5.2), the gel was incubated in the dark
in acridine orange solution (30 /Lg/ml, 30 min) and destained in an enamel pan through a
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number of changes of 10 mM phosphate buffer. The enamel adsorbs acridine orange and thus
reduces the time needed to remove the high background fluorescence of the gel. The gel was
viewed using DV light.
3.5 Design of VP2 primers
Despite the fact that primers are crucial elements of the PCR system, which can decide the
failure or success of the amplification reaction, there are a few guidelines available for primer
design (David, 1998). It is highly advisable to use one of the software packages available such
as Basic Local Alignment Search Tool (BLAST) (www.expasy.org/swis-prot).
During primer design some of the factors listed below should be taken into account.
(a) Melting temperature (Tm), one of the most essential parameters, should be between
68-78°, though temperatures of 50-55° can be used, but with great risk of mispriming.
In the absence of a computer program, the 2 + 4 rule can be used as an alterative quick
estimation i.e. Tm = 2(A + T) + 4(0 + C).
(b) Primer length, although there is no rule which specifies the exact length of primers to
use, the length can vary from a minimum of 18 to a maximum of 30 bases, and an
average of20-22 is commonly used.
(c) There should not be more than four of any single base in succession, particularly at the
3'-end of the primer where polymerisation is initiated.
(d) The presence of simple sequence repeats, such as CACACA or OTGTGT, in any of
the primers should be avoided to prevent binding of the primer to simple repeats
present at many sites in the genome.
(e) To allow higher binding and efficient polymerisation, the primers should end in a 0 or
C "clamp" rather than with A or T (David, 1998).
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3.5.1 Method
Reverse transcription polymerase chain reaction amplification of IBDV was performed using
two appropriate oligonucleotide primers. The primers were selected from the highly conserved
VP2 genome region based on a previously published sequence using the computer program
BLAST (Wu et al., 1992). The sequences of the two primers are given in Fig. 3.1. The inter
primer spacing for primer 1 and primer 2 is 108 base pairs. This set of primers specified a 150-
base-pair sequence located at nucleotide position 1760 to 1910 of the IBDV large RNA
segment (Fig. 3.2).
Primer 1 5' - CAA CAG TGT AGT CTC TCC CG -3' (anti-sense primer)
Primer 2 5'- AGA TGT TTG CTG TCA TTG AAG G -3' (sense primer)
Figure 3.1 Oligonucleotide primer pair designed for the detection of the VP2 genome of IBDV.
3.6 Titan® one tube RT-PCR system
The currently used two-step RT-PCR system increases the risk of contamination during the
addition of reverse transcriptase and Taq DNA polymerase at different intervals of the reaction
process, which results into higher error rates and low amplification (Barlic-Maganja et al.,
2002). These problems can be solved using the Titan® one tube RT-PCR system that uses one
optimised reaction buffer and a blend of enzymes to offer maximum performance. A single
tube also lowers the risk of contamination. The objective of this method is to avoid
contamination and achieve full-length transcription using a single buffer. Roche's Expand®
PCR system's blend of thermostable enzymes, results in very low error rates and allows for
larger amplified PCR products (up to 6 kb). The Expand@ PCR system uses a proofreading
polymerase and Taq DNA polymerase to produce the amplification product. This enzyme
combination is optimised to ensure a three-fold increase in fidelity, when compared to using
Taq polymerase alone (Roche, product information sheet, 2003). This technique enables
reverse transcription of IBDV RNA into cDNA and then amplification by PCR under a single
set of conditions, hence the possibility of contamination due to opening the reaction tube after
the initial reverse transcription, and the hands-on work required in the two-step technique is
reduced (Barlic-Maganja et al., 2002).
3.6.1 Materials
Buffers and reagents as described in Section 2.12.1
Primer 1 (anti-sense primer) 5' CAA CAG TGT AGT CTC TCC CG 3'.
Primer 2 (sense primer) 5' AGA TGT TTG CTG TCA TTG AAG G 3'.
Primers used in the present study were synthesised by the department of Molecular and
Cellular Biology University of Cape town.
3.6.2 Method
As described in Section 2.12.2
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Figure 3.2 Primer selection using BLAST from the highly conserved VP2 genome of infectious bursal
disease virus large RNA segment. The primer in red is the sense primer and the primer in blue is the anti-sense
primer. Bases in yellow is a BamHI restriction site.
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Table 3.1 Summary of the reaction components for one tube RT-PCR
Component Volume Final concentration
(JLI) in the RT-PCR (JLM)
Master mix 1:
DEPC treated ddH20 16.67
<lATP, PCR Grade, 10 Mm 1 200
dCTP, PCR Grade, 10 mM 1 200
dGTP, PCR Grade, 10 mM 1 200
dTTP, PCR Grade, 10 mM 1 200
Down stream primer, 30 JLM 0.6 0.4 (20 pmol)
Upstream stream primer, 30 JLM 0.6 0.4 (20 pmol)
Template RNA (42 JLg/ml) 0.63 2 ng/JLI
DTT-solution (100 mM) 2.5 5000
Total volume 25
Master mix 2:
DEPC treated ddH20 14
5 x RT-PCR buffer with Mg2+ 10 1500 JLM MgClz
Enzyme mix AMV and Expand 1
High fidelity PCR-system
Total volume 25
3.7 PCR product cleavage by BamID restriction endonuclease
The 645 restriction endonucleases described to date with 137 distinct specificities, are divided
into three general classes based on their size and their co-factor requirements for DNA
cleavage. High molecular weight multienzyme complexes are called type I endonucleases,
which require magnesium, ATP and adenosylmethionine for DNA cleavage. Type IT
endonucleases are of lower molecular weight and consist mostly of homodimers, require
divalent cations with a preference for magnesium for cleavage. Type III endonucleases require
ATP and magnesium for cleavage and adenosylmethionine as an allosteric effector. Due to the
ease of data acquisition and the high specificity of DNA sequence recognition, type IT
endonucleases are suitable model systems for studying protein and DNA recognition, and
specific DNA strand cleavage.
A restriction enzyme BamHI (from Bacillus amyloliquefaciens H), which is a type IT
restriction endonuclease, recognises the duplex symmetrical sequence 5' -GGATCC-3'. In the
presence of Mg+2 , the enzyme catalyses DNA cleavage between the guanines (GG), generating
5'-phosphoryl and 3'-hydroxyl staggered termini (Hensley et al., 1990). BamHI was used to
determine the correctness of the amplified PCR product. Thus, as shown in Fig. 3.10, cleavage
of the150 base pair PCR product should result in fragments of93 and 57 base pairs.
3.7.1 Materials
BamHI from Promega.
10 x restriction buffer from Promega.
Acetylated bovine serum albumin from Promega.
3.7.2 Method
PCR product (13 ,111), 10 x restriction buffer (2 ,111), acetylated BSA (0.2 ,111) andrestiction
enzyme, BamHI (2,111) were made up to 20 JLl with DEPC treated ddH20 (Section 3.4.1). The
sample was mixed in a microfuge (12 000 g, 5 s, RT) and incubated overnight at 37°C. Prior
to analysis by nondenaturing PAGE (Section 2.5.2) and agarose gel electrophoresis (Section






Infectious bursal disease virus purification was performed usmg CsCl density gradient
centrifugation (Section 3.2.2). A band of viral particles was clearly visible towards the top of





Figure 3.3 Schematic representation of IBDV purification from infected bursal tissue using CsCI
.density gradient centrifugation.
3.8.2 Tris-Tricine SDS-PAGE analysis ofIBDV purification
To determine the success of IBDV purification using CsCI density gradient centrifugation,
Tris-Tricine SDS-PAGE analysis was performed on the purified IBDV particles (Fig. 3.4).
Purified infectious bursal disease virus showed five protein bands at ca 90, 42, 32, 28 and
17 kDa (lane 5). The results presented here illustrate the value of the second CsCl density
(1.27 g1cm3) gradient centrifugation step that results in clearly visible protein bands (lane 4
compared to lane 5).








Figure 3.4 Tris-Tricine SDS-PAGE analysis ofIBDV purification steps from infected bursal tissue.
Samples (5 Jlg) were boiled for 3 min in 20 Jll of reducing treatment buffer and loaded onto 10% Tris-
Tricine SDS-PAGE. Samples were visualised by silver staining (Section 2.7.2.2). Lanes 1 and 6, molecular
weight markers, phosphorylase b (94 kDa), bovine serum albumin (67 kDa), ovalbumin (43 kDa), carbonic
anhydrase (30 kDa), soybean trypsin inhibitor (20 kDa) and a-lactalbumin (14 kDa); Lane 2, homogenised
bursal tissue; Lane 3, pellet obtained after centrifugation in a 40% (w/v) sucrose gradient; Lane 4, viral
particles from the interface after centrifugation over density gradient of 1.37 g/cm3 cesium chloride; and
Lane 5, viral particles from the interface after centrifugation over density gradient of 1.27 g/cm3 cesium
chloride.
The same gel was stained with Coomassie blue R250 (Section 2.7.1.2) but the bands were not
clearly visible, probably as a result of the lower sensitivity of this staining technique.
3.8.3 IBDV detection using transmission electron microscopy
Electron microscope analysis (Section 3.3.2) was performed to determine the presence of
infectious bursal disease virus in the sample purified by CsCl gradient centrifugation. The
result is presented in Fig. 3.5 and shows the same structural features as those described by
Botlcher et al. (1997); the virus is an isometric particle with a diameter of about 60 to 65 nm.
It is non-enveloped and appears to be single shelled with a relatively dark body.
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Figure 3.5 Negative staining electron microscopic analysis of infectious bursal disease virus. Bar
represents 120 nm
3.8.4 RNA purification
Even though the success ofIBDV purification was confinued by Tris-Tricine SDS-PAGE and
electron microscope analysis it was decided to make sure that IBDV was present in the
purified sample using the size of its double stranded RNA (dsRNA) genome. Secondly for
RT-PCR amplification purposes, it was necessary to purify double stranded IBDV RNA. As
shown in Fig. 3.6 (lane 3) the isolated IBDV dsRNA has a size of approximately 3200 bp.
There was contamination by chicken ssRNA from the bursa as shown by a band at 350 bp
(Fig. 3.6, lane 2). A second purification step using the agarase I purification kit (Section 3.4.2)
was thus needed to purify the double stranded viral RNA from the crude/contaminated sample
(lane 3).











Figure 3.6 RNA purification from mnv infected bursal tissue. Lane 1, molecular weight
markers; Lane 2, crude RNA and Lane 3, purified double stranded mDV RNA. The positions of ds
and ssRNA are indicated by the arrows.
To determine whether the purified mDV RNA is double stranded RNA, the crude RNA (Fig.
3.6, lane 2) was subjected to nondenaturing PAGE and stained with acridine orange (Section
3.4.2). The upper bands around 3200 bp appeared as bright green which is an indication of
dsRNA, while the band at the bottom of the gel i.e. band around 350 bp appeared bright red
which is an indication of ssRNA (result not shown).
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3.8.5 Amplification of IBDV double stranded RNA using RT-peR
Reverse transcription polymerase chain reaction amplification (Section 2.12.2) was performed
using the primers detailed in Fig. 3.1. Double stranded RNA of IBDV was detected as
indicated by a band at 150 bp (Fig. 3.7). Due to the small size of the amplified product (150
base pairs) it was very difficult to see the amplified peR product in a 1% (w/v) agarose gel,
but this problem was solved by increasing the agarose gel percentage to 2% (w/v) (Fig. 3.7A)
and by using a 15% nondenaturing polyacrylamide gel (Fig. 3.7B) which resulted in amplified
bands that could be easily observed. Due to the large number and close proximity to one
another of the DNA molecular weight markers, their sizes are only listed in the figure legend.
1 2 3 1 2
A B
Figure 3.7 Amplification of double stranded IBDV RNA using one tube RT-peR reaction.
A) Samples were analysed on a 2% (w/v) agarose gel after 40 cycles of one tube RT-peR and ':'
stained with ethidium bromide (Section 2.6.2). Lane 1, DNA molecular weight markers (2642 bp,
750 bp, 500 bp, 250 bp 200 bp, 150 pb, 100 bp, 50 bp); Lane 2, negative control without template;
and Lane 3, double stranded IBDV RNA (100 ng). B) 15% non-denaturing PAGE gel stained with
ethidium bromide (Section 2.5.2). Lane 1, double stranded IBDV RNA (100 ng); and Lane 2, DNA
molecular weight markers. Arrows indicate the position of the amplified product.
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3.8.6 Evaluation of commercial live IBDV vaccines using one tube RT-PCR
Due to the fact that most commercially available IBDV vaccines consist of killed or attenuated
viruses, they were useful for the evaluation of the one tube RT-PCR assay for the diagnosis of
IBDV. Four commercial IBDV vaccines, namely NOBILS® GUMBORO D78, NOBILS®
GUMBORO 228E, TAD Gumboro Vac 100ds (cloned) and TAD Gumboro Vac forte lOOOds
were used in the assay. Since the RNA is inside the virus, direct amplification using the
primers detailed in Fig. 3.1 was impossible. Instead, RNA first had to be isolated according to
the method in Section 3.4.2. A 150 bp band was amplified in all cases (Fig. 3.8). As a result of
the small size of the amplicon, the samples were also electrophoresed on a 15% nondenaturing
polyacrylamide gel (Fig. 3.8B). This resulted in improved resolution of the 150 bp amplicon.
1 2 3 4 5 6 1 2 3 4 5 6
A B
Figure 3.8 Amplification of live commercial IBDV vaccines using one tube RT-PCR. A) Samples
were analysed on a 2% (w/v) agarose gel after 40 cycles of one tube RT-PCR and stained with ethidium
bromide (Section 2.6.2). Lane 1, DNA molecular weight markers (2642 bp, 750 bp, 500 bp, 250 bp
200 bp, 150 pb, 100 bp, 50 bp); Lane 2, NOBILS® GUMBORO D78 (lOO ng); Lane 3, NOBILS®
GUMBORO 228E (100 ng); Lane 4, TAD Gumboro Vac forte 1000ds (lOO ng); Lane 5, TAD Gumboro
Vac 1000ds (100 ng) (cloned); and Lane 6, negative control without template. B) The same samples as in
panel A, analysed on a 15% nondenaturing PAGE gel stained with ethidium bromide (Section 2.5.2).
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3.8.7 BamID restriction digestion ofthe RT-PCR amplified IBDV product
To confirm the identity of the amplified 150 bp RT-PCR product (Section 3.8.5), restriction
digestion using BamHI was performed. The cleavage site of BamHI in the IBDV sequence is
shown in Fig. 3.9. BamHI cleaved the 150 bp PCR product into two fragments of the expected
size, i.e. 93 and 57 base pairs (Fig. 3.10). 1
AGATGTTTGCTGTCATTGAAGGCGTGCGAGAAGACCTCCAACCTCCATCTCAAAGAGGATCCTTCATACGAACTC
TCTCCGGCCACAGGGTCTATGGCTATGCTCCAGATGGGGTGCTCCCTCTGGAGACCGGGAGAGACTACACTGTTG
Figure 3.9 Nucleic acid sequence of the amplified 150 bp peR product of IBDV dsRNA showing the
BamHI restriction site. The primer sequences are shown in red and blue. Sequences shown in yellow are
duplex symmetrical sequence and the arrow indicates the BamHI cleavage site.
3.9 Discussion
This chapter described diagnostic techniques for IBDV, which included IBDV purification
using CsCI density gradient centrifugation, Tris-Tricine SDS-PAGE analysis of the protein
profile, electron microscopic analysis of IBDV particles, dsRNA purification and RT-PCR
amplification of the VP2 gene.
Despite reports that CsCI purification affects the stability of some purified viruses (Chen and
Ramig, 1992), IBDV purification using CsCI density gradient centrifugation was successful
giving a satisfactory yield of viral suspension. This was confirmed by Tris-Tricine SDS-PAGE
analysis (Fig. 3.4), which indicated that the isolated virus was probably IBDV showing five
viral proteins namely VPI, VP2, VP3, VP4 and VP5 with approximate molecular weights of
91, 42, 32, 28 and 17 kDa respectively, which agree with reported values of Schoder et al.
(2000). This result is also similar to that reported by Boot et al. (2000a) showing that IBDV
has dsRNA that is divided into two segments, A and B. The A-segment (3.3 kb) contains two
partly overlapping open reading frames (ORFs). The first, smallest ORF encodes the non-
structural viral protein 5 (VP5, 17 kDa). The second ORF encodes a polyprotein (110 kDa),
which is autocatalytically cleaved into VP2 (42 kDa), VP4 (28 kDa) and VP3 (32 kDa). The
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B-segment (2.9 kb) contains one large ORF, encoding the 91 kDa VP1 protein. VP2 and VP3
are the major viral proteins, with VP2 on the outer surface of the virus and it is believed to be
a viral attachment protein (VAP) to the receptor on the surface ofbursal cells.
1 2 3 1 2 3
A B
Figure 3.10 Restriction digestion of mnv 150 bp peR product using Bamm. A) Restriction
digestion samples were analysed on a 2% (w/v) agarose gel and stained with ethidium bromide (Section
2.6.2). Lane 1, DNA molecular weight markers (2642 bp, 750 bp, 500 bp, 250 bp, 200 bp, 150 pb, 100 bp,
50 bp); Lane 2, undigested 150 bp PCR product; and Lane 3, digested PCR product. B) The same samples
as shown in panel A were analysed on a 15% nondenaturing PAGE gel stained with ethidium bromide
(Section 2.5.2). The positions of the 93 and 57 cleavage products are indicated by the arrows.
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Since some reports revealed the instability of some strains of IBDV on banding in CsC1 gradients
(Bottcher et al. 1997), an IBDV sample obtained with centrifugation in a 40% (w/v) sucrose
cushion was used for electron microscopy examination. The isolated viral particles showed a
nonenve10ped isometric structure with a diameter of ca 60 to 65 run, consistent with the findings
of Bottcher et al. (1997).
The purification of viral dsRNA proved very difficult because there was contamination by
chicken ssRNA during homogenisation of bursal tissue. This was shown by the presence of
single and double stranded RNAs in the agarose gel (Fig. 3.6 Lane 2). Attempts to purify double
stranded viral RNA using 8 M LiCI were not successful. However, this problem was solved using
the agarase I purification kit (Section 3.4.2). Another problem encountered was the effect of
RNase during RNA purification. RNases are ubiquitous and cannot be easily deactivated, even
through autoclaving. This problem was resolved by using DEPC (diethylpyrocarbonate), which is
an RNase inhibitor in every buffer used with the exception of Tris containing buffers. This is
because in aqueous solution, DEPC hydrolyses rapidly to C02 and ethanol, with a half-life in
phosphate buffer of ca 20 min at pH 6.0 and 10 min at pH 7.0. This· hydrolyses is greatly
accelerated by Tris and other amines, which themselves became consumed in the process.
Therefore DECP cannot be used to treat solutions that contain Tris-buffers (Sambrook and
Russell, 2001).
The purified dsRNA of IBDV had a size of ca 3200 bp (Fig. 3.6 lane, 3) and its double stranded
nature was shown with acridine orange staining. These results match the findings of Azad et al.
(1985). Acridine orange can either intercalate into double stranded helical nucleic acids (green
fluorescence at 530 run) or bind electrostatically to phosphate groups of single-stranded
molecules (red fluorescence at 640 run) (McMaster and Carmichael, 1977). The size of
contaminating red staining chicken ssRNA (350 bp) matches with the size reported by De1any
(2000).
Finally to make sure that the virus being used throughout the present study was IBDV, an
additional powerful and sensitive diagnostic method was performed. The Titan® one tube RT-
PCR reaction was carried out to amplify viral RNA using specific primers. The primers were
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from the highly conserved VP2 genome region of IBDV and a 150 base pair amplified PCR
product was evident both on 2% (w/v) agarose and 15% nondenaturing PAGE gels (Fig. 3.7).
This result matches with the size reported by Wu et al. (1992). Titan® one tube RT-PCR
amplification was also performed on commercial IBDV vaccines to test for the presence of IBDV
and the result was positive (Fig. 3.8). The ability of the oligonucleotide primers to bind to
sequence within the genomic RNA of IBDV to initiate amplification by PCR indicated that the
oligonucleotide primers were relatively specific for IBDV (Wu et aI., 1992). Barlic-Maganja et
al. (2002) and Wu et al. (1992) used uninfected bursae as a negative control. In addition to that
Wu et al. (1992) included genomic nucleic acids of turkey hemorrhagic enteritis virus, infectious
bronchitis virus and reovirus. Due to their tropism to chickens, genomic nucleic acids of
Newcastle disease, Marek's disease and infectious bronchitis should have been included as
further negative controls.
Live vaccines were used in this experiment, which contain lyophilised IBDV. The vaccine virus
is grown in culture containing either allantoic fluid from eggs or tissue culture medium. During
purification of viral RNA from the vaccines there might be some contamination of chicken RNA.
This could result in the smeared banding patterns of the purified RNA (result not shown) and
amplified RT-PCR product (Fig. 3.8)
To determine the correctness of the 150 bp amplified PCR product, it was subjected to restriction
digestion with a specific restriction endonuclease (BamHI). BamHI, in the presence of
magnesium ions, cleaves between the guanine bases (GG) in the duplex symmetrical sequence
(restriction site) 5'-GGATCC-3' that is present in the IBDV VP2 gene sequence (Hensley,
1990). The enzyme cleaved the PCR product to produce digestion fragments of the expected sizes
of93 and 57 bases (Fig. 3.10).
The PCR technique is an exquisitely powerful and sensitive method for diagnosis of IBDV. In the
present study it was possible to detect IBDV in as little as 2 nglJLl of viral RNA from infected
bursal tissue by ethidium bromide staining after 40 cycles of PCR. This technique is based on the
principle that DNA is amplified exponentially by repeating cycles of heat denaturation,
annealing, and primer extension. Theoretically, if PCR is amplified for 50 cycles, the original
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DNA template will be amplified 1.13 x 1015 times. Reports indicated that for the detection of
most viruses, the optimum sites for PCR primers should be within sequences that are unique to
the viral genome in so far that they are conserved among all isolates or strains of the virus (Wu et
al., 1992). This report is supported by that by Barlic-Maganja et al. (2002), where
oligonucleotides for RT-PCR were selected from the highly conserved VP2 genome region of
IBDY. The forward primer corresponding to nucleotide positions 733-756 and the reverse primer
corresponding to nucleotide positions 1212-1189 were selected to amplify 479 base pairs. In the
present study the forward (sense) primer corresponded to nucleotide positions 1760-1782 and the
reverse (anti-sense) primer corresponded to nucleotide positions 1910-1890 of the highly
conserved VP2 genome region to amplify 150 base pairs.
All the above diagnostic methods confirmed that the purified virus was indeed IBDV. Chapter 4
describes the coupling of this virus to Sepharose 4B to form a matrix for affinity purification of
an IBDV receptor protein from uninfected bursal membranes.
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CHAPTER 4
IDENTIFICATION OF AN INFECTIOUS BURSAL DISEASE VIRUS RECEPTOR ON
THE SURFACE OF BURSAL CELLS
4.1 Introduction
A wide range of cell surface molecules serves as receptors for virus binding. Such receptors range
from cell specific transmembrane proteins, such as CD4 as a receptor for HIV, to the more
ubiquitous cell surface-associated carbohydrate moieties e.g. sialic acid for influenza virus (Kim
et al., 2002). These surface molecules are mainly responsible for the host cell specificity and the
site of triggering of the infection (Petit et al., 1992). Viruses exploit these cell surface components
to carry out their own life cycles, mostly to the disadvantage of the host. Viral host and tissue
specificity is determined by the recognition of the cellular receptors by virus particles (Rossmann,
1989). The binding of the virus to the receptor is followed by a biologically significant response,
usually infection of the cell (Uncapher et al., 1991; Gallagher et al., 1992; Varthakavi and
Minocha, 1996). Especially regarding the physiology of a virus, this step is crucial because it
determines the events that follow, i.e. penetration and replication (Hennache and Boulanger,
1977; McDermott et al., 2000). Therefore, to understand the pathogenesis, mode of infection and
the detailed mechanism of virus-cell interaction, it is very important to identify its corresponding
receptor and to characterise the molecular forces involved in viral binding (Gershoni et at., 1986;
Wang et al., 1991).
Identification of virus receptors has proven to be very difficult due to the following: (i) virus
particles, in addition to binding to cells via specific cell receptors in a biologically relevant
manner, also bind non-specifically followed by internalisation through fluid phase or constitutive
endocytosis; (ii) the presence of low numbers of specific receptors on the surface of host cells;
(iii) the possibility of multiple receptors for a single virus, as in the case of human
immunodeficiency virus 1 (HIV-1) and herpes simplex virus (HSV), and '(iv) involvement of
intermediate molecules (Varthakavi and Minocha, 1996). Due to the fact that binding of the virus
to the receptor plays a major role in determining penetration and tissue tropism, identification of
the IBDV receptor on the surface of bursal cells is essential to understand the molecular
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mechanism of IBDV infection and facilitate implication of pathogenesis and the design of
antiviral agents that can intervence early in viral infection (Ogawa et al., 1998b).
The objective of the part of the study reported in this chapter was the purification of an infectious
bursal disease virus receptor identified previously in this laboratory on the surface of bursal cells
(Edwards, 2000). The receptor was subsequently used for an inhibition assay to examine if
inhibition of IBDV binding to the receptor was possible using anti-IBDV receptor peptide
antibodies (Chapter 5). Membrane proteins were isolated from uninfected bursal tissue according
to the method of Nieper and Muller (1998). IBDV was coupled to a Sepharose 4B
chromatography matrix according to the method of Hennache and Boulanger (1977), for affinity
purification of the viral receptor protein from uninfected bursal membranes.
4.2 Isolation of membrane proteins
The most important step for structural and functional characterisation of receptor proteins is the
availability of high-level expression of cell surface receptors and preparation of sufficient
membrane fractions. For this purpose membrane fractions containing the receptors of interest at a
high density must be used. Such high receptor densities are only in rare cases directly available
from natural sources (Pick et al., 2003). It is important that prior to purification proteins should
.be solubilised from their tissue, biological membranes or inclusion bodies (Vuillard et al., 1995).
Membrane proteins include peripheral and integral membrane proteins (Thomas and McNamee,
1990). There is no clear indication yet whether the IBDV receptor on the surface of bursal cells is
a peripheral or integral membrane protein. Thus the whole complement of bursal membrane
proteins was isolated for the affinity purification ofIBDV receptor protein.
4.2.1 Peripheral membrane proteins
Peripheral membrane proteins are surface proteins, hydrophilic in nature and bound to the surface
through electrostatic interactions. They are water-soluble and can be easily purified by usual
chromatographic methods. Peripheral membrane proteins should be prepared under isosmotic
conditions i.e. 0.15 M NaCl. Ionic strength of the solution is very crucial, because high ionic
strength may cause premature solubilisation and low ionic strength non-specific association of
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peripheral membrane proteins respectively (Thomas and McNamee, 1990). However, if the
samples are intended for electrophoretic evaluation or ion exchange chromatography a very low
salt concentration is required (Vuillard et al., 1995).
During the purification of peripheral membrane proteins the following conditions have to be
considered. Gentle conditions including low-ionic-strength buffers, 0.1-1 mM EDTA, or high-
ionic-strength solutions with or without up to 1 M NaCI or KCl. To avoid permanent protein
denaturation, the pH should be in the range of 6-8 and isolation steps should be performed in the
cold. Due to their chaotropic and detergent-like solubilising properties, anions, such as iodide and
diiodosalicylate, have to be avoided (Findlay, 1990). Disruption of the membrane by detergents is
always accompanied by protease activation. For example, EDTA and thiol reagents may activate
proteolytic enzymes making the inclusion ofprotease inhibitors essential (Kaiser et al., 2002).
Some of the functional inhibitors include EDTA and ethylene glycol-bis (,6-aminoethylether)-N,
N, N', N'-tetraacetic acid (EGTA) (0.1-5mM), which inhibit divalent cation-dependent proteases
(Thomas and McNamee, 1990). Phenylmethylsulfonyl (PMSF), diisopropylphosphofluoride
(DFP) and 3,4-dichloroisocoumarin (3,4-DCI) inhibits serine proteases. Due to its toxicity and
short half-life in aqueous solutions at 25°C of only 35 or 110 min at pH 8.0 and 7.0 respectively,
PMSF should be prepared just before use and handled with care (Findlay, 1990). However, this
problem can be solved by the use of 4-(2-aminoethyl)benzenesulfonylfluoride (AEBSF), like
PMSF is an inhibitor of serine protease but more stable at physiological pH than PMSF
(Markwardt et al., 1974). Pepstatin A and [N-(L-3-trans-carboxyoxiran-2-carbonyl)-L-Ieucyl]-
amido(4-guanidino)butane] (E-64) are added to inhibit aspartic and cysteine proteases
respectively (Salvesen and Nagase, 1989). Dithiothreitol (DTT, 0.1-1 mM) is often added to
prevent oxidation. Since most of these compounds have the potential to covalently modify and/or
alter the activity of membrane proteins, caution is advised when using them (Thomas and
McNamee, 1990).
Many peripheral membrane proteins are not recovered by the above gentle conditions and they
require harsher treatments, which result in irreversible protein denaturation. Such treatments
include 6 M guanidine hydrochloride, 8 M urea, 1 mM p-chloromercuribenzoate, dilute acids, pH
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2.0-3.0 and dilute alkali, pH 9.5-11. However, because of its precipitant behaviour, which could
interfere with membrane recovery, alkali treatment is favoured ahead of acidic conditions
(Findlay, 1990; Josic and Zeilinger, 1996).
4.2.2 Integral membrane proteins and their isolation using detergents
Integral membrane proteins, however, are proteins having both hydrophilic and hydrophobic
regions, with hydrophilic regions exposed to the aqueous environment and hydrophobic regions
embedded in between the lipid matrix. (Thomas and McNamee, 1990). To analyse the biological
activity of integral membrane proteins, proteins should first be removed from their associated
lipid in the plasma membrane. These methods depend heavily on the use of detergents and the
nature of the detergent has a significant influence on the success of the purification (Diaz et al.,
1992; Hammond and Zarenda, 1996).
Lipids can be extracted from the matrix using orgamc solvents, but this can cause protein
denaturation. Chaotropic agents, urea, guanidine and enzymatic digestions have also been applied,
,
but these methods are not efficient enough for membrane proteins, which are more strongly bound
to the lipid matrix. For such aggregate molecules the use of detergents such as synthetic
detergents, bile salts and saponins is suitable (Helenius and Simons, 1975). Even in the presence
of detergents membrane proteins have a tendency to form aggregates, which affects the efficiency
of the purification method. Therefore choice of non-denaturing and effective solubilising
detergent is essential to determine the minimum ionic strength, which is suitable for the protein of
interest to be in consistently aqueous state and the maximum ionic strength, which will not affect
protein aggregation (Von Jagow et al., 1994).
Detergents are relatively small molecules possessing both hydrophilic and hydrophobic portions,
which are soluble in an aqueous environment through their hydrophilic portion. If they are present
In excess amounts, molecules associate through their hydrophobic portions into
thermodynamically stable aggregates (called micelles), which are in equilibrium with the free
monomers. Membrane solubility can be achieved by addition of detergents; when added to
membranes they swiftly separate into membrane bilayers until a point is reached whereby the
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membrane is no longer stable and begins to split up. If adequate amounts of detergent are added
the membrane is ultimately solubilised into its lipid and protein components (Findlay, 1990).
However, different detergent properties need to be considered when selecting a detergent for a
particular application, i.e. (a) purity, stability, and characterisability; (b) solubility in aqueous
media; (c) removability; (d) minimum interference with other assays (e.g., protein and binding
assay); (e) cost;(f) optical transparency; (g) non-ionic or zwitterionic character (meaning that the
protein will carry the same charge as the native protein and that the pH at which the detergent can
be used is not restricted); and absence ofphase separation (Shepherd and Holzenburg, 1995).
To facilitate events such as solubilisation, penetration of enzymes and other reagents,
chromatography, aliquoting, and accurate concentration determinations, membrane protein
purification should regularly take place in detergents (Stutzenberger, 1992; Staudinger and
Bandres, 2000; Kraft et a!., 2001). However, removal of detergents from purified membranes is a
critical step for the restoration of membrane biological activity (Vuillard et al., 1995; Hannam et
a!., 1998).
4.3 Preparations of bursal membranes
Due to its simplicity and rapidity the method of Nieper and Muller (1998), was used for the
preparation of plasma membrane from bursal tissue. The bursa of Fabricius was excised from an
area dorsal to the cloaca in the caudal body cavity (Fig. 4.1) (Nieminen et a!., 2001). The bursal
cells were placed in a hypotonic medium to allow the cells to swell and the surface membrane to
rise off the underlying cytoplasm, leaving a clear area under the surface membrane. The cells are
then broken in a dounce homogeniser with a tightly fitting pestle, which acts by building up and
suddenly releasing pressure (Kaiser et al., 2002). A bag with a large hole through which the
nucleus and cytoplasm were ejected remains. Membranes are then isolated by differential
centrifugation on gradients of sucrose (Warren, 1974).
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4.3.1 Materials
1 M MgCb.6HZO. MgCh.6H20 (2.03 g) was dissolved in 10 ml of dist.H20.
Washing buffer [25 mM HEPES, 154 mM NaCl, 0.5 mM MgCh, pH 7.4J. HEPES (0.9 g), NaCl
(1.35 g), and 75 pI of a 1 M MgCh solution were dissolved in 130 ml of dist.H20, adjusted to pH
7.4 with NaOH and made up to 150 ml.
Homogenisation buffer [25 mM HEPES, 30 mM NaCl, 0.5 mM MgCh, 1 mM DTT, 1 mM
PMSF, 1 gM pepstatin A, pH 8.0). HEPES (0.6 g), NaCl (0.175 g) and 50 JLl of a 1 M MgCh
solution were dissolved in 80 ml of dist.H20, adjust to pH 8.0 with NaOH and made up to 100 ml.
Before use, DTT (15 mg), PMSF (17 mg in 100 JLl of DMSO) and pepstatin A (65 JLg, 13 JLl of a
5 mg/ml solution in DMSO) were added.
Restoration buffer [25 mM HEPES, 600 mM NaCl, 0.5 mM MgCh, pH 8.0l. HEPES (0.9 g),
NaCl (5.25 g), and 75 JLl of a 1 M MgCh solution were dissolved in 130 ml of dist.H20, adjusted
to pH 8.0 with NaOH and made up to 150 ml.
25% (w/v) sucrose solution. Sucrose (12.5 g) was dissolved in homogenisation buffer and made
up to 50 ml with homogenisation buffer.
Bursa
Cloaca
Figure 4.1 The location of the bursa of Fabricius in chickens (after Clark, 1991).
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4.3.2 Method
The bursa (Fig. 4.1) was excised with scissors and washed three times in washing buffer. Bursal
material (10 ml) was resuspended in a 3-fold (w/v) excess of homogenisation buffer and kept on
ice for 10 min. Thereafter, the cells were disrupted by 30-40 strokes in a 'tight fitting' Dounce
homogeniser. Immediately after homogenisation, restoration buffer was added in order to achieve
a final NaCI concentration of 154 mM. EDTA was added to a final concentration of 1 mM. The
homogenate was centrifuged (5000 g, 10 min, 4°C) and two volumes of the clear supernatant was
layered over half a volume of a 25% sucrose cushion. After centrifugation (lOO 000 g, 1 h, 4°C)
(SW40 rotor, Beckman), plasma membranes forming a white band at the interface were collected,
diluted with washing buffer and sedimented by centrifugation (lOO 000 g, 30 min 4°C). The
membrane pellet was resuspended in washing buffer and aliquots of the membranes were stored
frozen at -20°C.
4.4 Methods for IBDV Receptor Isolation
Recently a number of viral receptors have been isolated for different infectious viruses using an
array of methods. Virus receptors can be identified using anti-receptor antibodies and anti-
idiotypic antibodies. Anti-idiotype antibodies are made against neutralising anti-receptor
antibodies. The anti-idiotype antibodies that bind to cell membrane proteins and inhibit either
virus binding and/or infection of cells usually bear the internal image of the original ligand and
thus are useful for the identification and isolation of the corresponding cell surface receptors (Xue
and Minocha, 1993).
The virus overlay protein-blotting assay is a more recent affinity based biochemical approach for
identification of receptors (Varthakavi and Minocha, 1996). Following separation of cells or
tissue by SDS-PAGE, proteins are electro-blotted to a nitrocellulose membrane and probed with
virus. Membrane proteins having higher affinity for the virus are detected as bands on the
nitrocellulose. The limitation of this technique is denaturation of membrane proteins, which can
occur during electrophoresis. As a result the virus may not recognise the denatured receptors
(Bass and Greenburg, 1991). According to the work by Edwards (2000), bursal membrane
proteins were electro-blotted onto nitrocellulose and incubated with IBDV. Following incubation
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with anti-IBDV antibody, the bands were detected using enzyme linked-secondary antibody
(rabbit anti-chicken IgY alkaline phosphatase conjugate). The result was not absolutely accurate
due to the interactions between the enzyme linked secondary antibody and the chicken bursal
membrane proteins i.e. protein bands at ca 40 and 80 kDa were also detected in the control where
no primary antibody and no virus were included in the incubations.
In the present study affinity chromatography was performed to isolate the IBDV receptor protein
in uninfected bursal tissue membrane preparations. Infectious bursal disease virus was used as a
ligand and attached to an activated Sepharose 4B chromatography matrix assuming that a bursal
membrane protein that acts as a receptor would bind to the virus (IBDV) (Bass and Greenburg,
1991).
4.4.1 IBDV affinity column preparation
Cyanogen bromide activation of cellulose and agarose derivatives is the most commonly used
method for protein immobilisation. Any polymeric matrix with cleavable vicina1 hydroxyl groups
can be used in this method. Agarose is a linear polymer consisting of D-galactose and 3,6-
anhydro-D-galactose (Boyer, 1993). Sepharose is a trademark for beaded agarose prepared by
Pharmacia. During the activation process cyanogen bromide reacts with agarose beads to form a
cyclic reactive imidocarbonate, which is susceptible to nucleophilic attack by amino groups
present in the ligand protein to form N-substituted imidocarbonates as demonstrated in Fig. 4.2.
The cyclic imidocarbonate may be converted to a cyclic carbonate in aqueous solutions yielding



















Figure 4.2 Immobilisation of proteins on cyanogen bromide activated vicinal diols on beaded
agarose (after Wong, 1991). See text for details
Column preparation was performed according to the method of Hennache and Boulanger (1977)
used for the coupling of adenovirus to a CNBr-activated Sepharose 4B matrix. These authors used
a high salt concentration (600 mM NaCl) to elute adenovirus receptor protein from the column.
4.4.1.1 ~aterials
2 M sodium carbonate. Na2C03 (21.19 g) was dissolved in dist.H20 and made up to 100 ml.
Wash buffer A [200 mM NaHC03 buffer, pH 9.61. NaHC03 (8.4 g) was dissolved in 450 ml of
dist.H20, adjusted to pH 9.6 with NaOH, and made up to 500 ml.
Wash buffer B [200 mM NaHC03 buffer, pH 9.21. NaHC03 (0.84 g) was dissolved in 180 m1 of
dist.H20, adjusted to pH 9.2 with NaOH, and made up to 200 ml.
Wash buffer C [100 mM sodium acetate buffer, 500 mM NaCl, pH 4.01. Acetic acid (5.72 ml) and
NaCI (14.61 g) were dissolved in 450 ml of dist.H20, adjusted to pH 4.0 with NaOH and made up
to 500 ml.
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Coupling buffer [100 mM NaHC03 buffer, 500 mM NaCl, pH 8.3). NaHC03 (4.2 g), and NaCI
(14.61 g) were dissolved in 450 ml of dist.H20, adjusted to pH 8.3 with NaOH, and made up to
500 ml.
Blocking agent [1 M ethanolamine-HCl buffer, pH 8.01. Ethanolamine (6.06 ml), was added to
80 ml of dist.H20, adjusted to pH 8.0 with HCl and made up to 100 ml.
Chromatography buffer [10 mM Tris-HCI buffer, 50 mM NaCl, 0.1% (w/v) Na-deoxycholate,
0.02% (w/v) NaN3, pH 8.0]. Tris (1.21 g), NaCl (2.92 g), Na-deoxycholate (1 g) and NaN3 (0.2 g)
were dissolved in 950 ml of dist.H20, adjusted to pH 8.0 with HCl and made up to 1 litre.
4.4.1.2 Method
Sepharose 4B gel (5 ml) was washed with 150 ml dist.H20 in a Buchner funnel, on Whatman
No.1 filter paper, and transferred to a small beaker. After the gel settled the supematant was
removed. Dist.H20 (5 ml) and 2 M Na2C03 (10 ml) were added to the gel and the mixture placed
on ice, in a fume hood, and mixed gently until the temperature decreased to 4
Q
C. The rate of
stirring was increased and 1 M CNBr solution in acetone was added as rapidly as possible.
The gel mixture was mixed for 75 min, transferred to a Buchner funnel and washed with 100 ml
(dist.H20), 100 ml (wash buffer A) and 100 ml (wash buffer B). During washing, the gel was
stirred gently with a glass rod to prevent it from caking during filtration. The activated gel was
washed with excess coupling buffer, transferred to a glass bottle and allowed to settle. Excess
coupling buffer was removed by aspiration, and approximately 10 mg of IBDV in coupling buffer
was added to the suspension and mixed end-over-end for 14 h at 4QC.
The gel was allowed to settle and the excess coupling buffer, containing any unbound IBDV, was
removed. Blocking agent (10 ml) was added to the remaining gel and the slurry was mixed end-
over.;.end (2 h, RT). The gel was washed on a Buchner funnel with coupling buffer and wash
buffer C, to ensure that no free ligand remained ionically linked to the gel. The gel was finally
washed and suspended in chromatography buffer, packed into a column (6 cm x 0.5 cm) and
washed with 10 column volumes of chromatography buffer.
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4.4.2 Affinity purification of IBDV receptor proteins
4.4.2.1 Materials
Chromatography buffer. As per Section 4.4.1.1
Dissolving buffer [10 mM Tris-HCl, 50 mM NaCl, 0.5% Cw/v) Na-deoxycholate, 0.02% Cw/v)
NaN3, pH 8.0]. Tris (0.30 g), NaCl (0.73 g), Na-deoxycholate (1.25 g) and NaN3 (0.05 g) were
dissolved in 200 ml of dist.H20, adjusted to pH 8.0 with HCl and made up to 250 ml.
Chromatography buffers [10 mM Tris-HCl, 150/600 mM NaCl, 0.1% Cw/v) Na-deoxycholate,
0.02% Cw/v) NaN3, pH 8.0]. Tris (0.30 g), NaCl (2.19/8.77 g), Na-deoxycholate (0.25 g) and
NaN3 (0.05 g) were dissolved in 200 m1 of dist.H20, adjusted to pH 8.0 with HC1 and made up to
250 ml.
Dialysis buffer [10 mM Tris-HCl, 50 mM NaCl, 0.02% Cw/v) NaN3, pH 8.0]. Tris (1.21 g), NaCl
(2.92 g) and NaN3 (0.2 g) were dissolved in 950 m1 of dist.H20, adjusted to pH 8.0 with HC1 and
made up to 1 litre.
4.4.2.2 Method
Bursal membrane preparations (Section 4.3.2) (10 mg) were solubilised by mixing with 10 ml of
dissolving buffer by stirring for 30 min at 4°C in order to prevent the aggregation and
precipitation of proteins (Thomas and McNamee 1990). The total volume of solubilised
membranes were passed through the column once and cycled through the column overnight at 4°C
(flow rate 10 m1/h). Following elution of unbound proteins with chromatography buffer, loosely
and tightly bound proteins were eluted with the same buffer containing 150 and 600 mM NaCl
respectively. Elution of protein was monitored by the absorbance measuring the absorbance at
280 run of 1 ml samples. The peak corresponding to the fractions eluted with 600 mM NaCl was
pooled and dialysed overnight against dialysis buffer and concentrated using PEG 20 000 (Section
2.3.1). The concentrated fraction was further concentrated with SDS-KCl precipitation (Section
2.3.2.2) prior to analysis by reducing Tris-Tricine SDS-PAGE (Section 2.4.4).
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4.5 Results
4.5.1 Tris-Tricine SDS-PAGE analysis of bursal membrane purification
Bursal membrane proteins were isolated from uninfected bursal tissue according to the method of
Nieper and Muller (1998) using homogenisation and sucrose density gradient centrifugation.
Following isolation the membrane proteins were analysed by Tris-Tricine SDS-PAGE. This
showed that the bursal membrane contains a number of receptor proteins with molecular weights
in the range between 94 and 14 kDa (Fig. 4.3). In order to determine which of the membrane










Figure 4.3 Tris-Tricine SDS-PAGE evaluation of bursal membrane protein isolation. Sample (5 J1.g)
was boiled for 90 s in 20 J1.l of reducing treatment buffer and separated on 10% Tris-Tricine SDS-PAGE gel.
Proteins were visualised by silver staining (Section 2.7.2.2). Lane 1, molecular weight markers, as in Fig.
3.3 and Lane 2, isolated membrane proteins from non-infected bursal tissue.
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4.5.2 IBDV receptor protein isolation using IBDV affinity chromatography
Infectious bursal disease virus was coupled to a Sepharose 4B chromatography matrix for affinity
purification of IBDV receptor proteins. Membrane preparations isolated from virus free bursal
tissue were circulated overnight through the affinity column at 4°C. It was assumed that proteins
in the mixture not having affinity to the virus would pass through the column, while proteins that
have specific affinity for the virus (i.e. receptors) would bind to the immobilised virus and be
retained on the column (Robyt and White, 1987). Following removal of impurities and non-
specifically attached membrane proteins using 50 mM followed by 150 mM NaCl in the
chromatography buffer, receptor proteins were eluted from the column using the same buffer of
high salt concentration (600 mM NaCl) (Fig. 4.4). The 150 mM NaCl-containing chromatography
buffer was used to remove non-specifically bound receptor proteins, since a certain proportion of
viral binding is non-specific and umelated to specific viral receptors (Tradieu et al., 1982).
The elution profile showed that three peaks of membrane proteins were eluted. The first peak
represents unbound membrane proteins, eluted using 50 mM NaCl chromatography buffer. The
second peak represents loosely bound membrane proteins, possibly proteins that adhere non-
specifically to the virus and washed from the column using chromatography buffer containing
150 mM NaCl. The last peak represents specific IBDV receptor protein eluted using

























Figure 4.4 Affinity purification of IBDV receptor protein on an IBDV affinity column. Solubilised
bursal membranes were circulated overnight through the column (3 ml bed volume, equilibrated in
chromatography buffer) at 4°C with a flow rate of 10 mllh. Following elution of unbound proteins with
chromatography buffer, loosely and tightly bound proteins were eluted by 150 mM and 600 mM of NaCl in
the same buffer. Arrows indicate points during the elution where the NaCl concentration was increased.
4.5.3 Reducing Tris-Tricine SDS-PAGE analysis of viral receptor protein
To determine whether IBDV has a single or multi receptor sites on the surface of bursal cells, the
peak corresponding to the fraction eluted with 600 mM NaCI from the IBDV affinity column
(Fig. 4.4) was analysed by reducing Tris-Tricine SDS-PAGE (Fig. 4.5). Since the collected
fraction was very dilute successive concentrating methods were performed using PEG 20 000
(Section 2.3.1) and SDS-KCI precipitation (Section 2.3.2.2) to attain a reasonable concentration
prior to Tris-Tricine SDS-PAGE analysis. In this fraction a doublet with a molecular weight of










Figure 4.5 Reducing Tris-Tricine SDS-PAGE analysis of mDV receptor protein. Sample (5 Jlg)
was boiled for 90 sin 20 JlI ofreducing treatment buffer and separated on 10% Tris-Tricine SDS-PAGE
gel. Proteins were visualised by silver staining (Section 2.7.2.2). Lanes 1 and 3, molecular weight markers
as in Fig. 3.3 and Lane 2, purified receptor protein (the peak corresponding to the fraction eluted with
600 mM NaCI from the IBDV affinity column).
4.6 Discussion
In this chapter, an effort was made to isolate an IBDV receptor protein from the surface of
chicken bursal cells. Bursal membranes were isolated, solubilised and a receptor protein purified
on an IBDV-Sepharose 4B affinity column. The purified receptor proteins were subsequently
analysed using reducing Tris-Tricine SDS-PAGE.
Preparation of bursal membrane protein was performed according to the method of Nieper and
Muller (1998). Since solubilisation of membrane proteins using detergents activates the release of
harmful proteases, inhibitors such as PMSF, had to be added prior to solubilisation to effect
inhibition of serine proteases. To stabilise the nuclear membrane during incubation in hypotonic
homogenisation buffer, MgCh was used at a relatively high concentration to aggregate the
lymphoid cells. A dounce homogeniser was used to homogenise bursal cells to avoid the
liberation of peripheral membrane proteins that could occur when a more vigorous lysis method
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such as agitation with glass beads is used (Kaiser et al., 2002). Restoration buffer containing
25 mM HEPES, 600 mM NaCI and 0.5 mM MgCh, pH 8.0 (Section 4.3.1) was included to retain
innate biological activities in the plasma membranes by maintaining isotonic condition of the
homogenate. The presence of divalent cations after restoration can lead to aggregations of plasma-
membranes with the nucleus and may also activate metalloproteases (Nieper and Muller, 1998).
EDTA was employed to chelate divalent cations. The isolated bursal membrane preparation
obtained in the present study (Fig. 4.3) showed a similar protein banding pattern to that reported
by Nieper and Muller (1998).
The biochemical technique that was applied in this section for the identification of IBDV receptor
protein was a useful and specific technique. Hennache and Boulanger (1977) used a similar
method for the purification of adenovirus receptor proteins using an adenovirus-Sepharose 4B
affinity column. This affinity matrix has been shown to retain the biological activity of the
affinity-purified products and it is relatively easy to use. In addition this approach may allow for
the actual isolation and purification of receptors involved in viral attachment (Bass and
Greenberg, 1991). However, the amino groups generated on the Sepharose by CNBr activation
could result to lack of specificity in ligand attachment. Due to the fact that virus particles can non-
specifically adhere to many substances, identification of virus receptors has proved to be
extremely difficult (Varthakavi and Minocha, 1996). But this problem was improved by the
three-step increment of NaCl concentration from 50 to 150 and then to 600 mM (Hennache and
Boulanger, 1977). Non-specifically bound receptor proteins were eluted from the column using
elution buffer with 150 mM NaCl (Fig. 4.4). Due to the possibility of a high affinity of the virus
for its receptor, high salt concentration (600 mM NaCl) was expected to disrupt the interaction
between the virus and the receptor. The application of this technique in the purification of
monovalent virus-receptor complex is not as effective when compared to multivalent virus-
receptor complexes (Bass and Greenberg, 1991). However, this method could be helpful for the
isolation of specific receptor proteins of other infectious viruses.
The IBDV receptor isolated in the present study from the surface of bursal cells showed a
molecular weight of 40 kDa. The 40 kDa receptor protein appeared to be fragmented showing
another band below it. This could be due to the effect of denaturation by mercaptoethanol and
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high temperature during sample treatment with the reducing treatment buffer prior to reducing
Tris-Tricine SDS-PAGE analysis. A duplicate sample should be run in non-reducing Tris-Tricine
SDS-PAGE to see if that was the reason for having a doublet. However, due to scarcity of
material non-reducing Tris-Tricine SDS-PAGE was not carried out.
Previous work in this laboratory identified two possible receptor proteins on the surface of bursal
cells of 32 and 40 kDa (Edwards, 2000). Nieper and Muller (1996) reported that IBDV bound to
proteins with molecular masses of 40 and 46 kDa expressed on chicken embryo fibroblast cells
and chicken lymphocytes by using a virus overlay protein blotting assay (VOPBA). Based on the
above three independent results, the 40 kDa receptor protein seems to be the major IBDV receptor
protein on the surface of bursal cells. Unlike the present study where only the doublet was
observed a number of other minor bands are evident on the gels besides the major bands at 40 and
46 kDa (Nieper and Muller 1996) and at 40 and 32 kDa (Edwards 2000). Although the bursal
material used in the present study was excised from young and adult chickens, no observable
difference was evident in the banding pattern of the isolated receptor protein.
IBDV seems to have a receptor protein on the surface of bursal cells with a molecular weight of
40 kDa. In contrast, many other viruses exhibit possible multiple receptors e.g. HN and herpes
simplex virus. HIV uses CD4 as its main attachment receptor but also interacts with glycolipid
galactosyl ceramide to mediate infection and herpes simplex virus binds to mannose-6-phosphate
Rand heparan sulfate (Varthakavi and Minocha, 1996; Schneider-Schaulies, 2000; Kim et al.,
2002). This result could encourage further inhibition studies because it would be easier to
interfere with the binding of one receptor compared to inhibiting multi-receptors. The above
statement could be further elaborated in such a way that if inhibition is for example using anti-
receptor peptide antibodies it will require isolation, sequencing and production of anti-receptor
peptide antibody for each receptor. This is expensive and using many antibodies at a time could
lead to complications.
In Chapter 5, production of anti-IBDV receptor peptide antibodies in rabbits will be presented.
Furthermore, an inhibition assay of IBDV binding to the receptor using anti-IBDV receptor
peptide antibody will be examined in an ELISA format.
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CHAPTERS
INIDBITION OF INFECTIOUS BURSAL DISEASE VIRUS BINDING USING ANTI-
RECEPTOR PEPTIDE ANTIBODIES
5.1 Introduction
Generally, antibodies have been raised against proteins purified from their natural sources or
bacterially expressed fusion proteins (Danbolt et al., 1998). The use of synthetic peptides has
several advantages over this type of approach. It is relatively easy to prepare and allow the rapid
translation of sequence infonnation into a reagent that targets a specific protein domain (Field et
al., 1998). The amino acid properties of the peptide sequence must be considered in order to
detennine whether the synthetic peptide will have the appropriate epitope(s) that will result in
immunogenicity capable of producing antibodies, which will interact with the native protein. Such
properties include: .hydrophilicity, areas of high segmental mobility, hydropathicity, surface
accessibility and high concentration of proline residues which fonn part of the B turns (corners)
known to fonn parts of epitopes (Thorpe, 1994).
It is generally recommended that in order to raise anti-peptide antibodies against small peptides it
is essential to enhance their immunogencitiy by coupling them to carrier proteins (Van
Regenmortel et al., 1988). Moreover, when short peptide sequences are used as the immobilised
antigen in solid-phase immunoassays, the use of peptide-carrier conjugates is required since
peptides of 6 to 15 residues usually do not bind efficiently to plastic surfaces (Suzuki et al., 1997).
It is worthwhile to test if an conjugated peptide binds to the plate. The selection of carrier
molecule is normally based on criteria such as availability of reactive sites, size, solubility,
immunogenicity, commercial availability and cost. The commonly used carrier molecules are
bovine serum albumin (BSA) and keyhole limpet hemocyanin (KLH) (Verdoliva et al., 1995).
Currently different coupling methods are available to prepare peptide-carrier conjugates. The
most frequently used coupling agents are glutaraldehyde, bis-diazotized benzidine (BDB),
carbodiimides and m-maleimidobenzoyl-N-hydroxy-succinimide ester (MBS) (Briand et al.,
1985).
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The immune response can be improved by the use of adjuvants, e.g. Freund's adjuvant can
enhance the immune response by causing a 'depot' effect, i.e. allowing a slow release of antigen
(Westwood and Hay, 2001). Based on the amount of serum required, source and availability of
the antigen, antibodies can be raised in different experimental animals (Thorpe, 1994).
The objective of the study reported in this Chapter was the preparation of anti-peptide antibodies
against a sequence in the IBDV receptor protein and block viral binding to the receptor using the
anti-receptor peptide antibodies as additional proof that the receptor isolated is that for IBDV. The
epitope prediction program, Predict7 (Carmenes et al., 1989), was used to analyse the potential
immunogenicity of the peptides from the 32 kDa receptor protein previously identified as a
possible IBDV receptor protein in this laboratory (Edwards, 2000). Two peptides were
synthesised, conjugated to a carrier protein, rabbit serum albumin, using MBS and immunised
subcutaneously into rabbits. IgG was isolated from rabbit serum and the production of anti-
peptide antibodies was monitored using ELISA with immobilised peptide. IgG was affinity
purified on column prepared by immobilising the antigenic peptides. The affinity-purified
antibodies were used for ELISA, western blot and assays for inhibition ofviral binding.
5.2 Anti-peptide antibodies
Antibodies are the main tool for the identification, localisation, and purification of biologically
interesting molecules. Furthermore, they are useful to define the structure and function of
proteins, to localise the antigenic determinants contributing to idiotypic systems, and to obtain
sequence specific ligands useful for the development of affinity purification strategies. Synthetic
peptides are used as candidate vaccines for various infectious diseases including HN, foot-and
mouth disease, influenza, hepatitis B and cholera (Posnett et al., 1988; Van Regenmortel et al.,
1988; Verdoliva et al., 1995).
Polyclonal antibodies raised against a multivalent antigen bind to different epitopes on the antigen
with a varied range of affinities. In contrast in monoclonal antibody (mAb) production, the B-cell
producing a single one of these antibodies is selected and proliferated in large quantity. This
results in relatively large amounts of antibody with consistent quality and characteristics (Thorpe,
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1994). Monoclonal antibodies are highly specific but have the drawback that they may be non-
representative of the antibody population as a whole (Westwood and Hay, 2001). Production of
site-specific antibodies using synthetic peptides for various biochemical and functional studies has
become a well-accepted method (Dupont et al., 2003). Peptides, which represent proteins with a
limited number of antigenic determinants, are very convenient for the production of anti-native
protein antibodies. This implied that the peptides have a similar conformation as the sequence in
the native protein (Gerritse et al., 1990).
In comparison to conventional polyclonal antibody production methods the amount of useful
antibody produced by synthetic peptides is relatively small, because of the restricted number of
epitopes in the short peptide sequence. Secondly, due to the small size of the epitope, anti-peptide
antibodies also rarely cross-react with other proteins. The other limitation is that recognition
depends on the region of the protein where the peptides are from i.e. if the chosen peptide is
buried within the protein, the resulting antibody may not recognise the native protein (Field et al.,
1998).
For anti-peptide antibody production appropriate epitopes can be designed from the protein of
interest based on their hydrophilicity, areas of high segmental mobility, hydropathicity and
surface accessibility. These criteria are described in detail in Section 5.3.
5.3 Designing of peptides for anti-peptide antibody production
The only structural information accessible for most of the proteins identified to date is their amino
acid sequence; usually deduced from the nucleotide sequence of the corresponding gene. The
need to raise specific anti-peptide antibodies and current attempts to develop synthetic peptide
vaccines have emphasised the usefulness of predicting the location of continuous epitopes in
proteins. Thus the accumulated information of antigenic structure of a few well-characterised
proteins has served as empirical rules for predicting the position of continuous epitopes III
proteins from certain characteristics of their primary structure (Van Regenmortel et al., 1988).
One of the most commonly used methods for predicting the location of epitopes involves
identifying regions in the polypeptide sequence that possess a high proportion of hydrophilic
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residues. It is known that hydrophobic amino acids are buried inside the native structure of
globular proteins, whereas hydrophilic proteins correspond to residues, which are exposed to the
soluble environment at the surface of the molecule where they can interact with water. The
relationship between hydrophilicity and antigenicity reproduce the general relationship between
surface accessibility and antigenicity. As antibodies bind to the surface of proteins, the sequences
that constitute epitopes will have a surface orientation (Van Regenmortel, 1986).
There is a correlation between mobility and surface exposure, since regions of proteins, which are
buried inside the molecule tend to be less flexible than those found on the surface of the molecule.
When anti-antibodies were produced against peptide fragments of the protein myohaemerythrin
that represent the mobile and non-mobile regions of the molecule, the correlation between
antigenicity and atomic mobility was empirical. Anti-peptide antibodies against the highly mobile
residues reacted strongly with the protein whereas antibodies raised against the less mobile
regions did not (Stem, 1991). Peptide sequences with a higher degree of structural variety are also
more preferred as immunogens, because they may contain different structures that are unique to
different genetic backgrounds (Richman and Reese, 1988).
Predict7 a computer program for epitope prediction (Cannenes et al., 1989) was performed on the
two amino acid sequences of the 32 kDa viral receptor protein identified and partially sequenced
in this laboratory (Edwards, 2000) to see if they are immunogenic. This program analyse protein
structural features using seven different algorithms. They include N-glycosylation sites,
hydrophilicity, hydropathy, flexibility, surface probability, antigenicity, and secondary structure
analysis. Peptide sequences with higher values of hydrophilicity, flexibility, surface probability
and antigenicity are considered to be good immunogens. In this study sequences in red, replacing












Figure 5.1 Amino acid sequence of the root adhesin from Pseudomonas fluorescens and internal peptide
sequence of the 32 kDa chicken bursal membrane protein. Black sequence is that of the root adhesin. Sequence in
red is that obtained from digestion of the 32 kDa bursal membrane protein. X, represents residues without information
and the underlined sequences represent mismatches. Sequences in red are those used to raise antibodies in rabbits
(Edwards, 2000).
According to Edwards (2000) the N-terminal amino acid sequence of the 32 kDa bursal receptor
protein showed homology with the amino acid residues of a root adhesin from Pseudomonas
fluorescens. In the present study a computer search using the program BLAST 2.0, from the Swiss
Prot website (http://www.expasy.ch) was done to determine if any new sequences were added to
the data bank since 2000 that could be aligned with the IBDV receptor sequences elucidated by
Edwards (2000). Homology was still only found with the above adhesin. A computer search for
structural homology was also carried out using the three-dimensional position-specific scoring
matrix (3D-PSSM) software package (http://www.sbg.bio.ic.ac.uklservers/3dpssml). The
method employs structural alignments of homologous proteins of similar three-dimensional
structure in the structural classification of proteins (SCOP) database to obtain a structural
similarity of residues (Kelley et al., 2000). Structural homology of 95% was obtained between
Escherichia coli outer membrane protein A transmembrane domain and Pseudomonas fluorescens
adhesin (Fig. 5.2). Using this program a sequence identity of only 18% was obtained with the
103
outer membrane protein A transmembrane domain of Escherichia coli, which is too low for
sequence alignment.
A B
Figure 5.2 The 3D structure of the outer membrane protein A transmembrane domain from Escherichia coli
that shows structural homology with the 32 kDa IBDV receptor protein. Panel (A) shows space fill and (B)
ribbon models. The individual antiparalle1 beta strands forming a transmembrane beta barrel are shown in separate
colours.
5.4 Choice of an appropriate carrier
For antibody production by B-cells, antigens need to stimulate both B-cell and helper T-cell
responses. To accomplish these criteria antigens must possess the following epitopes, (1) an
epitope that can bind to the surface antibody of a virgin B-cell (this epitope will indicate the
specificity of the antibody produced), and (2) on degradation must generate fragments that can
induce a response from helper T-cell by stimulating binding to both class II MBe molecule and a
T-cell receptor. The best way for the antigens to accomplish the above two requirements is
coupling the peptides/antigens to carrier molecules (Field et al., 1998). The commonly used
criteria for successful carrier proteins for coupling of antigenic peptides are as follows, the
potential for immunogenicity, the presence of suitable functional groups for conjugation with
peptides, solubility properties even after derivatization although this is not an absolute
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requirement, as precipitated molecules can be highly irnrnunogenic, and lack of toxicity in vivo
(Herrnanson, 1996).
Because the maj ority of the antibody production is usually against the carrier, antibodies against
the peptide of interest constitute a very small percentage. To avoid these problems antigenic
peptides should be conjugated to self-proteins (Posnett et al., 1988). Since the aim of this project
was to produce anti-peptide antibodies against an IBDV receptor protein for studying receptor-
ligand interaction, and because the one peptide appeared not to be particularly immunogenic, it
was considered important to keep the antibody response to the carrier molecule to a minimum.
For these reasons peptides were coupled to rabbit serum albumin (RSA) prior to antibody
production in rabbits.
5.5 Conjugation of the IBDV receptor peptide to a carrier protein
A most important consideration during the design of a peptide for anti-peptide antibody
production is the method to be used for coupling of the peptide to a carrier protein. Most coupling
methods require a free amino, sulfhydryl, phenolic, or carboxylate group (Harlow and Lane,
1988). Su1fhydryl groups are found on cysteine side chains, phenolic groups on tyrosines, and
carboxylate groups on aspartate, glutamate and the carboxy-terrninus. Free amino groups are
fo:und on lysine side chains or on the amino-terminus. Coupling methods should be used that link
the peptide to the carrier via either the carboxy- or amino terminal residue. If antibody should be
prepared against the amino-terminal residues of the peptide, coupling should be performed
through the carboxy-terrninus of the peptide and vice versa. The simplest way to ensure exclusive
coupling through either N-or C-terminal residue. is to add an extra cysteine residue on either
terminus of the peptide for MBS coupling (Harlow and Lane, 1988).
In this project all peptides were extended with an extra cysteine residue at the C-terminus to
facilitate chemical coupling with MBS to RSA. MBS is a heterobifunctional cross-linking reagent
(Table 5.1), which is used for the directional coupling of synthetic peptides containing a free SH
group to carrier proteins in a two-step procedure (Fig. 5.3). It contains one maleirnide group
(which is SH-group reactive), and one N-hydroxysuccinimide group (which is amino reactive).
The first step involves activation of the carrier that involves the reaction of MBS with the amino
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groups of the carrier. Free unreacted MBS is removed before activated carrier (which now has a
number of maleimide groups incorporated) is reacted in the second step with free SH groups in
the peptide sample. For this purpose the peptide sample is reduced with DTT, 2-
mercapthoethanol, or sodium borohydride immediately prior to coupling (Danbolt et al., 1998).
The reduced peptide is separated from unreacted reducing agent using molecular exclusion
chromatography as described in the next section.
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Figure 5.3 Preparation of peptide-carrier conjugate using MBS. The MBS malemeide group reacts
with the primary amine group (NHz) on the carrier molecules (RSA) to form a stable amide bond (MBS-
activated carrier molecule). The MBS-activated carrier molecule targets sulfhydryl-containing peptides to
form the peptide-carrier-conjugate (after Hermanson, 1996).
5.6 Molecular exclusion chromatography
Molecular exclusion chromatography was used to separate activated carrier from MBS and
reduced peptides from DTT during peptide-carrier protein conjugation (Section 5.6.4) and peptide
affinity column preparation (Section 5.9.3). The separation of macromolecules on cross-linked
dextrans according to their size has been a common method to purify biological materials from a
mixture. Separation is caused by the geometry-dependent partition of the macromolecules
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between a continuous phase and the interior pores of the gel (Whitaker, 1950; Porath and Flodin,
1959; Brooks et al., 2000). Following equilibration and packing of the spongelike, porous
matrix/gel into a column, sample consisting of different sized molecules is applied to the column,
followed by the equilibration buffer. Molecules too large to enter the small pores of the matrix
move through the space between the pores and elute from the column before small molecules,
which are able to enter the pores. The latter molecules diffuse in and out of the pores, which
delays their movement and elution from the column (Reiland, 1971).
5.6.1 Materials
MBC buffer [100 mM NaH2P04.2H20, 0.02% (w/v) NaN3, pH 7.0]. NaH2P04.2H20 (15.6 g) and
NaN3 (0.2 g) were dissolved in 950 ml of dist.H20, adjusted to pH 7.0 with NaOH, and made up
to 1 litter.
5.6.2 Method
From the calculations made to obtain a packed bed volume of 10 ml Sephadex G-10 (4 g) or
15.5 ml Sephadex G-25 (5.5 g) dry gel were placed in separate beakers containing appropriate
volumes of MEC buffer. The gel was mixed gently with a glass rod before incubating at RT
overnight to allow the gel to swell. Following swelling, half the volume of the supernatant was
decanted. The gel suspension was transferred into a vacuum flask containing appropriate volumes
of degassed buffer respectively. Degassing was performed using a vacuum pump with occasional
swirling of the flask. After the gel materials had settled, approximately 90 % of the supematant
were removed by suction in order to remove fine particles. The slurries of degassed gels were
transferred into appropriate columns 1 x 12 cm for Sephadex G-10 and I x 23 cm for Sephadex
G-25. Each column was equilibrated with at least 20 column volumes ofMEC buffer before use.
5.6.3 Materials for conjugation
MEC buffer [100 mM NaP04buffer, 0.02% (w/v) NaN3, pH 71. As described in Section 5.6.1
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Reducing buffer [100 mM Tris-HCI buffer, 1 mM Na2EDTA, 0.02% (w/v) NaN3, pH 8J. Tris
(1.21 g), Na2EDTA (0.037 g) and NaN3 (0.02 g) were dissolved in 80 ml of dist.H20, adjusted to
pH 8 with HCI and made up to 100 ml.
Ellman's reagent buffer [100 mM Tris-HCl. 10 mM Na2EDTA, 0.1% (w/v) SDS, pH 81. Tris
(1.21 g), Na2EDTA (0.37 g) and SDS (1 g) were dissolved in 80 ml of dist.H20, adjusted to pH 8
with HCI and made up to 100 ml.
DTT (l0 mM). 7.71 mg ofDTT was dissolved in 5 ml of Reducing buffer just before use
Ellman's reagent (l0 mM). 10 mg was dissolved in 2.5 ml of Ellman's reagent buffer just before
use.
MBS (3.2 mM). MBS (1 mg) was dissolved in dimethylformamide (DMF, 200 JlI). DMF must be
amine free and dry to prevent undesired side reaction.
5.6.4 Method
Carrier protein (2.14 Jlmol, equivalent to 3.65 mg RSA) was dissolved in phosphate buffer
(1664 JlI Section 2.8.1). MBS (336 JlI, 4.28 Jlmol, giving a 1:40 molar ratio of carrier: MBS) was
added and stirred slowly and acylation of the carrier allowed to proceed at RT for 30 min. The
activated carrier was separated from free MBS by molecular exclusion chromatography (MBC) on
a Sephadex G-25 column (1 x 20 cm) pre-equilibratedin MEC buffer at a flow rate of 10 ml/h.
The absorbance at 280 nm of the eluate was monitored and the activated carrier collected as the
first peak. The subsequent peak:, representing unreacted MBS was discarded.
Peptide sequence one (IBDVR-l) (4 mg, 2.72 Jlmol, giving a molar ratio of peptide to activated
carrier of 40:1) was dissolved in DMSO (100 JlI) and reducing buffer (900 Jll) added. DTT (1 ml)
was added and reduction of the peptide allowed to proceed for 1.5 h at 37°C. Reduced peptide was
separated from excess DTT by MEC on a Sephadex G-l 0 column (1 x 13 cm) pre- equilibrated in
MBC buffer at a flow rate of 10 ml/h. Fractions (1 ml) were collected in microfuge tubes and
10 JlI of each fraction mixed with an equal volume of Ellman's reagent to construct the elution
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profile. A yellow colour was an indication of the presence of the eluted peptide, thereafter,
fractions with excess DTT, indicated by an intensely yellow colour, were eluted. The reduced
peptide was immediately mixed with activated carrier and incubated for 3 h at RT. The same
method was used for conjugation of peptide sequence two (IBDVR-2). Carrier protein
(2.56/Lmol, equivalent to 4.34 mg RSA) and MBS (403 /LI, 5.11 /Lmol, giving a 1:40 molar ratio
of carrier: MBS) were used.
5.7 Production of anti-IBDV receptor peptide antibodies in rabbits
Immunogens, such as peptide-carrier conjugates are routinely mixed with an adjuvant to improve
the immune response in experimental animals. Adjuvants are immunopotentiators, which activate
Band T-cell responses to elicit long lasting antibody responses (ten Hagen et al., 1993). They
play a major role in the immune response by increasing the persistence of the antigen in the host's
immune system, that is, they allow progressive release of the antigen from the immunisation site,
and protect immunogens from proteolytic enzyme degradation (Maurer and Callahan, 1980).
Antigenic processing by macrophages is a crucial aspect of the immune system, hence any step,
which can affect macrophage activation, will stimulate the immune response (Maurer and
Callahan, 1980). The presence of bacteria, especially in Freund's complete adjuvant (Table 5.2),
cause inflammation at the site of injection and infiltration by macrophages. These events enhance
the immune response effectively (Diano et al., 1987). For these reasons addition of adjuvants
during immunisation will result in a high level of antibody production (Audibert et al., 1982).
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Table 5.2 Composition and use of Freund's adjuvants (Thorpe, 1994)
Adjuvant Composition and use
Freund's complete adjuvant (FCA)
Freund's incomplete adjuvant (FIA)
5.8 Choice of animal
Mineral oil containing heat-killed mycobacteria
(Mycobacterium tuberculosis or M butyricum).
Used as an emulsion with aqueous immunogen in
the first immunisation
Mineral oil
Used as emulsion with aqueous immunogen for
booster injections
The choice of animal for immunisation depends on the amount of antibody required and on the
source of the antigen. In principle it is not possible to raise antibodies using self-proteins, for
example producing antibodies to rabbit proteins in rabbits. Although in rare cases this can be done
with intracellular domains of membrane proteins, e.g. the C-terminal domain of the excitatory
amino acid carrier glutamate transporter, which is identical in rabbit, humans, and rat (Danbolt et
al., 1998).
Although chickens are usually the best choice for antibody production because they are cheap,
easy to handle and higher amounts of antibody can be collected from egg yolk than the equivalent
volume of rabbit serum (Goldring and Coetzer, 2003). The present study required the production
of anti-peptide antibodies against a chicken bursal receptor protein. Rabbits were thus used and
represent a suitable alternative in terms of cost, ease of handling and relatively ease in bleeding
and being good responders.
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Immunogen dose depends on the type of antigen and animal species used and normally ranges
from 50 to 200 Jlg per immunisation (Verdo1iva et al., 1995). Although dose of antigen is not
necessarily related to the amount of antibody produced, it is essential that the amount of antigen to
be injected is not very small because it can lead to tolerance towards the antigen (Florence and
Hau, 1994).
Two rabbits per peptide-conjugate were immunised subcutaneously with 200 Jlg of peptide-RSA
conjugate per immunisation per animal (Coetzer et al., 1991). The peptide-conjugates were
administered with FCA at a 1: 1 (v/v) ratio for the first injection and with FIA for booster
injections, in a total volume of 1 m1 per rabbit. Rabbits were immunised five times at three week-
intervals (0, 3, 6, 9 and 12). Blood was collected 9 weeks after the first immunisation by bleeding
of the ear vein, and screened for anti-peptide reactivity by an indirect enzyme-linked-
immunosorbent assay (ELISA) (Section 2.9.2). Sera obtained before the primary immunisation
served as a negative (non-immune) control for ELISA, western blot and inhibition assays.
5.9 Affinity chromatography
Affinity purification was used to purify specific anti-peptide antibodies and the IBDV receptor
protein by immobilising the synthetic peptides (Section 5.9.3) or IBDV (Section 4.4.1.2) to the
respective affinity matrices. In affinity chromatography a specific type of molecule (ligand) is
cova1ently bound to a suitable chromatography matrix, typically 4% cross-linked beaded agarose
(Sepharose-4B) (Fig. 5.4). The ligand has a specific affinity for one of the molecules in the
mixture to be purified. A sample with a mixture of macromolecule to be purified is applied to the
column. During the circulation process molecules not having affinity for the ligand directly elute
from the column, while molecules with an affinity for the ligand bind reversibly with high affinity
and specificity (Robyt and White, 1987).
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Figure 5.4 Schematic diagram illustrating the principles of affinity separation. Sample (a) comprising
product and impurities is brought into contact with a solid phase (b) derivatised with a specific ligand. Product is
selectively adsorbed at the expense of impurities (c) and desorbed (d) by application of an appropriate mobile
phase. The solid phase is finally is regenerated for further use (after Mohan and Lyddiatt, 1997).
Following washing to remove unbound and non-specifically bound molecules, conditions are
changed to elute the molecule of interest from the ligand in its natural state. Due to the fact that
binding of the molecule to the ligand is as a result of electrostatic and hydrophobic interactions
and van der Waals forces, samples are desorbed from the ligand by changing the pH or salt
concentration (Mayers and van ass, 1992). If elution of the molecules is not possible using the
above methods, a mild denaturing agent can be used to deform the structure of the protein, hence
to reduce the interaction of the molecule with the ligand. The most commonly used reagents are
HCI, CNS-, ClO-4, and CChCOO-, but they must be used with care because they may cause
permanent structural deformation (Boyer, 1993).
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5.9.1 Peptide-affinity column preparation
Rabbit anti-peptide IgG preparations obtained by PEG precipitation from serum (Section 2.8.2)
were purified using affinity chromatography on a column prepared by immobilising the antigenic
peptides. Matrices containing iodoacetyl agents are excellent activated supports for the
immobilisation of ligands containing sulfhydryl groups. The matrices will offer extremely stable
thioether bonds between the ligands and matrices (Fig. 5.5). The coupling reaction with sulfhydryl
ligand is very fast, taking only 15 min and can be carried out at pH 8.0-8.5 (Hermanson et al.,
1992). To make binding more efficient, steric hindrance can be reduced by the use of spacer arm























Immobilisation of peptides to iodoacetyl-containing matrices (after Hermanson et al.,
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Prior to coupling, the peptides with a cysteine residue at the C-tenninal were first reduced by DTT
to produce sulfhydryl groups to. react with iodoacetyl agarose of the SulfoLink™ gel. The
manufacturers, Pierce, prepare iodoacetyl agarose by the addition of iodoacetic acid to the
agarose.
5.9.2 Materials
Tris buffer (50 mM Tris-HCl buffer, 5 mM EDTA pH 8.5). Tris (6.05 g) and EDTA (1.86 g) were
dissolved in 950 ml of dist.H20 adjusted to pH 8.5 with HCl and made up to 1 litre.
MEC buffer [100 mM NaP04 buffer, 0.02% (w/v) NaN3, pH 7J. As described in Section 5.6.1
10 mM DTT. As described in Section 5.6.3
Ellman's reagent buffer [100 mM Tris-HCl, 10 mM Na2EDTA, 0.1% SDS (w/v), pH 8]. As
described in Section 5.6.3
10 mM Ellman's reagent. As described in Section 5.6.3
Blocking buffer (50 mM Cysteine, 50 mM Tris, 5 mM EDTA, pH 8.5). Cysteine (8.78 mg) was
dissolved in 1 ml of Tris buffer (before use).
1 M NaCl, 0.05% (w/v) NaN3: NaCl (58.44 g) and NaN3 (0.5 g) were dissolved in llitre of
dist.H20.
0.1 M Na-phosphate buffer, 0.02% (w/v) NaN3, pH 7.6: NaH2P04.H20 (15.6 g) and NaN3 (0.2 g)
were dissolved in 950 ml of dist.H20, adjusted to pH 7.6 with NaOH and made up to 1 litre.
5.9.3 Method
Peptide sequence one (IBDVR-l) and IBDVR-2 (5 mg) of each were individually dissolved in
100 ILl of DMSO and 400 ILl Tris-HCl buffer. The peptides were reduced by adding 500 ILl of
10 mM DTT to the dissolved peptide with stirring. The mixture was incubated for 1.5 h at 37°C.
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The reduced peptide was separated from free DTT on a Sephadex G-I0 column (1x13 cm), pre-
equilibrated in MEC buffer at a flow rate of 10 ml/h. Fractions (1 ml) were collected and the
elution profile was determined by the addition of Ellman's reagent (10 JLI) to an equal sample
volume from each fraction. The first fractions with a light yellow colour indicated the elution of
the reduced peptide and an intensely yellow colour the elution of unreacted DTT peak.
The SulfoLink™ gel was supplied as a 50% slurry and 2 ml of the slurry was packed into a
polystyrene chromatography column. The liquid was drained from the gel until the wet cake
remained. The gel was washed with 6 column volumes (6 ml) of Tris-HCI buffer. The reduced
peptide was added to the gel. The gel was mixed at RT by end over end rotation for 15 min and
incubated at RT for 30 min without mixing. The buffer was drained. The column was washed
with three column volumes (3 ml) of Tris-HCI buffer. The non-specific binding sites on the gel
were blocked by 1 ml of blocking buffer. The gel was mixed at RT by end over end rotation for
15 min and incubated at RT for 30 min without mixing. The column was washed with 16 column
volumes (16 ml) of 1 M NaCI, 0.05% (w/v) NaN3 and with 2 column volumes (2 ml) of Na-
phosphate buffer. The column was stored at 4°C until use.
5.10 Modified western blot to enhance recognition by renaturation of IBDV
receptor protein in the gel
Dunn (1986) reported two modifications of western blots, which enhance immunochemical
recognition of proteins. The first modification is the use of carbonate blot buffer at pH 9.9, instead
of the more commonly used Tris-glycine buffer at pH 8.3 during electrophoretic transfer. This
alteration was reported to improve the recognition of Escherichia coli FI-ATPase by monoclonal
antibodies. The second modification was incubation of the gel in renaturation buffer, intended to
aid the renaturation of proteins, prior to the electrophoretic transfer step. According to Dunn




3 mM Na2C03. Na2C03 (0.318 g) was dissolved and made up to 1 litre.
10 mM NaHC03. NaHC03 (0.84 g) was dissolved and made up to llitre.
Carbonate blot buffer (10 mM NaHC03, 3 mM Na2C03, 20% methanol, pH 9.9). A solution of
3 mM Na2C03 (0.318 g/l) was titrated with a solution of 10 mM NaHC03 (0~84 g/l) to pH 9.9 and
20% methanol was added.
Renaturation buffer (50 mM Tris-HCl, 20% glycerol pH 7.4). Tris (6.05 g) and glycerol (200 ml)
were made up to 950 ml with dist.H20, adjusted to pH 7.4 with HCI and made up to 1 litre.
5.10.2 Method
Following Tris-Tricine SDS-PAGE of affinity purified 40 kDa IBDV receptor protein as
described in Section 2.4.4., the gel was incubated in renaturation buffer for 1 h at room
temperature. At 15 min-intervals the buffer was removed and fresh buffer added. The Bio-Rad
blotting equipment was assembled as described in Section 2.10.2 and the gel was blotted for 4 h at
400 mA in carbonate blot buffer. After blotting, detection of the 40 kDa IBDV receptor protein on
nitrocellulose membrane was carried out using the anti-IBDVR-l and IBDVR-2 antibodies as
described in Section 2.10.2.
5.11 Inhibition assay
In the present study to determine whether the anti-IBDV receptor peptide antibodies could block
IBDV binding to the receptor, an inhibition assay was performed on ELISA plate. A schematic
presentation of the ELISA is given in Fig. 5.10 (the Figure is placed in Section 5.12.5 to aid
interpretation of the results).
5.11.1 Materials
ELISA reagents as per Section 2.9.1
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Purified 40 kDa IBDV receptor protein from Section 4.4.2.2.
IBDV from Section 3.2.2.
5.11.2 Method
The purified 40 kDa IBDV receptor protein was coated (1 JLg/ml) in PBS (150 III per well, 4°C,
overnight). Non-specific binding of antibody was prevented by blocking the wells with 0.5%
BSA-PBS (200 JLI, 1 h, 37°C), and the plates were washed three times with PBS-Tween. Wells
were incubated with serial two-fold dilutions of anti-IBDV receptor peptide antibody (panel I),
IBDV (panel IT), IBDV + anti-IBDV receptor peptide antibody (panel III), non-immune rabbit
IgG (panel IV) and BSA-PBS (panel V) of step 2 (Fig. 5.10), starting from 100 Ilg/ml prepared on
the plate in 0.5% BSA-PBS and incubated (100 JLI, 2 h, 37°C). The plates were washed three times
with PBS-Tween. The wells were incubated with serial two-fold dilutions of IBDV (panels I and
IV), anti-IBDV receptor peptide antibody (panel IT) and PBS (panel III and V) of step 4 (Fig.
5.10), starting from 100 JLg/ml prepared on the plate in 0.5% BSA-PBS and incubated (100 JLI,
2 h, 37°C). The plates were washed three times with PBS-Tween. HRPO-linked secondary
antibody (goat anti-rabbit-HRPO-linked), at a suitable dilution (1 in 20 000 in 0.5% BSA-PBS)
was added to each well and incubated (120 Ill, 1 h, 37°C). Following washing three times with
PBS-Tween, substrate solution (150 JLl) was added to each well and colour was allowed to
develop in the dark against the background of the controls (usually 10-15 min) and the ~05 of
each well was measured in a Titertek ELISA plate reader.
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5.12 Results
5.12.1 Epitope mapping of putative IBDV receptor peptide sequences
Epitope mapping of the two peptide sequences of the 32 kDa bursal receptor protein was carried
out using Predict? to determine regions of hydrophilicity, flexibility, surface probability and
antigenicity (Fig. 5.6).
Peptide sequence one (IBDVR-l) appeared to be more immunogenic than IBDVR-2. The
IBDVR-l sequence (Fig. 5.6 A) showed the highest degree ofhydrophilicity, surface probability,
flexibility and antigenicity towards its N-terminus, thereby suggesting that the N-terminus is more
immunogenic. Conjugation to the carrier protein would thus be done via the C-terminus. The
IBDVR-2 sequence (Fig. 5.6 B) appeared not to be very immunogenic overall, but slightly more
hydrophilic and antigenic at the N-terminus. The peptide had almost the same values of flexibility
both at its N-and C-termini. The only parameter that had higher values at the C-terminus was
surface probability, but the peptide was nevertheless coupled to the carrier protein via its C-
terminus. Since these peptides were immunogenic towards their N-terminal, an extra cysteine
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Figure 5.6 Epitope prediction plots for the 32 kDa mnv receptor protein peptide sequences (N-terminal
sequencing done by Edwards, 2000). (A) Sequence IBDVR-I, KHlEDGYNPGASIGYF and (B) Sequence
IBDVR-2, NLADFMAQYPATN. The parameters plotted are: hydrophlicity (+), surface probability ( ),
antigenicity (x) and flexibility (.).
5.12.2 Evaluation of anti-IBDV receptor peptide antibody production
To assess the production of anti-peptide antibodies against the peptide sequences of the IBDV
receptor protein in rabbits, ELISAs (Section 2.9.2) were used to monitor antibody production by
titrating test antibodies against the free peptides coated as antigens. Although two rabbits were
used for each peptide, but due to their close similarity in antibody response to the same peptide,
the response of only one rabbit per peptide is shown. In the present study only antibodies from
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week zero and nine were monitored because all the rabbits died before further blood samples were
taken. The ELISA result showed that antibodies were produced in rabbits against IBDVR-l (Fig.
5.7 A) and IBDVR-2 (Fig. 5.7 B) when compared to non-immune antibody production. Although
IBDVR-2 appeared to be less immunogenic than IBDVR-l when analysing using Predict7 (Fig.
5.6 B), almost the same antibody response was obtained as against IBDVR-l. Anti-IBDVR-l
antibodies appeared to have relatively higher reactivity to the peptide especially at low
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Figure 5.7 ELISAs monitoring titre of rabbit anti-mnV receptor peptide antibodies produced against
peptides corresponding to sequences in the mnv receptor protein. Microtitre plates were coated with
IBDVR-l (panel A) or IBDVR-2 (panel B) (5 tlg/ml in PBS, 4°C, overnight). Plates were incubated with serial
two-fold dilutions of week zero (.) and week 9 (.) antibodies. The concentration of the antibodies was
between 100 tlg/ml and 6.25 /lglml. Antibody binding was detected using goat anti-rabbit-HRPO-linked
antibodies and visualised with ABTSIH20 2 substrate. Absorbance values were read at 405 nm in a Titertek
ELISA plate reader. Each point is the average absorbance of duplicate samples.
5.12.3 Evaluation of affinity purified anti-IBDV receptor peptide antibodies
To evaluate the reactivity of affinity purified anti-IBDV receptor peptide antibodies against their
corresponding peptides, ELISAs (Section 2.9.2) were performed against the free peptides coated
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as antigens. The ELISA result showed that the affinity-purified anti-IBDV receptor peptide
antibodies appeared to have increased reactivity against the respective peptides (Fig. 5.8 A and B)
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Figure 5.8 Reactivity of affinity-purified anti-IBDV receptor peptide antibodies against peptides
corresponding to sequences in the IBDV receptor protein in ELISA. Microtitre plates were coated
with IBDVR-l (panel A) or IBDVR-2 (panel B) (5 ILg/ml in PBS, 4°C, overnight). Plates were incubated
with serial two-fold dilutions of non-immune (+) and affinity purified anti-IBDV receptor peptide
antibodies from week 9 (.). The concentration of the antibodies was between 100 ILg/ml and 6.25 ILg/ml.
Antibody binding was detected using goat anti-rabbit-HRPO-linked antibodies and visualised with
ABTSIHzOz substrate. Absorbance values were read at 405 nm in a Titertek ELISA plate reader. Each
point is the average absorbance of duplicate samples.
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An ELISA was also carried out to determine whether the affinity purified anti-ffiDV receptor
peptide antibody could recognise the whole ffiDV receptor protein. The affinity purified native
40 kDa mDV receptor protein was coated on an ELISA plate. The result showed that the anti-
ffiDVR-l antibodies recognised the native 40 kDa ffiDV receptor protein very well (Fig. 5.9 A)
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Figure 5.9 Recognition of native 40 kDa IBDV receptor protein using anti-ffiDV receptor peptide
antibodies in an ELlSA. Microtitre plates were coated with affinity purified 40 kDa mDV receptor protein
(1 Jlg/ml in PBS, 4°C. overnight). Plates were incubated with serial two-fold dilutions of affinity purified anti-
IBDVR-l (panel A) or IBDVR-2 (panel B) (-) or non-immune antibodies (.). The concentration of the
antibodies was between 100 Jlg/ml and 6.25 Jlg/ml in BSA-PBS. Antibody binding was detected using goat anti-
rabbit-HRPO-linked antibodies and visualised with ABTSIH20 2 substrate. Absorbance values were read at 405 nm
in a Titertek ELISA plate reader. Each point is the average absorbance of duplicate samples.
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5.12.4 Western Blotting
Western blot analysis was perfonned on the affInity purified IBDV receptor protein using affinity
purified anti-IBDVR-1 and IBDVR-2 antibodies. No reaction was observed. The western blot was
repeated using different concentrations of both the anti-IBDV receptor peptide antibodies and
IBDV receptor protein. The modified western blot procedure using the modified transfer buffer
and renaturation of proteins in the gel prior to electro blotting were done (Section 5.10.2), but no
reaction was observed.
5.12.5 Blocking of IBDV binding to its receptor using anti-receptor peptide antibodies
Anti-peptide antibody against the IBDV receptor protein was used to detennine whether the anti-
receptor peptide antibody could block viral binding to the receptor. To assess this an inhibition
assay was carried out in an ELISA fonnat. Diagrammatic presentations of the assays are given in
Fig. 5.10. An ELISA plate was coated with purified 40 kDa IBDV receptor protein (Fig. 5.10,
panel I). Wells were incubated with anti-receptor peptide antibody. This was followed by
incubation firstly with IBDV and secondly by goat anti-rabbit-HRPO conjugate (detection
antibody). The result showed that anti-receptor peptide antibody strongly blocked the binding of
IBDV to the receptor as evidenced by the high absorbance values (dark blue line, Fig. 5.11).
To ascertain whether IBDV could block ariti-receptor peptide antibody binding to the receptor,
IBDV receptor coated wells were incubated with IBDV (Fig. 5.10, panel IT). The wells were
incubated with anti-receptor peptide antibody followed by detection antibody. Lower absorbance
readings (pink line, Fig. 5.11) than those described above were recorded, suggesting that IBDV did
not completely block anti-peptide antibody binding to the receptor as anti-receptor antibody did
(dark blue line, Fig. 5.11).
In a further assay competition between anti-receptor peptide antibody and IBDV for binding to
the receptor was determined (Fig. 5.10, panel III). When compared to binding of anti-receptor
peptide antibodies to receptor (dark blue line, Fig. 5.11) there was a decrease in absorbance values
(yellow line, Fig. 5.11), indicating some degree of competition i.e. that some virus bound to
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receptor, thereby preventing anti-receptor peptide antibody binding. This result confirmed the
high affinity of the anti-receptor peptide antibodies for receptor. As a negative control wells were
incubated with non-immune rabbit IgG followed by IBDV and detection antibody (Fig. 5.10,
panel N). The result (light blue line, Fig. 5.11) showed that non-immune IgG did not affect IBDV
binding to the receptor and that the effects seen in the above assays were not due to non-specific
binding of rabbit IgG to the receptor. A second control was also included to determine whether
the HRPO-linked detection antibody recognised the IBDV receptor protein non-specifically (Fig.
5.10, panel V). No signal was observed (green line, Fig. 5.11).
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Figure 5.10 Schematic representation of blocking mnv binding to mnv receptor using anti-receptor
peptide antibodies in an ELISA. Symbols next to panel numbers refer to those used in Fig. 5.11 depicting the
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Figure 5.11 Blocking of mnv binding to its 40 kDa receptor protein using anti-receptor peptide
antibody. Mfinity purified native 40 kDa mDV receptor protein was coated onto microtitre plates (1 JLg/ml in
PBS, 4°C, over night). The wells were incubated with serial two-fold dilutions of anti-receptor peptide
antibody (+), mDV (.), anti-receptor peptide antibody + mDV ( ), non-immune IgG (x) and BSA-PBS
(e). The wells were then incubated with serial two-fold dilutions ofmDV (+), anti-receptor peptide antibody,
(.), PBS ( ), mDV (x) and PBS (e). Antibody binding was detected using goat anti-rabbit-HRPO-linked
antibodies and visualised with ABTSIHzOz substrate. Absorbance values were read at 405 nm in a Titertek
ELISA plate reader. Each point is the average absorbance ofduplicate samples.
5.13 Discussion
In this chapter evaluation of the immunogenicity of IBDV receptor peptides was done. This was
followed by conjugation of the peptides to a carrier protein and production of anti-IBDV receptor
peptide antibodies in rabbits. To determine the reactivity of the anti-IBDV receptor peptide
antibodies before and after affinity purification, ELISAs were carried out by immobilising the
antigenic peptides to microtitre plates. Western blotting was also included to determine the
specificity of the antibody to the IBDV receptor protein transferred to the nitrocellulose
membrane. An inhibition assay was done in an ELISA format to determine whether the anti-
IBDV receptor peptide antibodies could block IBDV binding to the receptor, thereby giving
further evidence that the receptor isolated in the present study is specific for IBDV.
Immunogenicity was evaluated usmg hydrophilicity, flexibility, antigemcIty and surface
probability parameters (Van Regenmortel et al., 1988) of the amino acid sequences obtained in a
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previous study in this laboratory (Edwards, 2000). These values were determined usmg a
computer program for ,prediction of protein antigenic determinants from amino acid sequences,
Predict7 (Carmenes et al., 1989). All the above parameters are related to accessibility at the
surface of the molecule. Since antibodies bind to the surface of proteins it is expected that
epitopes would tend to consist of residues exposed at the protein surface (Schulze-Gahmen et al.,
1986; Van Regenmortel et al., 1988).
Procedures in anti-peptide antibody production usually recommended conjugation of peptides to
carrier molecules since they are assumed to be too small to be immunogenic by themselves
(Richman and Reese, 1988). For this reason peptides were conjugated to RSA via MBS. The
possibility of antibody production in rabbits using RSA as carrier protein was explored.
According to many authors one of the criteria for a successful carrier molecule is the potential for
immunogenicity (Hermanson, 1996). However, the use of self-proteins as carriers in antibody
production to minimise antibody production against the carrier has been reported (Posnett et al.,
1988). It is thought that this directs the immune response principally toward the hapten, rather
than the carrier (Hermanson, 1996). Using this strategy in the present study good antibody
production against the peptides was obtained. However, tests should have been done to determine
antibodies recognition of RSA in an ELISA. Although not specifically tested, no antibody
production against the carrier is suspected. In a parallel study in this laboratory, using rabbit (X2-
macroglobulin complexed with a protease antigen to produce anti-protease antibodies in rabbits,
no antibodies were produced against az-macroglobulin (Laura Huson personal communication).
Coupling of peptides to carrier proteins has a marked effect on the antigenic determinants of a
peptide. It appeared that conjugation of peptides to a carrier with carbodiimide results in linkage
between carboxylic side chains and amine groups (Posnett et al., 1988). Richman and Reese
(1988) reported that conjugation of a helical peptide to KLH had altered its native structure
sufficiently that the antibodies raised against this conjugated peptide were unable to recognise the
corresponding protein structure. Furthermore, destruction of epitopes had also been evident in the
glutaraldehyde conjugation of a tobacco mosaic virus peptide to bovine serum albumin.
Conjugation by means of a terminal cysteine, is among the least intrusive coupling methods
(Posnett et al., 1988). Because of its ability to avoid modification of internal lysines in the
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peptide, the thiol coupling method is preferable to use (Field et aI., 1998). Peptides were therefore
conjugated to RSA by means of a C-terminal cysteine via MBS.
In the present study antibodies were produced against both peptides although IBDVR-2 appeared
to be non immunogenic according to the Predict7 immunogenicity analysis. This result suggests
that with careful synthesis, coupling, dosage and immunisations, most sequence might be used to
induce antibodies specific for the peptide itself. Secondly, conjugation with the carrier protein
may modify determinants of the peptide sequence sufficiently to enhance immunogenicity
(Posnett et al., 1988).
Since the peptide usually represents only a minor fraction of the total molecular weight of the
peptide-carrier conjugate, the antibodies of interest may represent only a minor fraction of the
total amount of antibodies produced, depending on the immunogenicity of the carrier protein
(Posnett et al., 1988). Thus affinity purification was needed to purify the antibody of interest by
immobilising the antigenic peptides to the affinity column. In principle, only antibodies against
the peptide and not against the carrier should bind to the column. However, sometimes-unwanted
antibodies, such as aldehyde and polyreactive antibodies, do bind (Danbolt et al., 1998). To
determine the success of·affinity purification, ELISAs were done using affinity purified
antibodies. The affinity purified anti-IBDV receptor peptide antibodies showed an increased
reactivity with the peptides compared to non-affinity purified anti-IBDV receptor peptide
antibodies.
Affinity purified anti-IBDVR-l antibodies recognised the whole IBDV receptor protein in an
ELISA, but recognition by anti-IBDVR-2 antibodies was very weak. Recognition of the whole
protein depends on the region of the protein where the peptides are from i.e. if the chosen peptide
is buried within the protein, the resulting antibody may not recognise the native protein (Field et
al., 1998). The present result matches with this report, because according to Predict7 epitope
mapping, IBDVR-2 showed very low values ofhydrophilicity, flexibility, antigenicity and surface
probability, which are the characteristic features of amino acids buried within the native structure
of globular proteins (Van Regenmortel, 1988). This might be the reason why the anti-IBDVR-2
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antibodies were not able to recognise the native 40 kDa IBDV receptor protein in an ELISA
where the immobilised protein retains at least part of its native conformation.
Neither of the anti-IBDV receptor peptide antibodies recognised the 40 kDa IBDV receptor
protein on a nitrocellulose membrane. The reasons for non-reactivity in the western blot could be
two-fold. The reducing buffer in SDS-PAGE containing SDS and 2-mercapthethanol may have
denatured the epitopes of the receptor protein, or transfer of the receptor protein from the gel to
the nitrocellulose membrane could have been incomplete. Receptor proteins on the blot are
denatured and conformationally restrained, which may inhibit many protein-protein interactions
(Premont and Hall, 2002). This was supported by the finding that an epitope important in IBDV
neutralisation was destroyed by treatment with SDS (Fahey et aI., 1989). In their study several of
the IBDV neutralising monoclonal antibodies failed to react on western blots with viral proteins
separated by SDS-PAGE.
The state of folding of proteins is particularly important when monoclonal antibodies, which
recognise only a single epitope, are used, because many antibodies recognise assembled
topographic determinants, which do not exist on denatured proteins (Dunn, 1986). This may also
be applicable to anti-peptide antibodies. There have also been incidences where isolated proteins
of low or moderate molecular weight do not electro-elute efficiently from a gel. Such proteins
may be fortuitously at their isoelectric point, consequently have no tendency to migrate in the
electric field exerted (Gershoni and Palade, 1983). There is also a possibility that certain classes
ofproteins do not bind to nitrocellulose (Towbin et al., 1979).
Sodium oligooxyethylene dodecyl ether sulfates (DESs), with oxyethylene units of more than four
has been found not to cause denaturation of bovine serum albumin. If a protein binds such a
detergent, the protein is expected to be efficiently electrophoresed in the presence of the detergent
retaining its native structure. This may be worthwhile exploring for analysis or separation of
membrane proteins without denaturing them. However, DES is prohibitively expensive (Koide et
al., 1987). In addition an attempt was made to retain the native structure of the receptor protein by
renaturation. Because protein renaturation prior to blotting can enhance recognition of antigen by
some antibodies, a much larger effect can be obtained by transferring the proteins in a more
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alkaline blotting buffer without SDS (Dunn, 1986). However, no result was observed in the
present study.
The inhibition assay showed that anti-IBDV receptor peptide antibodies successfully blocked the
binding of IBDV to its receptor protein on the surface of bursal cells. However, in a parallel assay,
despite the fact that IBDV interfered with the binding of the anti-IBDV receptor peptide
antibodies to the receptor, the inhibition was not strong enough to block anti-IBDV receptor
peptide antibodies binding to the receptor entirely. This result suggests that the binding of IBDV
to the receptor was not as effective as the binding of anti-IBDV receptor peptide antibody to the
receptor. This could be due to the effects of CsCl during IBDV isolation, as CsCl appeared to
affect the stability of viruses during the purification procedure. Chen and Ramig (1992) reported
that some viruses such as human rotaviruses appear to lose their outer capsid during CsCI gradient
centrifugation.
A competition assay done to determine the affinity of anti-IBDV receptor peptide antibodies and
IBDV for the IBDV receptor protein also suggested that the anti-IBDV receptor peptide
antibodies had higher affinity for the receptor than for IBDV. To show that the binding of anti-
IBDV receptor peptide antibodies to the IBDV receptor is specific, non-immune rabbit IgG was
used instead of the anti-peptide antibody but no blocking of IBDV binding to the receptor was
observed. A second negative control was included to make sure that there was no non-specific
interaction between the IBDV receptor protein and the secondary (detection) antibody (goat-anti-
rabbit-IgG-HRPO linked) and no interaction was evident.
The anti-IBDV receptor peptide antibodies raised in rabbits recognised the corresponding peptide
sequence and the native IBDV receptor protein in an ELISA tests. Results of the inhibition assay
showed that anti-IBDV receptor peptide antibodies blocked IBDV binding to the receptor. In the
same assay the affinity of the anti-IBDV receptor peptide antibodies appeared to be higher than
that of IBDV. These results suggest that this may indeed be the IBDV receptor, because




Infectious bursal disease virus is the prototype member of the Avibirnavirus genus III the
Birnaviridae family. It causes considerable economic losses to the poultry industry worldwide
and represents a major hazard for various species of wild birds (Caston et al., 2001). IBDV has a
tropism for lymphoid tissue of chickens and infects actively dividing and differentiating B-
lymphocytes in the bursa of Fabricius. When the infection is not fatal it causes severe
immunosuppression and increased susceptibility to secondary infections (van den Berg et al.,
2000). Currently the most effective method for IBDV control is vaccination, using either
attenuated live or inactivated IBDV vaccines (Juul-Madsen et al., 2002). These commercial
IBDV vaccines are selected based on their ability to induce a strong antibody response (Kim et
al., 2000). Identification of the IBDV receptor protein on the surface of bursal cells may help to
understand the molecular mechanism of IBDV infection and facilitate the design of antiviral
agents that can interfere with IBDV binding prior to crossing the bursal membrane.
The IBDV genome is made up of two segments of double-stranded RNA; segment A (3.2 kb) and
segment B (2.8 kb). Both segments are confined within a single-shelled icosahedral capsid of
60 urn in diameter. Segment A contains two partially overlapping ORFs. The first ORF encodes
VP5 (17 kDa), which is a non-structural protein, whose functional properties are unknown,
although it appears to be important in virus release and dissemination. The second ORF encodes
for a 110 kDa polyprotein that is autoproteolytically cleaved into three structural proteins of the
mature virion, namely VP2 (42 kDa), VP3 (32 kDa), and VP4 (28 kDa) (Boot et al., 2000b).
Biochemical analysis of purified capsids from virions revealed that VP2 and VP3 are the major
structural proteins of the virus, while VP4, a serine-lysine protease is involved in the proteolytic
maturation of the polyprotein (Birghan et al., 2000). VP2 contains major neutralising epitopes,
suggesting that it is at least partly exposed on the outer surface of the capsid. While VP3 contains
a very basic carboxy-terminal region, which is likely to interact with the packaged RNA, it is
believed to be on the inner part of the capsid (Caston et al., 2001). This analysis strengthens the
hypothesis that VP2 is the major host protective antigen of IBDV (Lin et al., 1993). Segment B
contains an ORF that encodes VPl (95 kDa), which is assumed to be the RNA-dependent RNA
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polymerase that is responsible for the reactions of transcription and replication (Caston et al.,
2001).
Although live and inactivated IBDV vaccines are highly efficient, the effectiveness of these
vaccines decreases in the presence of maternal antibodies, and some of them cause bursal atrophy
because of lymphoid cell depletion. In recent years, the emergence of new virulent strains, cost
considerations and risk of reversion to virulent forms have resulted in the effectiveness of live
and killed vaccines being reduced (Ho et al., 1999). Therefore, highly efficacious and safe IBDV
vaccines are needed (Tsukamato et aI., 2002).
Although several studies have been conducted on VP2 and VP3 for use in vaccines, success has
only been obtained in vitro. In the present study a different avenue was investigated to prevent
infection, i.e. one based on interfering with the binding of IBDV to the host receptor proteins.
Since cellular receptors play a crucial role in virus pathogenesis, the identification of the receptor
is necessary to understand host range, tissue tropism, pathogenesis, penetration, virus replication
and the disease symptoms produced by the virus (Wang et al., 1991; Kim et al., 2002). Thus
antiviral strategies can be evaluated based on these events (Nieper and Muller, 1998). In order to
prove this hypothesis, information needed to be gathered on the IBDV receptor proteins on the
surface of bursal cells that IBDV binds to. Previous work in this laboratory identified two
possible IBDV receptor proteins on the surface of bursal membranes of 32 and 40 kDa. N-
terminal amino acid sequencing of the 32 kDa receptor protein and a Lys-C digestion product
was conducted and this provided data to start the present study (Edwards, 2000). The nucleotide
sequence coding for this protein was shown to be present in the chicken genome (Edwards,
2000). The difference in size between the PCR products obtained from PCR and RT-PCR in the
latter study could possibly be due to the presence of an intron, which are only present in
eukaryotic DNA and this suggested that the proteins sequenced were most likely of chicken
origin.
The objective of the present study was to isolate IBDV receptor proteins .from the surface of
bursal cells, prepare anti-peptide antibodies against the receptor sequence previously determined
and use the antibodies to prevent IBDV binding to the putative receptor to prove its identity. As
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an adjunct to this part of the study, methods for IBDV detection were also evaluated. To this end
IBDV was isolated from infected bursal tissue using CsCI density gradient centrifugation and its
isolation was analysed using Tris-Tricine SDS-PAGE and electron microscopy. In addition to
electron microscopy, several methods can be used for the detection of IBDV; such methods
include: virus isolation in cell culture, embryonated chicken eggs, or young specific-pathogen-
free (SPF) chickens, immunofluorescent staining technique, agar gel precipitation, antigen
capture ELISA, or immunohistochemistry. However, these methods are time consuming, labour
intensive, expensive, or non-specific. Besides they lack the ability to detect low levels of IBDV
antigens in tissues (Barlic-Maganja et al., 2002). Thus a highly sensitive and specific method was
required for diagnostic purposes.
In the present study Titan® one-tube RT-PCR was carried out on the purified double stranded
viral RNA and commercially available live IBDV vaccines after the double stranded RNA was
isolated. For most viral diagnosis, the optimum sites for PCR primers are within sequences that
are unique to the viral genome among all isolates or strains of the virus (Wu et al., 1992). Thus
the primers were selected from the highly conserved VP2 genome region of IBDV for the
amplification of the VP2 protein gene and conditions were optimised for the RT-PCR reaction.
The sequence of primer 1 (anti-sense primer) was 5' - CAA CAG TGT AGT CTC TeC CG -3'
and the sequence of primer 2 (sense primer) was 5'- AGA TGT TTG CTG TCA TTG AAG G-
3'. The inter primer spacing for primers 1 and 2 was 110 base pairs. This set of primer specified a
ISO-base pair sequence located at nucleotide position 1760 to 1910 of the IBDV genome (Wu et
al., 1992).
The one-step RT-PCR procedure was used for reverse transcription of IBDV RNA into cDNA
and then amplification by PCR under a single set of conditions. Using this technique it was
possible to detect as little as 2 ng!JlI of viral RNA from infected bursal tissue by ethidium
bromide staining after 40 cycles of PCR. This powerful and sensitive technique is based on the
principle that IBDV RNA is transcribed into cDNA and the DNA is amplified exponentially by
repeating cycles of heat denaturation, annealing, and primer extension (Barlic-Maganja et al.,
2002). Because of the minimum hands-on work and low possibility of contamination, Titan® one
tube RT-PCR was preferred over the regular RT-PCR technique (Barlic-Maganja et al., 2002).
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The presence of the virus was demonstrated by the amplification of a 150 bp band as visualised
on 2% agarose and 15% nondenaturing PAGE gels. This product was proved to be correct by
restriction digestion with a specific restriction endonuclease, BamHI. This enzyme recognised the
duplex symmetrical sequence and cleaved the product between the guanines to produce digestion
fragments of the correct size, of93 and 57 bps (Hensley et al., 1990). Due to the small size of the
amplified PCR product (150 base pairs) and restriction digestion fragments (93 and 57 bps) the
resolution of the products in a 1% (w/v) agarose gel was very poor. Thus for higher resolution of
these bands an increase in gel percentage to 2% (w/v) was needed. Although it was possible to
detect the bands on a 2% (w/v) gel, the resolution was still not optimal. Also, because of the
higher gel concentration it was difficult to prepare gels since they tended to polymerise before
pouring or insoluble agarose granules appeared on the gel, which could affect the mobility of the
products. These problems were resolved by using a 15% nondenaturing polyacrylamide gel,
although it was time consuming (16 h electrophoresis).
Live vaccines were used in the present study for RT-PCR amplification of the VP2 sequence. The
smearing of the amplified band observed in agarose or polyacrylamide gels could be due to
contaminating chicken RNA since the vaccine virus is propagated in allantoic fluid.
Infectious bursal disease virus was attached to a Seph"arose 4B chromatography matrix for
affinity purification of the viral receptor protein from uninfected bursal membranes. In the
previous study in this laboratory, Edwards (2000) isolated 40 and 32 kDa IBDV receptor proteins
whereas, in the present study the isolated IBDV receptor protein showed two prominent bands of
40 kDa (Chapter 4).For the visualisation of the IBDV receptor protein the same gel system (Tris-
Tricine SDS-PAGE) and percentage (10%) was used as was reported by Edwards (2000). This
receptor protein was recognised in an ELISA by the anti-peptide antibodies prepared using the
32 kDa receptor protein sequences determined in the previous study (Chapter 5). These results
suggest that the 32 kDa receptor protein could be a fragment of the 40 kDa IBDV receptor
protein. This fragmentation could be the result of 2-mercaptoethanol, SDS and heating during
preparation for Tris-Tricine SDS-PAGE. According to Edwards (2000) there is no sequence
overlaps between the N-terminally sequenced 40 and 32 kDa proteins of the bursal membrane
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proteins. However, this was very difficult to conclude, because the peptide sequence, especially
of the 40 kDa, was very short. Sequence overlaps might have been obtained in relatively longer
sequences. Thus, in further studies, more IBDV receptor proteins could be purified for N-
terminal amino acid sequencing to provide a longer sequence to determine the sequence overlap
of the receptor protein with the N-terminally sequenced 32 kDa protein.
In order to multiply, a virus must first infect a cell. The host range of a particular virus defines
both the type of tissue, and the animal species that the virus infects. To infect a cell, the virion
must attach to the cell surface, penetrate the cell and become sufficiently uncoated to make its
genome accessible to the host machinery. for transcription and translation. The attachment step
constitutes specific binding of a viral protein (anti-receptor) to a constituent of the cell surface
(receptor) (Kim et al., 2002). It seems very promising to interfere with the viral attachment stage
before the virus crosses the membrane barrier.
In the present study IBDV appeared to have two prominent receptor bands around 40 kDa.
However, a number of viruses use more than one distinct attachment receptor, such as HN that
uses CD4 as its main attachment receptor but also interacts with glycolipid galactosyl ceramide
to mediate infection (Kim et al., 2002). Thus, from a prophylaxis point of view, having a single
membrane receptor protein may be an advantage over multi-receptors,because it will be difficult
to block multi-receptor sites (Varthakavi and Minocha, 1996). Blocking this receptor protein
will potentially inhibit IBDV binding and subsequent multiplication (infection). Two of the most
commonly used therapies in blocking of virus-receptor interactions are either anti-receptor
antibodies or soluble receptors. Furthermore, other chemicals or pharmacologies could be
developed that specifically block virus binding either at the level of the cell receptor or the viral
attachment protein (VAP) (Bass and Greenberg, 1992). Kim et al. (2002) reported that a
polyclonal antibody against the 30 kDa Hantaan virus receptor protein blocked binding of
Hantaan virus to Vero-E6 cells and reduced virus infection by 70%.
Anti-IBDV receptor peptide antibodies were raised in rabbits against two IBDV receptor protein
sequences. ELISA results confirmed that the anti-IBDV receptor peptide antibodies recognised
the peptide sequences and the isolated 40 kDa IBDV receptor protein. However, the ELISA
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response for the isolated 40 kDa IBDV receptor protein is about 60% that of the peptide sequence
(this percentage was taken from the absorbance reading at concentration of 25 ,ug/ml). This
difference in recognition by the anti-IBDV receptor peptide antibodies could be due to (1)
impurities in the isolated 40 kDa IBDV receptor protein preparation, or (2) some of the amino
acid residues in the peptide sequence could be buried in the native IBDV receptor protein.
Further evidence that the anti-IBDV receptor antibodies probably recognIse the native
conformation of the receptor were given by the results of the inhibition of virus binding assays
and the western blot (no recognition, see below). The inhibition assays showed that the anti-
IBDV receptor peptide antibodies effectively blocked the binding of IBDV to the receptor and
thus recognise the native receptor conformation. The competition assay also proved that anti-
IBDV receptor peptide antibodies had higher affinity for the receptor than for IBDV. In addition,
inhibition of IBDV binding by the anti-IBDV receptor peptide antibodies was confirmed to be
specific, when inhibition of IBDV binding with non-immune rabbit IgG showed no inhibition.
These results strongly suggest that the IBDV receptor isolated here is indeed a receptor for
IBDV. For more structural and functional studies IBDV receptor could be purified using the anti-
IBDV receptor peptide antibodies as a ligand in the affinity column.
In contrast to the ELISA result, the anti-IBDV receptor peptide antibodies did not recognise the
40 kDa IBDV receptor protein in a western blot. This may be due to epitope denaturation of the
receptor protein either by SDS or 2-mercaptoethanol in the reducing treatment buffer used for
SDS-PAGE (Premont and Hall,.2002). There was also a possibility of denaturation by detergents
such as Na-deoxycholate used during the affinity purification of this receptor protein (Hannam et
al., 1998). To avoid these complications an attempt was made to retain the native structure of the
receptor protein by renaturation. It was suggested that protein renaturation prior to electro-
blotting can improve recognition of antigen by some antibodies (Dunn, 1986). According to
Dunn (1986) the use of glycerol in the renaturation buffer enhanced the binding of antibody to all
the ATPase subunits of Escherichia coli, suggesting this would be useful for other protein
antigens. Moreover, incubation of the gel in renaturation buffer and blotting using bicarbonate
buffer could improve retention of smaller proteins on the nitrocellulose membrane and enhance
folding of the proteins into conformations that more closely resemble the native state of the
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protein. However, no recognition of the IBDV receptor protein was obtained using the anti-IBDV
receptor peptide antibodies, suggesting that these attempts at renaturation were not successful.
Normally, most of the viral receptors did not evolve to serve as viral receptors, but they may
have specific biological functions for the host cells. The biological function of the 40 kDa IBDV
receptor protein on the surface of bursal cells is not yet known. However, some of the receptors
that have been identified so far are cell surface molecules of known biological functions,
including the CD4 molecule for the binding ofHN (Adlish et al., 1990; Thaker et al., 1994). The
outcome of the inhibition studies suggests that IBDV infection could be reduced by blocking the
IBDV receptor site using anti-IBDV receptor peptide antibodies, but the effect on the natural
function of the rceptor will have to be evaluated.
The study could also be directed towards the viral attachment protein (VP2) by sequencing VP2
and raising anti-peptide antibodies in rabbits against VP2. The effectiveness of IBDV inhibition
by anti-IBDV receptor peptide antibodies can be compared with that by the anti-VP2-peptide
antibody at electron microscopy level using immunofluorescent techniques. Since the IBDV
receptor protein could have its own biological function, like CD4 as HN receptor, blocking the
receptor using anti-receptor peptide antibody in vivo could affect the biological function of the
receptor. Thus it would be more convenient to think of blocking the VP2 from binding to the
receptor using anti-VP2 peptide antibodies. Alternatively, the use of virus as a vector to carry the
genes for VP2 can be investigated. This would involve inserting the gene encoding VP2 (against
which protective responses are generated in the host) into the genome of an avirulent virus. The
virus would multiply and present the viral epitope/antigen to the immune system of the chicken.
The chicken would mount both a humoral and a cell-mediated immune response to it (Murphyet
al., 1999). Using single proteins displaying immunodominant epitopes as vaccines induces
effective protective immunity and eliminates the risk of viral replication in the host due the
absence of genetic material (Hansson et aI., 2000).
In conclusion, a 40 kDa IBDV receptor protein on the surface of bursal cells was isolated. The
anti-IBDV receptor peptide antibodies effectively blocked the binding of IBDV to the receptor.
The results presented in this study could provide an insight for further studies into the
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development of effective IBDV infection controls. Control could be based on interfering with
virus-receptor interaction. These include either the use of viral attachment protein (VP2) as a
subunit vaccine or production of antibodies against covalently crosslinked complexes of soluble
IBDV receptor protein and VP2 to interfere with virus receptor attachment.
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